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Preface
Globally, there is a continuous concern for research and development of alloys 
for medical and biomedical applications. The goal is to improve both the classic 
technologies of implant implementation and the technologies of synthesis of the 
biomaterials from which they are executed, with a final aim to promote a new 
generation of multifunctional implants with long-term performances. 
Biomaterials have been used for several thousand years by ancient cultures in Egypt, 
Babylon, Greece, Italy, China, and Central and South America to replace different parts 
of the human bone system. These materials were used and developed before coining 
of the modern term “biompatibility,” which was introduced about 60 years ago when 
researchers began to study and develop this field.
Biomaterials must be biocompatible, meaning they must be non-toxic and not release 
ions so that they can be tolerated by the human body for long periods of time (decades). 
They must also have certain mechanical properties, including mechanical stability 
depending on the application in which they are used, and they must resist demands 
and not break or deform excessively over time. Finally, biomaterials require efficiency, 
that is, they must be reliable, accessible, cost-effective, easy to process, and sterile. 
Considering all this, when obtaining biomaterials, raw materials of high purity are 
selected and the influence of the alloying elements must be studied. 
The global biomaterials market is constantly growing due to an increasing population that 
is susceptible to diseases, such as cardiovascular, dental, orthopedic, and neurological 
conditions. Expansion and improvement of the market are necessary to improve the 
health of patients and extend the duration of use of biomaterials in the human body.
This book provides an overview of biomaterials science with a focus on health and 
medical applications that can be improved with new biomaterials with non-allergenic 
elements. These materials are designed to meet functional requirements and  overcome 
the disadvantages of classical alloys used as biomaterials in human tissue.
Over seven chapters, this volume explains the problems created by classical alloys and 
examines how the new generation of biomaterials helps both doctors and patients. What 
is remarkable for the domain of biomaterials is the evolution and substantial efforts that 
have been made every day for constant improvement.
This book is designed for students, doctors, patients, and researchers worldwide. 
Petrică Vizureanu (Academic editor)
Gheorghe Asachi Technical University of Iași,
Romania
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Biomedical Implants for 
Regenerative Therapies
Andrea Domingues Goncalves, Wendy Balestri  
and Yvonne Reinwald
Abstract
Regenerative therapies aim to develop novel treatments to restore tissue 
function. Several strategies have been investigated including the use of biomedi-
cal implants as three-dimensional artificial matrices to fill the defect side, to 
replace damaged tissues or for drug delivery. Bioactive implants are used to 
provide growth environments for tissue formation for a variety of applications 
including nerve, lung, skin and orthopaedic tissues. Implants can either be 
biodegradable or non-degradable, should be nontoxic and biocompatible, and 
should not trigger an immunological response. Implants can be designed to 
provide suitable surface area-to-volume ratios, ranges of porosities, pore inter-
connectivities and adequate mechanical strengths. Due to their broad range of 
properties, numerous biomaterials have been used for implant manufacture. To 
enhance an implant’s bioactivity, materials can be functionalised in several ways, 
including surface modification using proteins, incorporation of bioactive drugs, 
growth factors and/or cells. These strategies have been employed to create local 
bioactive microenvironments to direct cellular responses and to promote tissue 
regeneration and controlled drug release. This chapter provides an overview of 
current bioactive biomedical implants, their fabrication and applications, as well 
as implant materials used in drug delivery and tissue regeneration. Additionally, 
cell- and drug-based bioactivity, manufacturing considerations and future 
trends will be discussed.
Keywords: biomaterials, bioactive biomedical implants, stem cells, drug delivery, 
manufacturing
1. Introduction to bioactive implants
Implants are man-made devices that are fabricated for the implantation inside 
body to replace or support a biological structure, together with delivering drugs and 
monitoring body functions. They can remain in the body temporarily or perma-
nently [1]. To date, biomedical implants are used not only as sensory devices [2]; 
brain and neural devices including neuronal, cochlear and retinal implants [3, 4]; 
subcutaneous implants [5]; cardiovascular devices such as vascular grafts, stent, 
heart valves, pacemakers [3]; sutures and wound dressings [6]; spinal [7] and den-
tal implants [8]; cosmetic [9] and structural implants [10] including rods, braces, 
craniofacial, hip and knee replacements; but also as ophthalmic devices including 
glasses and contact lenses as well as insulin delivery devices [6].
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In recent years, scaffolds made of synthetic or natural polymers were developed to 
regenerate damaged or deteriorated tissues, or to deliver drugs to specific locations. 
Scaffolds are three-dimensional (3D) structures that mimic the native extracellular 
matrix (ECM) of tissues and provide a substrate for cell adhesion and proliferation.
These biomedical implants can be made of bioactive materials. The term “bioac-
tive” means that a material can affect its surrounding tissue biologically. Scaffolds 
can include molecules that promote a biological response in the region where they 
are implanted. Moreover, cells can be included in these scaffolds to promote healing 
and regeneration, as they naturally secrete growth factors and cytokines [11].
The risks related to the surgery during the placement or removal of the implant 
include infection and implant failure. Also, inflammation reaction against the 
material or rejection needs to be taken into consideration [1]. Here, we report what 
it is known about bioactive biomedical implants, their desired properties and their 
applications, focusing on the techniques and materials used for their fabrication. 
We further provide an overview of cell-based and drug-based implants, implant 
manufacture and its considerations.
2. Biomaterials for implants in drug delivery and regenerative therapies
To assist native tissue regeneration or/and replacement, implants are made of 
biomaterials, which support cell and tissue growth through cell adhesion, prolifera-
tion and differentiation, prevent unwanted cell and tissue growth, tailor tissue 
response and prevent immunological responses [12].
Biomaterials have been used for controlled drug delivery systems, sutures and 
adhesives including biodegradable and non-biodegradable materials, cardiovascular 
grafts, reconstructive and orthopaedic implants, ophthalmic devices such as cor-
neas and contact lenses, and dental implants [13]. Various types of materials have 
been used to produce biomedical implants. These include bioceramics, polymers, 
metals and composites, which are further discussed below. Table 1 summarises 
current biomedical applications for biomaterials.
Application Material References




(vascular prostheses, artificial 
valves, stents, cardiac-assisted 
pumps, blood bags and catheters)
Polymers, metals and ceramics; polyurethane 
(PU); polyesters (PE); polybutesters (PBE); 
polypropylene (PP) and PTFE; stainless steel
[15–21]
Central nervous system and 
peripheral nervous system 
(scaffolds for nerve regeneration)
Polycaprolactone (PCL), silk, collagen [11, 22–26]
Orthopaedic applications (total hip 
replacement, hip arthroplasty, total 
knee arthroplasty, bone screws, 
orthodontic brackets and wires; 
bone fillers and scaffolds as bone 
replacements)
Chromium, cobalt, molybdenum, nickel, titanium 
and zirconium alloys, ultrahigh molecular 
weight polyethylene (UHMWPE), Ti-6Al-4V, 
ceramic-coated steels, stainless steel, copper; 
natural polymers like collagen, chitosan, alginates, 
synthetic polymers, ceramics like bioglasses, 
hydroxyapatite and beta-TCP; poly(l-lactic acid) 
(PLLA); poly(lactic acid), poly(lactic-co-glycolic 
acid) (PLGA), polycaprolactone (PCL)
[11, 12, 14, 
27–33]
Table 1. 
Examples of biomedical applications for currently used biomaterials.
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2.1 Bioceramics
Ceramics are chemically inert and possess low thermal and electric conductivity 
as well as physical properties, which make them a suitable material glass for bio-
medical implants [34, 35]. Bioceramics are osteoinductive and osteoconductive and 
possess mechanical properties like native bone. Their use as biomedical implants 
prevents the transmission of diseases and immunogenicity. To date, bioceramics are 
utilised for dental, periodontal, maxillofacial and orthopaedic applications [36]. 
In comparison to non-resorbable bioceramics, degradable ceramics exhibit lower 
mechanical strength. Their chemical and physical composition determines their 
biological response [37].
Ceramics produced from aluminium, zirconium and titanium oxides possess 
bending, tensile and compressive strength at least 3 times higher than natural 
bone and are used mainly for pin-type dental implants and root- and endosteal 
plate forms [38]. The first zirconia implants were reported in the 1970s. These 
implants exhibited the ability to integrate into bone tissue, accumulate less 
plaque and provide improved aesthetics compared to titanium implants [39, 40].  
Hence, titanium-zirconium alloys, also called Straumann Roxolid or Roxolit 
(TiZr1317), are often used as dental implants due to their enhanced mechani-
cal properties and osseointegrative properties that are often used as dental 
implants [41].
Calcium phosphate-based bioceramics such as tricalcium phosphate (TCP) 
are similar in chemical composition to the inorganic phase natural bone tissue. 
TCP exhibits better biodegradation, restorability and bioactivity in vivo than 
hydroxyapatite and is commonly used for orthopaedic, dental and maxillofacial 
applications. Complete resorption of orthopaedic implants fabricated from TCP 
was reported after up to 2 years in the rat tibia and for the formation of cancellous 
bone [42].
Amorphous or low crystalline hydroxyapatite (HAp) is bioactive and bioresorb-
able. The preparation of synthetic HA at high temperatures results in high crystal-
linity. Biodegradation and resorbability of HAp are very slow. HAp bioceramics are 
commonly used for small defects in the case of bone loss or fractures of the tibia, 
calcaneus and vertebra. HAp is not employed for load-bearing bone applications 
because of its poor mechanical properties. The modification of HAp with stron-
tium, magnesium and silicon ions resulted in enhanced mechanical and biologi-
cal properties [43]. Improved bioresorbability was achieved by zinc—[44] and 
 manganese—[45] substitution of HAp.
Dicalcium phosphates (DCP) are biodegradable ceramics composed of calcium 
phosphates and water. DCPs are widely added to material compositions to modify 
their physical properties. Dehydrated DCP is known as brushite, which is used in 
tibial plate and distal metaphysis bone fractures [46].
Historically, ceramics have been used as dental and orthopaedic implant mate-
rials. However, compared to other material classes, ceramics have not 
been used extensively as implant materials due to their limited load-bearing 
capacity [14].
2.2 Polymers
Polymers are macromolecules that consist of covalently bonded repeating units, 
which can be of the same (homopolymers) or different (co-polymers) molecule 
type [27]. A variety of natural and synthetic polymers are used as soft tissue trans-
plants, facial prostheses, denture, hip and joint replacements as well as medical 
adhesives, sealants and coatings [14].
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Polymers are commonly selected based on their physical characteristics, compo-
sition, and mechanical properties; how easily they can be modified and moulded; 
their heat and electric conductivity as well as their ability to integrate into and 
attach to native tissue [47].
2.2.1 Natural polymers
Natural polymers possess similar properties to native tissues. They are non-toxic 
and exhibit protein binding-sites and biochemical moieties that are important for 
tissue regeneration. However, natural polymers are often associated with immu-
nological reactions, low mechanical strength and degradation at body temperature 
limiting their usability [14].
One of the most commonly used natural polymers is collagen. More than twenty 
different collagens are known in connective tissues such as bone, tendon, skin, 
cartilage and ligaments of the ECM of different species. Collagen type I is the main 
component in bone, skin and tendon, whereas type II is found in articular cartilage. 
Because of its abundance in nature, its importance for tissue homeostasis and 
growth, collagen has been investigated as material for bone, cartilage, tendon, skin 
and blood vessel regeneration [11]. In the clinic, collagen is used for the generation 
of dermal tissue, neo-tissue formation and wound healing [14]. Further natural 
polymers are chitosan, hyaluronic acid, fibrin and silk.
Silk, or silk fibroin, is a naturally occurring polymeric protein produced by 
insects and worms. The protein content gives rise to silk’s biocompatibility and its 
high tensile strength making it an ideal biomaterial for biomedical applications as 
gels, sponges and films [11, 48–53]. Silk composites fabricated from silk-chitosan 
and silk-hydroxyapatite have been used to improve silk’s elasticity, degradation and 
porosity [54, 55].
Hyaluronic acid (HA), a non-adhesive glycosaminoglycan (GAG), occurs mostly 
in connective, epithelial, and neural tissue [56]. HA is commonly used as hydro-
gel for the regeneration of bone, cartilage and the vascular system and for drug 
delivery [11].
Chitosan is a biodegradable polysaccharide produced through partial deacety-
lation of chitin. Chitosan scaffolds exhibit similar properties to naturally occurring 
GAGs, leading to their bioactivity, and support cellular adhesion [11, 57]. It has 
been investigated as scaffold material in combination with collagen and HA, as well 
as PCL for bone, cartilage and nerve regeneration [11].
2.2.2 Synthetic polymers
Synthetic polymers were developed with tailored physical and chemical prop-
erties depending on the desired application to overcome limitations of natural 
polymers. Synthetic polymers are linear, branched or cross-linked depending on 
their molecular arrangement [58] and possess amorphous or crystalline struc-
tures [27]. In addition, synthetic polymers are cheaper in production and enable 
improved functionality [11]. Commonly used synthetic polymers are poly(lactic 
acid-co-glycolic acid) (PLGA), polyglycolic acid (PGA), polylactic acid (PLA), 
polycaprolactone (PCL) and poly-hydroxybutyrate (PHB) [11, 27, 59, 60].
PGA, PLA and PCL are used for sutures, interference screws, fixation plates 
for meniscal repair and craniomaxillofacial fixtures and 3D scaffolds. However, 
they are known to induce inflammatory responses and are limited in mechanical 
integrity and controlled degradation. Hence, metal/polymer composites  
such as Mg/PCL have been developed [27]. Biodegradable synthetic polymers  
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are chosen based on the required physical, chemical and mechanical material 
characteristics (Table 2).
2.3 Metals and alloys
Due to their mechanical properties, the ease of their processing and the pos-
sibility to sterilise them, metals and alloys are ideal materials for biomedical 
implants [34].
Metals are commonly used as load-bearing orthopaedic implants such as wires, 
screws, fixation plates, artificial joints for hips, knees, shoulders and ankles, as well 
as for dental, cardiovascular and craniofacial applications [14].
Novel magnesium alloys have been investigated for orthopaedic and cardiovas-
cular applications [84, 85]. Combining magnesium alloys with aluminium or rare 
earth metals improves their mechanical properties [86, 87]. However, the accumu-
lation of these elements is associated with neurotoxicity and hepatotoxicity [88]; 
hence, these alloys are not suitable for biomedical applications. Instead, extensive 
research is carried out to develop nontoxic magnesium alloys [89], such as Mg-Si 
and Mg-Sr alloys [90].
Titanium alloys are among the most commonly used metal alloys [91] due 
to their biocompatibility [92] and corrosion resistance [93]. Their composition 
Synthetic polymer Application References
Poly(l-lactic acid) (PLLA); poly 
(d-lactic acid) (PDLA)
Sutures, drug delivery, vascular grafts, bone 
screws, fixation pins, dermal filler for facial 
atrophy (Scultra™)
[11, 61]
Poly(lactic-co-glycolic acid) (PLGA) Drug delivery [11, 62]





Tissue regeneration [60, 64, 65]
Poly-para-dioxanone (PPD) Internal fracture fixation, medical implant as 
films, foams and moulded scaffolds
[47, 66, 67]
Low-density polyethylene (LDPE), 
high-density polyethylene (HDPE)
Total hip arthroplasty and treatment of 
osteolysis as polymer-ceramic composites; 
rhinoplasty surgery
[68–71]
Poly(methyl methacrylate) (PMMA) Orbital medical implants, rhinoplasty, 
cranioplasty, bone cement in hip joint 
replacement, dental implant for restoration and 
aesthetics
[72–76]
Polydimethylsiloxane (PDMS) Enclosing implantable electronic devices 
and sensors, medical implants, oesophagus 
substitutes, catheters, shunts, blood pumps and 
peacemakers
[77–80]
Polyamides (PA), e.g., nylon and 
nylon-composites
Sutures, fabrication of dentures; scaffold 
materials and nanofillers for bone regeneration
[81, 82]
Carbon nanotubes (CNT) and 
composites
Metal coatings for load-bearing musculoskeletal 
implants to improve surface porosity, reduce 
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and microstructure vary depending on their elemental composition [94]. The 
mechanical properties of B-titanium alloys have a Young’s modulus like bone 
but possess a low fatigue strength. Their mechanical properties can be enhanced 
through the addition of silicon dioxide, zirconium dioxide and Yttrium oxide. 
Furthermore, to increase their wear resistance, titanium alloys are surface treated. 
Pure titanium alloys are used in pacemaker cases, ventricular devices, implantable 
drug pumps, screws and staples in spinal surgery, dental implants and craniofacial 
implants. Ti-6Al-4V alloys are used in hip and knee replacements and dental 
implants. Due to the release of aluminium and vanadium ions, which can cause 
neurological conditions such as Alzheimer’s, Ti-6Al-4V alloys are not considered 
safe for long-term use. β-Titanium alloys substituted with stabilising elements like 
zirconium, tantalum and molybdenum are safer compared to Ti-6Al-4V [27], and 
alternative titanium alloys, vanadium free Ti-6Al-7Nb and Ti-5Al-2.5Fe, are being 
developed [95].
Titanium has become the material of choice for implants; however, com-
ponents of prosthetics are still manufactured from gold alloys, stainless steel, 
nickel-chromium alloys and cobalt-chromium alloys [35]. Cobalt chromium 
alloys enable the fabrication of customised grafts including subperiosteal 
implants. They are mainly composed of cobalt, chromium and molybdenum, 
which give rise to corrosion resistance and mechanical properties [96, 97]. 
Stainless steel alloys such as iron-chromium-nickel-based alloys are used as 
orthopaedic implants such as ramus blade, ramus frame, stabiliser pins and  
some mucosal inserts. Due to its nickel content, these alloys possess a low 
 corrosion resistance and induce immunological reactions in patients with nickel 
allergies [34, 38].
3. Implant properties
Implant materials should possess adequate chemical and physical properties  
to allow for host tissue infiltration and nutrient transport; biocompatibility to  
avoid immunological responses; and corrosion resistance, degradation and biore-
sorbability to enable normal cellular activity and controlled implant degradation 
[14, 27, 98]. In addition, temporary implants should possess a highly interconnected 
porous structure to allow cell migration and nutrient and waste transport, provide 
suitable surface topography to support cell adhesion and growth, as well as allow for 
the release of bioactive molecules if applicable [5, 11, 12].
Mechanical properties like Young’s Modulus, tensile, compressive and shear 
strength, yield strength and fatigue strength are required to ensure uniform stress 
distribution, to minimise the movement or fracture of the implant [34].
3.1 Surface properties
Surface properties influence cell adhesion and cellular and tissue responses. 
Surface tension determines the wettability by a wetting fluid, such as blood or 
water [11, 34]. Implant surfaces are also categorised by roughness, texture and the 
orientation of irregularities [38, 99]. The surface textures can vary from concave or 
convex. Concave surface textures occur due to additive treatments such as hydroxy-
apatite coatings, whereas convex surfaces are created through etching and blast-
ing. Furthermore, implant surfaces can either be isotropic, meaning that implant 
properties are independent from the measurement direction, or anisotropic, which 
means properties are directionally dependent [12, 34].
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3.2 Corrosion and degradation of implants
3.2.1 Metal corrosion
Corrosion is the involuntary breakdown of metals by an electrochemical reac-
tion and through the loss of ions from the metal surface in an acidic, an alkaline or 
a neutral environment. It is one of the most common reasons for implant failure 
[98]. Table 3 summarises the types of corrosions that have been observed in metal 
implants [98–100].
Magnesium for example corrodes faster with an increase of impurities such as 
nickel, copper and iron [101]. The higher the purity of magnesium, the slower its 
corrosion rate. However, pure magnesium is not suitable for medical implants due 
to its mechanical characteristics. Instead, calcium is used for the grain refinement in 
magnesium alloys [102]. Orthopaedic implants fabricated from Mg-Ca alloys were 
observed to corrode over a 3-month period after bone formation [103]. Magnesium’s 
mechanical properties can also be enhanced through Mg-Zn with calcium, manga-
nese, yttrium or zirconium [104, 105]. Mg-Zn alloys withstand galvanic corrosion 
and biocorrosion in vitro; however, biocorrosion in vivo resulted in a 2 mm/year 
reduction of a Mg-Zn alloy used as rods in femur shafts [106].
3.2.2 Polymer degradation
Polymer degradation, or biodegradation, occurs through a process called hydro-
lysis. The polymer surface is attacked by organisms, which secrete enzymes break-
ing down ester bonds in macromolecules. The resulting smaller polymer molecules 
are further converted into carbon dioxide and water. The process of biodegradation 
varies for each polymer [27, 107, 108]; however, all polymers lose their mechani-
cal integrity. To date, PGA, PLA and PLGA among others have been explored for 
biomedical implants [27]. Their degradation into non-toxic by-products made them 
favourable materials for temporary biomedical implants [109]. Poly(l-lactic) acid 
Corrosion type Explanation Biomedical implants
Crevice 
corrosion
• Occurs in narrow regions
• Metal ions create localised positive 
charge in the crevice




• Occurs in implants with small surface pit
• Metal ions react with chloride ions 
resulting in rough surfaces
• Orthopaedic and dental implants
Galvanic 
corrosion
• Occurs due to electrical gradient between 
Co-Cr alloys, Ni-Cr, Ag-Pd,  
Au-ternary Ti
• Oral/dental implants




• Occurs due to cyclic stress • Bone cement
• Femoral implants
• Bone plates and screws at the bone-
stem interface
• Stem-cement interfaces of modular 
hip implant
Table 3. 
Types of corrosions observed in metallic biomedical implants.
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(PLLA) has been shown to induce inflammatory responses in vivo upon degradation 
due to its high crystallinity; hence, poly(d, l-lactic acid) (PDLA) was synthesised 
[110, 111].
PLGA degrades into acidic moieties, which in higher concentrations can affect 
the microenvironment of the implant’s surrounding tissue. This can be especially 
important for drug delivery applications, where pH-sensitive drugs are used [11]. By 
increasing the amount of poly(glycolic acid) (PGA) compared to poly(lactic acid) 
(PLA) in PLGA, the degradation rate is reduced; hence, less acidic by-products are 
formed [11].
3.3 Biocompatibility
Biocompatibility indicates a desired response of the implant to its biological 
surrounding [34] and depends on biodegradability and corrosion. The ISO 10993 
standard series is used to assess biocompatibility of medical grade materials and 
medical devices [112]. Test categories investigate the materials’ cytotoxicity, 
sensitization, irritation, toxicity, implantation and biodegradation [71]. Materials 
that meet these criteria include noble metals and titanium, their alloys, cobalt-based 
alloys, but also alumina, zirconia, quartz, fused silica, bioglass, silicon, biocompat-
ible polymers like epoxies, silicones, polyurethanes, polyimides, silicon-polyimides, 
polycyclic-olefins, silicon-carbons, and liquid crystal polymers [113].
3.4 Foreign body response
Foreign body response (FBR) is a non-specific immune reaction of the body to 
implanted materials. This inflammatory reaction can happen in response to surgical 
implantation of biodegradable or non-biodegradable materials present in medical 
devices or implants [114, 115]. FBR can modulate the safety and/or function of the 
implanted material. FBR is characterised by distinct phases, namely onset, progres-
sion and resolution [116] (Figure 1). The onset starts with the surgical implantation 
of the biomaterial, for example, subcutaneously, which causes local tissue damage 
[117]. Upon tissue damage, vessel permeation to cells and proteins increases and 
coagulation occurs where inflammatory mediators like vascular endothelial growth 
factor (VEGF) plays an important role along with neutrophils and macrophages to 
initiate the wound healing process. In parallel, angiogenic factors stimulate local 
vasculature.
FBR comprises of a biomaterial-dependent and biomaterial-independent reac-
tion (Figure 1). If biodegradable materials are present, the FBR will persist until the 
material is fully degraded. With non-degradable or long-term implants, a fibrotic 
capsule creating a barrier between the material and the body will form.
Progression of FBR depends on the material’s surface chemistry and wettabil-
ity [118], where protein, antibody and macrophage adsorption can vary due to 
the material’s intrinsic properties. Additionally, fibrinogen can be adsorbed by 
the implant altering its structure. During FBR’s progression, leukocyte extraver-
sion occurs from the blood vessels. These migrate towards the foreign body. 
Consequently, polymorphonuclear neutrophils (PMNs) are activated, which 
recruit cells including macrophages to the site. Macrophage activation leads to the 
recruitment of fibroblasts, monocytes and more PMNs [116], which ultimately 
increases production of extracellular matrix and hence implant encapsulation and 
fibrosis.
Phagocytosis occurs from the onset when antibodies are non-specifically 
adsorbed by the biomaterials, thus recruiting phagocytes. During progression, 
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phagocytosis by macrophages is continuously promoted through the degradation of 
the material through biodegradation.
Material particles too large to be phagocyted cause the formation of larger mul-
tinucleated cells by fusion of macrophages. These so-called foreign body giant cells 
possess an irregular shape with more than 20 nuclei dispersed randomly. Giant cells 
will usually disappear once the foreign body is fully degraded. Surface roughness 
and surface/volume ratio of the implant can influence the adhesion of macrophages 
or prevalence of fibrosis [114].
As part of FBR, fibrosis is critical in tissue engineering, since capsule for-
mation can prevent the diffusion of molecules (e.g., drugs) and continuous 
fibrosis formation can lead to capsule shrinkage thus affecting the implant 
structure [119]. It has been shown that inhibition of TGF-β can reduce capsule 
formation [120].
Finally, resolution of the foreign body response involves the degradation of the 
biomaterial or removal of the non-degradable material.
3.4.1 Immunomodulation for circumventing the foreign body response
Biomaterials’ characteristics partly determine the body’s immune response to 
the implant. Implant pore size and morphology are critical since they can allow 
immune cells and macromolecules to interact with the implant. In addition, degra-
dation products derived from implants like scaffolds and medical devices, as well as 
their constantly changing surfaces, can trigger the immune response [121]. Recent 
implants can carry therapeutic cells. These cellular implants provoke an immune 
response due to encapsulated cells, posing further challenges besides biomaterial 
compatibility and design [122–124].
Figure 1. 
Foreign body response to implant materials. Sequence of events and responses leading to the fibrous capsule 
formation and foreign body giant cell formation (adapted from [117]).
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fibrosis formation can lead to capsule shrinkage thus affecting the implant 
structure [119]. It has been shown that inhibition of TGF-β can reduce capsule 
formation [120].
Finally, resolution of the foreign body response involves the degradation of the 
biomaterial or removal of the non-degradable material.
3.4.1 Immunomodulation for circumventing the foreign body response
Biomaterials’ characteristics partly determine the body’s immune response to 
the implant. Implant pore size and morphology are critical since they can allow 
immune cells and macromolecules to interact with the implant. In addition, degra-
dation products derived from implants like scaffolds and medical devices, as well as 
their constantly changing surfaces, can trigger the immune response [121]. Recent 
implants can carry therapeutic cells. These cellular implants provoke an immune 
response due to encapsulated cells, posing further challenges besides biomaterial 
compatibility and design [122–124].
Figure 1. 
Foreign body response to implant materials. Sequence of events and responses leading to the fibrous capsule 
formation and foreign body giant cell formation (adapted from [117]).
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Polymers such as collagen, alginate, chitosan, polyethylene glycol, polyvinyl 
alcohol and polyurethane are used in several implantable products that may have an 
inherent biocompatibility. Understanding how these polymer’s chemical and physi-
cal properties can be used to either avoid immune response or modulate it, while 
improving their functionality, is crucial for the advancement of these systems [121].
Strategies to circumvent the FBR include changing the biomaterial’s surface 
properties like wettability, its chemical moieties, and surface charge, because they 
affect protein adhesion to the biomaterial [121, 125].
To create more hydrophilic surfaces, monolayers of hydrophilic polymers such as 
polyethylene glycol (PEG) and polyethylene oxide (PEO) are added, thus prevent-
ing protein adsorption altogether [126]. The deposition of chemical moieties like 
amino (▬NH2), carboxyl (▬COOH), hydroxyl (▬OH), and methyl (▬CH3) groups 
allows the modulation of cellular adhesion influencing inflammatory cell infiltra-
tion and macrophage response affecting the fibrotic capsule thickness around 
the implant [121]. Surface charge is important for the FBR immunomodulation. 
There have been contradicting reports on how exactly neutral, positive or nega-
tive charges reduce the inflammatory response connected to the FBR. Generally, 
negatively charged surfaces tend to inhibit the immune response through reduced 
cell  adhesion [127].
Moreover, implant topography including texture, shape and size has shown to 
trigger an FBR [121]. Therefore, several manufacturing techniques like particles, 
assembled monolayers and photolithography are used to create variety of shapes, 
sizes and surface topographies [128, 129]. Surface roughness at the nanoscale 
can modulate protein adsorption [130], while variations in surface roughness at 
microscale affect cells directly [131]. For example, the inflammatory response of 
titanium used for dental or orthopaedic applications can be decreased by altering its 
surface nano-and microstructures via physical or chemical procedures [121].
Macrophage interaction with differently shaped biomaterials demonstrated 
preferred internalisation of nanorods via pinocytosis compared to nanospheres. 
Additionally, sharper cornered surfaces led to more acute immune responses than 
smoother surfaces [121, 132]. Moreover, spherical alginate capsules of 1.5 mm or 
greater were reported to be more biocompatible than their smaller, non-spherical 
comparators, demonstrating that larger, rounder, smoother capsules could diminish 
the FBR [133].
The use of decellularised ECM as scaffolds by removing immunogenic compo-
nents to avoid an acute response but keeping the original structure has been stud-
ied. While decellularised ECMs contribute to a pro-regenerative environment [134], 
it has been discussed that the immune response modulation still depends on the 
original tissue from which the ECMs have been obtained. Therefore, this option still 
presents a potential solution with more research needed to advance its understand-
ing, manufacturing and impact [134].
The incorporation of bioactive molecules such as adhesion molecules, drugs and 
growth factors to promote immunological interaction with the host attenuating 
its response has been investigated. Bioactive molecules bound to the biomaterial 
for controlled release aiding tissue regeneration [125] include proinflammatory 
molecules like prostaglandins [135] and anti-inflammatory molecules like cytokines 
[136]. Combining their delivery with glucocorticoids improved tissue regenera-
tion and attenuation of inflammation [137]. In recent years, the encapsulation of 
immune cells that act as producers or inducers of specific biological responses to 
reduce inflammation and/or induce repair has been investigated as immunomodula-
tion strategy [125]. Examples include the encapsulation of MSCs to decrease the 
fibrosis in FBR [138] or the encapsulation of macrophages to mediate pro-angiogenic 
activation [139].
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Overall, understanding the fundamental biological systems associated with FBR 
and the structural, physical and chemical properties of biomaterials will lead to 
new designs and strategies allowing to circumvent or work together with the natural 
body’s response towards implants.
4. Bioactive implants
Implants can be bioactive, inducing an alteration to the surrounding tissue, 
by their own biomaterials imparting this alteration to the surrounding tissue, by 
releasing a drug (or drugs) inducing bioactivity, or by containing cells that can 
produce bioactive molecules. In the following sub-sections, we discuss the implant 
bioactivity induced by drugs and cells implicating in drug delivery and in tissue 
regeneration.
4.1 Bioactive implantable and injectable drug delivery systems
Bioactive implants may incorporate active substances including small chemicals, 
peptides, proteins, hormones and even cells, which will have a therapeutic function 
in the human body. For drug delivery, these systems are commonly administered via 
parenteral route by injection or implantation. There are also implantable drug deliv-
ery systems that can be administered via ocular administration or via surgical pro-
cedures such as brain implants (e.g., Gliadel®). Implantable drug delivery systems 
are designed to slowly release the active substance(s) that they carry, thus avoiding 
repetitive injection. The active substance is delivered at a consistent predictable 
rate creating a drug release profile. This avoids peaks and troughs in the drug-blood 
level, which is common for non-long acting injectable products (e.g., intravenous 
solutions). Implantable drug delivery systems can be also injected subcutaneously, 
intramuscular or via other sites including intra-articular. They include implants 
and suspensions of micro- or nano-particles. Typically, these systems are preferred 
when the active substance has a poor absorption by other means of administration 
or a short half-life. The major advantages of such systems are improved pharmaco-
kinetics, control of the drug release rate, and enhanced patient acceptability due to 
the reduction of side effects by maintaining the drug-blood level constant and by 
decreasing administration frequency [140, 141].
Sustained drug release is obtained via diffusion of the active substance through a 
biomaterial matrix, or released through biomaterial biodegradation, or a combina-
tion of both mechanisms. To date, commonly used biomaterials for drug delivery 
are either biodegradable like PCL and PLA or non-biodegradable like polydimeth-
ylsiloxane, polyethyl vinyl acetate, or titanium alloy [141]. Several approaches have 
been developed to produce implantable drug delivery systems [142] and to control 
the drug release. These include (i) using diffusion via membrane permeation, either 
porous or semi-porous membranes; (ii) controlling drug release by matrix diffusion 
using porous polymers; (iii) reservoir systems, where the drug is encapsulated in an 
inner reservoir; and (iv) actively releasing the drug from the implant via osmotic 
pressure, electric current, vapour pressure, hydrolysis or ultrasound activation.
Typically, simple rod-like solid implants, produced by hot melt extrusion 
processes using biodegradable polymers like PLA, PCL, PLGA and PEVA, 
often display a biphasic drug release kinetics showing a burst release due to the 
drug being deposited on the surface or near the surface of the implant, fol-
lowed by a zero-order kinetics reflected by drug diffusion, matrix erosion, or 
a combination of both depending on the polymeric biomaterial used. Table 4 
summarises drug release systems that are currently commercially available or 
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Overall, understanding the fundamental biological systems associated with FBR 
and the structural, physical and chemical properties of biomaterials will lead to 
new designs and strategies allowing to circumvent or work together with the natural 
body’s response towards implants.
4. Bioactive implants
Implants can be bioactive, inducing an alteration to the surrounding tissue, 
by their own biomaterials imparting this alteration to the surrounding tissue, by 
releasing a drug (or drugs) inducing bioactivity, or by containing cells that can 
produce bioactive molecules. In the following sub-sections, we discuss the implant 
bioactivity induced by drugs and cells implicating in drug delivery and in tissue 
regeneration.
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Bioactive implants may incorporate active substances including small chemicals, 
peptides, proteins, hormones and even cells, which will have a therapeutic function 
in the human body. For drug delivery, these systems are commonly administered via 
parenteral route by injection or implantation. There are also implantable drug deliv-
ery systems that can be administered via ocular administration or via surgical pro-
cedures such as brain implants (e.g., Gliadel®). Implantable drug delivery systems 
are designed to slowly release the active substance(s) that they carry, thus avoiding 
repetitive injection. The active substance is delivered at a consistent predictable 
rate creating a drug release profile. This avoids peaks and troughs in the drug-blood 
level, which is common for non-long acting injectable products (e.g., intravenous 
solutions). Implantable drug delivery systems can be also injected subcutaneously, 
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and suspensions of micro- or nano-particles. Typically, these systems are preferred 
when the active substance has a poor absorption by other means of administration 
or a short half-life. The major advantages of such systems are improved pharmaco-
kinetics, control of the drug release rate, and enhanced patient acceptability due to 
the reduction of side effects by maintaining the drug-blood level constant and by 
decreasing administration frequency [140, 141].
Sustained drug release is obtained via diffusion of the active substance through a 
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tion of both mechanisms. To date, commonly used biomaterials for drug delivery 
are either biodegradable like PCL and PLA or non-biodegradable like polydimeth-
ylsiloxane, polyethyl vinyl acetate, or titanium alloy [141]. Several approaches have 
been developed to produce implantable drug delivery systems [142] and to control 
the drug release. These include (i) using diffusion via membrane permeation, either 
porous or semi-porous membranes; (ii) controlling drug release by matrix diffusion 
using porous polymers; (iii) reservoir systems, where the drug is encapsulated in an 
inner reservoir; and (iv) actively releasing the drug from the implant via osmotic 
pressure, electric current, vapour pressure, hydrolysis or ultrasound activation.
Typically, simple rod-like solid implants, produced by hot melt extrusion 
processes using biodegradable polymers like PLA, PCL, PLGA and PEVA, 
often display a biphasic drug release kinetics showing a burst release due to the 
drug being deposited on the surface or near the surface of the implant, fol-
lowed by a zero-order kinetics reflected by drug diffusion, matrix erosion, or 
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under development. There are numerous advantages to using implants in drug 
delivery such as the possibility of removal after treatment, the consistent and 
predictable drug release, and versatility in manufacture using various bioma-
terials. However, there are potential disadvantages of this dosage form, where 
often a specialised device (e.g., trocar) and technique are needed for implanta-
tion and removal requires minor surgical procedures. Additionally, there may be 
complications in locating the implant for removal since it can migrate from its 
original location. From a commercialisation point of view, this type of bioactive 
implant may require complex regulatory and commercial strategies for market 
approval [154].
Injectable drug delivery systems, such as particulate suspensions or hydrogels 
like in situ forming gel depots, are designed from biodegradable biomaterials, 
injected (e.g., subcutaneous, intramuscular), form a depot, erode when in contact 
with body fluids, and release the drug by diffusion and erosion [149]. Injectable 
depots are not designed to be retrieved. Examples of injectable depots are micro- or 
nano-scale particles, where the drug is encapsulated within the polymer matrix. 
The polymeric particles are commonly prepared from biodegradable materials (e.g., 
PLGA, PCL, or silica) since the intent is to deliver the depot system once by injec-
tion, let it erode and release the drug with time.
Choosing the polymer grade, type and combining polymer types can help tune 
the drug release as necessary [149, 154]. Key points in preparing these bioactive 
depots are the choice of the biomaterial (biodegradable/erodible), the physico-
chemical properties of drug to be encapsulated (i.e., hydrophobic or hydrophilic), 
the drug loading needed to deliver the therapeutic dose, and the inherent phar-
macokinetics of the drug. This will inform the choice of manufacturing methods, 
often by emulsification. Common polymers used in these preparations are PLGA 
and PLA, where their long safety records deem these polymers as preferred, even 
though some minor inflammatory responses can still be reported [150].
Hydrogels, prepared from different types of biomaterials (e.g., hyaluronic acid, 
polyesters and chitosan) have been extensively investigated as carriers for sustained 
drug release [152, 155]. In situ forming hydrogels as injectable depots pose major 
advantages over other drug release systems since they allow for rapid, painless and 
easier administration through smaller needle sizes. These biodegradable in situ 
depots are of low viscosity prior injection and solidify into a gel or solid depot after 
injection, typically due to a specific trigger depending on the chemistry of the 
chosen biomaterial [153].
4.2 Bioactive cell-based implants as drug delivery systems
Before commercialising a cellular implant, it needs to be approved by FDA’s 
Cellular, Tissue and Gene Therapies Advisory Committee. The Committee evaluates 
the safety and effectiveness of cellular implants for the reconstruction, repair or 
replacement of damaged tissues [156].
Cell-based drug delivery systems can be defined as technologies capable of 
treating diseases using living cells to deliver the therapeutic bioactive molecules 
in the body, as either transport system or as production units [157]. Some 
examples of commercially available or under development cell-based implants 
are shown in Table 5. These cell-based drug delivery systems are used as constant 
producers of bioactive molecules in the form of implant devices. Judging by 
the current developments in this technology, a major driving force behind this 
type of delivery is the improvement in treatment of insulin-dependent diabetes 
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PLGA, PCL, or silica) since the intent is to deliver the depot system once by injec-
tion, let it erode and release the drug with time.
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the drug release as necessary [149, 154]. Key points in preparing these bioactive 
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the drug loading needed to deliver the therapeutic dose, and the inherent phar-
macokinetics of the drug. This will inform the choice of manufacturing methods, 
often by emulsification. Common polymers used in these preparations are PLGA 
and PLA, where their long safety records deem these polymers as preferred, even 
though some minor inflammatory responses can still be reported [150].
Hydrogels, prepared from different types of biomaterials (e.g., hyaluronic acid, 
polyesters and chitosan) have been extensively investigated as carriers for sustained 
drug release [152, 155]. In situ forming hydrogels as injectable depots pose major 
advantages over other drug release systems since they allow for rapid, painless and 
easier administration through smaller needle sizes. These biodegradable in situ 
depots are of low viscosity prior injection and solidify into a gel or solid depot after 
injection, typically due to a specific trigger depending on the chemistry of the 
chosen biomaterial [153].
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Before commercialising a cellular implant, it needs to be approved by FDA’s 
Cellular, Tissue and Gene Therapies Advisory Committee. The Committee evaluates 
the safety and effectiveness of cellular implants for the reconstruction, repair or 
replacement of damaged tissues [156].
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in the body, as either transport system or as production units [157]. Some 
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4.3 Bioactive cellular implants as tissue replacements
When damages due to disease, injury or trauma lead to the degeneration 
of tissues, it is necessary to provide support for their repair, replacement or 
regeneration. Common approaches include tissue transplantation, both from the 
patient’s own body (autograft) and from a donor (allograft). However, harvesting 
autografts is expensive and invasive and the patient may experience infections 
and hematomas. While for the allografts, there are risks of rejection along with 
the infections due to the surgery or the transplanted tissue [158]. With tissue 
engineering, biological implants are developed that restore, maintain and improve 
the tissue function [159]. Implants provide the environment for cell adhesion and 
proliferation to grow new tissues. They can also include active substances like 
growth factors and drugs as well as cells to aid tissue regeneration [11]. Cell-based 
scaffolds are either cultured in vitro with the aim of synthetizing tissues that can 
be implanted, or to be implanted directly in the damaged region [158]. Table 6 
summarises some of the recent studies about cell-based implants tested on in vivo 
models.
4.3.1 Primary cells versus stem cells
The advantage of using cell-based scaffolds is the possibility to customise the 
construct using cells derived from the patient (primary cells). In this way, there is 
no risk of rejection due to immunological incompatibility. Cells can be isolated from 
biopsies and then seeded on the scaffold (Figure 2). However, primary cells are dif-
ferentiated, post-mitotic cells. This leads to a limited lifespan, where after a limited 
number of cell doubling, they will enter in senescence and stop dividing, but are 
still viable [166, 167]. Moreover, primary cell types are difficult to culture, because 
they have difficulties adhering and proliferating in vitro [168].
To overcome problems associated with primary cells, stem cells have been 
be used. Stem cells are present in most if not all tissues and, according to 
their origin, they can be classified into embryonic and adult stem cells. Stem 
cells are able to both duplicate (self-renew) and differentiate in one or more 
cell types [167].
Embryonic stem cells (ESCs) are isolated from inner cell mass of embryo at the 
blastocyst stage. They can differentiate in any cell type (pluripotency) and have a 
high rate of self-renewal. Unfortunately, they can cause an immune response, as 
they are derived from a different body, so immunosuppression is necessary to avoid 
rejection. Moreover, the injection of undifferentiated ESC can lead to the formation 
of teratoma [169].
Adult stem cells (ASCs) are multipotent cells that can differentiate in a limited 
number of cell types, which reside in a specific microenvironment, the stem cell 
niche. Their role is to replace damaged and dead cells in the tissue to maintain 
homeostasis [170].
ASCs can be isolated from bone marrow, blood, adipose tissue, liver and skin 
[169]. Compared to ESCs, ASCs proliferate more slowly and have limited expan-
sion capacity in vitro. Like primary cells, they can enter in senescence [171]. With 
age, their regenerative potential, growth and divisions are affected [172]. The most 
commonly used type of ASCs is mesenchymal stem cells (MSCs). These cells can 
differentiate into musculoskeletal cells, marrow and other cells of connective tissue, 
and they can provide trophic support and modulate the immune response [173]. 
They can migrate to a damaged region and promote healing by secreting molecules 
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Examples of recent studies on cell-based implants.
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Induced pluripotent stem cells (iPSCs) originate from fully differentiated 
somatic cells, which are dedifferentiated to form iPSCs by a process called repro-
gramming. The methodology was developed in 2006 [176] and involves the stimu-
lation of genes that are active during the embryogenesis. Thanks to the cell 
derivation, the implantation of these cells does not lead to rejection. However, as 
with ESCs, iPSCs can form teratoma. Moreover, some of the genes that are activated 
are also associated with tumour development [177].
Figure 2. 
Source of cells used for cell-based implants. Image adapted from [168].
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To generate tissue replacements, it is essential to resemble the native extra-
cellular matrix (ECM). Therefore, the matrix composition, shape and physical 
properties are crucial. Nanofibers, sponges or gels have been fabricated using 
numerous different techniques or combinations of techniques to mimic the native 
ECMs. Some of these techniques and their biomedical applications are presented 
in Table 7.
5.1 Solvent casting particulate leaching
Solvent casting particulate leaching is a technique developed in 1993 by Mikos 
et al., where a polymer is dissolved in an organic solvent and the polymer solution 
is mixed with an insoluble porogen. The solvent is evaporated by solvent casting 
or freeze-drying techniques. The evaporation leads to a porogen-polymer com-
pound, which is washed to remove the porogen leaving a porous polymer matrix 
behind [187, 188]. This method is relatively easy to use and inexpensive [189]. Pore 
size, porosity and interconnectivity can be controlled selecting the right polymer, 
porogen and their concentration [190].
5.2 Phase separation
Phase separation employs temperature changes that separate the polymeric solu-
tion in two phases: the lean phase (low polymer concentration) and the rich phase 
(high polymer concentration). Briefly, the polymer is dissolved in a solvent, then, 
the temperature is rapidly decreased to have a liquid-liquid separation and two-
phase solid is formed [191]. Finally, the liquid is removed by extraction, evapora-
tion or sublimation [192].
5.3 Freeze-drying
Freeze-drying technique or lyophilisation [193] is based on a sublimation pro-
cess that will produce a porous scaffold. A polymer is added to a mixture of water 
and organic solvent and moved into a mould. The mixture is quickly frozen and, by 
lowering the pressure to few millibars, the water and the organic solvent sublimate. 
The complete removal of the liquid phase takes place under vacuum [189, 194, 
195]. To control porosity and pore size, polymer/water ratio, ionic concentration, 
viscosity and pH, together with freezing rate and temperature, can be changed 
[194, 195].
5.4 Electrospinning
Electrospinning is used to produce micro- and nanofibers. It is widely used 
as it can produce matrix that can resemble the native ECMs. Nanofiber scaffolds 
offer mechanical support and a nanoscale environment for the cells [196, 197]. 
A polymer solution is added to a syringe. Then, high voltage is applied, and the 
solution accelerates to a collector of opposite charge. The solution-air inter-
face changes from rounded to conical, due to the repulsive electrostatic forces 
between the polymer molecules in solution and the attractive force between the 
polymer solution and the collector. The polymer solution is ejected from the 
syringe when the electrostatic forces are higher than the surface tension of 
the solution. Then, the solvent evaporates, and the solid polymer is deposited 
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Techniques used for the fabrication of bioactive implants.
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on the collector. By changing the voltage, collector, polymer concentration and 
solvent, it is possible to control the size of the fibres [196, 198].
5.5 Additive manufacturing techniques
Additive manufacturing (AM) techniques, or solid freeform fabrications 
(SFFs), are based on the use of computer-aided design (CAD) to fabricate scaf-
folds. The CAD controls the layer-by-layer deposition of material. The advantage 
of these methods is the full control of the topography of the construct [196, 198].
Three-dimensional (3D) printing is a commonly used AM technique that was 
developed at the Massachusetts Institute of Technology in 1990s [198, 199]. The 
CAD is converted in a stereo lithography (STL) file and exported to the 3D printer 
to control the movement and deposition of the material.
This technique allows the inclusion of cells within the scaffold, as high tem-
perature or solvents are not required for its production [200]. In recent years, 3D 
printing has been used to produce scaffolds and anatomically customised implants 
based on MRI and CT scans. The AM can be classified in three different approaches 
[201], namely laser-based (stereolithography, selective laser sintering, electron 
beam melting and binder jetting) [202–204], nozzle-based (fused deposition 
modelling and melt electrospinning writing) [204–208] and indirect 3D printing 
[209–211].
5.6 Injection moulding
Injection moulding is one of the most commonly used techniques for large-
scale production of thermoplastic items. The plastic is melted and injected into a 
mould of desired shape. When the material solidifies, the mould is removed, and 
the finished part is extracted [212]. Metal constructs can also be fabricated with 
this technique. Metal injection moulding uses fine metal powders mixed with 
a binder and is injected with a conventional thermoplastic moulding machine. 
The binder is then removed, and the product is formed. This method allows the 
production of constructs with a sophisticate shape and higher mechanical  
properties [213].
5.7 Self-assembly
Self-assembly is the spontaneous formation of molecular units in supramolecu-
lar structures, without external intervention. These molecules interact through 
hydrogen bonding, van der Waals and electrostatic forces. Due to their biocom-
patibility and biodegradability, peptides are commonly used for self-assembly. 
Specific structure can be created by modifying the amino-acidic composition of 
the peptides [189, 214]. These nanostructures can be used in drug delivery and 
tissue engineering [215].
5.8 Manufacturing considerations
The manufacturing of bioactive implants, whether these are for tissue engi-
neering or for drug delivery purposes, includes several common aspects. These 
include the manufacturing methods that are employed, the biomaterial source, use 
of solvents, scalability, the need for aseptic facilities or if final product sterilisa-
tion is preferred, and if a specifically designed device is needed to administer the 
implant.
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Most importantly, the regulatory strategy for filing needs to be in place soon 
in product development to define all the data that are needed for submission. It is 
important to define if the bioactive implant will be considered a drug product, a 
medical device, or a combination product (drug-device), and in which markets 
should it be launched, as different markets have different regulations and requisites 
for the different categories.
Comprehensive reviews and discussions on the regulatory aspects for filing 
medical devices, and combination products in the biomedical field were reviewed 
[216–218]. Ragelle et al. provide an excellent perspective for nanoparticle-based bio-
materials, its manufacture and regulatory outlook for biomedical engineering [219].
To enable the use in animals and humans, the sterilisation process is impor-
tant. If the manufacturing method is simplified enough, the use of aseptic 
technique for manufacturing, using filters and a particulate-free environment, 
will be possible although costly and complex for significantly large-scale manu-
facturing. For devices where metals are used, sterilisation by moist or dry heat 
may be possible.
However, for implants that involve polymers or heat-sensitive bioactive mol-
ecules, the preferred sterilisation method is gamma-irradiation. The drawback 
of using this technique is the potential risk to polymer and/or bioactive molecule 
degradation, changing the release rate and potentially compromising the efficacy of 
the implant [150]. Depending on the biomaterial and bioactive molecule involved, 
there may be ways to avoid degradation upon gamma-irradiation, such as using an 
antioxidant mixed with the drug. Apart from aseptic conditions, gamma-irradiation 
of the final product remains the best solution but exposes one of the disadvantages 
of developing bioactive implants as it is still a costly technique bringing its own 
risks [220].
6. Summary
In this chapter, we reviewed the current literature about bioactive biomedical 
implants applicable to regenerative therapies and used in drug delivery. To gener-
ate new biomedical implants, biomaterials are continuously developed, either 
through entirely new or by combining advantageous properties of well-known 
and safe biomaterials to improve the application and effectiveness of implants. 
Thus, materials that enhance the natural response of the body and simultane-
ously provide support for cell adhesion and proliferation are required. Another 
field that has developed in recent years is cell-induced bioactivity, where cells 
are used in implants for tissue regeneration and disease treatment. While there 
are several manufacturing techniques to create application-specific bioactive 
implants, new technologies, such as additive manufacturing, bring advantages 
and versatility to the field.
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Chapter 2
Dental Implants
İhsan Çağlar Çınar, B. Alper Gültekin, Alper Sağlanmak
and Cem Töre
Abstract
The goal of modern dentistry is to return patients to oral health in a predictable
fashion. The partial and complete edentulous patient may be unable to recover
normal function, esthetics, comfort, or speech with a traditional removable pros-
thesis. The patient’s function when wearing a denture may be reduced to one sixth
of the level formerly experienced with natural dentition; however, an implant
prosthesis may return the function to near-normal limits. The esthetics of the
edentulous patient is affected as a result of muscle and bone atrophy. In order to
replace a missing tooth, the development of materials science and technology
improved the materials for implant application. Nowadays, titanium has become
the most popular implant material due to its advantages. The first submerged
implant placed by Strock was still functioning 40 years later. Recently, zirconia
implants and innovative surface designs are being researched and practiced. In this
chapter, these materials will be comparatively discussed through contemporary
literature and research.
Keywords: implant corrosion, dental implants, oral implantology,
titanium implants, zirconia implants, oxide layer, zirconium dioxide, Ti-6Al-4V,
calcium phosphate ceramics, osseointegration
1. Introduction
Modern dentistry aims to restore a patient’s oral esthetics, contour, function, and
speech. Depending on the patient’s needs, the total treatment may range from
treating a single tooth with caries to restoring edentulous arches with severe bone
resorption.
Implant dentistry has made predictable success a reality for cases in the more
difficult part of this spectrum through research, improvements in diagnostic tools,
techniques, implant materials, and designs. Endosteal implants are manufactured
materials inserted in edentulous ridges via surgery so they can serve as a foundation
for the prosthesis [1]. Most implants that will be discussed in this chapter will be
root form implants which mimic the root shape of a tooth.
1.1 History of dental implants
The desire to restore lost teeth is not a new concept. Dental implant surgery is
one of the oldest practices in dentistry second only to tooth extractions. There is
archeological evidence that humans have attempted to replace missing teeth with
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The goal of modern dentistry is to return patients to oral health in a predictable
fashion. The partial and complete edentulous patient may be unable to recover
normal function, esthetics, comfort, or speech with a traditional removable pros-
thesis. The patient’s function when wearing a denture may be reduced to one sixth
of the level formerly experienced with natural dentition; however, an implant
prosthesis may return the function to near-normal limits. The esthetics of the
edentulous patient is affected as a result of muscle and bone atrophy. In order to
replace a missing tooth, the development of materials science and technology
improved the materials for implant application. Nowadays, titanium has become
the most popular implant material due to its advantages. The first submerged
implant placed by Strock was still functioning 40 years later. Recently, zirconia
implants and innovative surface designs are being researched and practiced. In this
chapter, these materials will be comparatively discussed through contemporary
literature and research.
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1. Introduction
Modern dentistry aims to restore a patient’s oral esthetics, contour, function, and
speech. Depending on the patient’s needs, the total treatment may range from
treating a single tooth with caries to restoring edentulous arches with severe bone
resorption.
Implant dentistry has made predictable success a reality for cases in the more
difficult part of this spectrum through research, improvements in diagnostic tools,
techniques, implant materials, and designs. Endosteal implants are manufactured
materials inserted in edentulous ridges via surgery so they can serve as a foundation
for the prosthesis [1]. Most implants that will be discussed in this chapter will be
root form implants which mimic the root shape of a tooth.
1.1 History of dental implants
The desire to restore lost teeth is not a new concept. Dental implant surgery is
one of the oldest practices in dentistry second only to tooth extractions. There is
archeological evidence that humans have attempted to replace missing teeth with
root form implants for thousands of years. Remains from ancient China dating
39
4000 years ago have carved bamboo pegs, tapped into the bone, to replace lost
teeth, and 2000-year-old remains from ancient Egypt have similarly shaped pegs
made of precious metals. Some Egyptian mummies were found to have transplanted
human teeth, and in other instances, teeth made of ivory [2]. Central American
Incas tapped seashells in bone similar to the Chinese [3].
In 1809, Maggiolo introduced root shaped gold implants followed by Harris
introducing porcelain teeth supported by lead-coated platinum posts [4, 5]. Gold,
magnesium, copper, brass, aluminum, silver, and soft steel plated with nickel and
gold was used to fabricate implants by Lambotte in 1900s [6]. Corrosion of most of
these metals by body tissues was observed which in return caused electrolytic
action. In 1909, Greenfield introduced an implant in the form of a cylindrical
lattice-cage which differed substantially from the root form implants [7]. A cali-
brated cylindrical bur was used for the osteotomy to preserve an inner core of bone
within the implant. This was also the first design which separated the endosteal
implant from the abutment which was to be connected on the implant weeks later
through an internal attachment after healing. In 1940, Bothe described a titanium
implant and bone interface as bone fusing [8]. The first two-piece titanium screw-
type implant was designed in 1946 by Strock [9]. The direct implant-bone interface
desired by Strock was called ankylosis.
Brånemark’s studies in bone marrow healing in 1952 led to dental implant appli-
cation in dogs in early 1960s, and implant integrations in bone were achieved
without adverse reaction in surrounding tissues. Implant applications in humans
with Brånemark philosophy were started in 1965, and 10-year results were
published in 1977 [10]. Osseointegration, which has become the term used today for
implants instead of ankylosis or bone fusing, was defined by Brånemark as a direct
contact between the implant surface and living bone that can be observed through a
light microscope [11].
Through advances in material sciences, manufacturing processes, research, and
clinical studies, the usage of dental implants have become an essential part of
contemporary restorative dentistry.
1.2 Dental implant material properties
1.2.1 Metals and alloys
Majority of the dental implants to date have been fabricated from metals and
alloys. American Society for Testing and Materials and International Standards
Organization have created guidelines for standardizing implant materials [12, 13].
1.2.1.1 Titanium and titanium: 6 aluminum: 4 vanadium (Ti-6Al-4V)
Titanium and its alloys are the most widely used materials for dental implants
[14]. This metal group forms retentive oxides in contact with room temperature air
or solutions containing oxygen such as tissue fluids. This provides an advantage
since this titanium oxide surface minimizes biocorrosion. In the case of an oxide
surface becoming scratched or removed during implant placement into bone, the
surface reoxidizes in the bone tissue. This regenerative biocorrosion preventing
layer is one of the reasons for the wide use of titanium in dental implants [15].
Bothe et al. reported bone growth in contact with titanium surfaces in rabbits
[8]. Several researchers studied and expanded the indications for use of titanium in
implant devices. The reason reported is titanium’s non-reactive nature and its resil-
ience to corrosion [16, 17]. General properties of alloys and metal used in implant
fabrication are detailed in Table 1 [12].
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The titanium alloy with the most widespread use is titanium-aluminum-vana-
dium. This alloy has approximately six times the strength of compact bone, and as a
result, thinner structural parts can be incorporated into the implants without
risking breakage or cracking. The alloys modulus of elasticity is 5.6 times greater
than compact bone. Several studies have investigated and documented the titanium
oxide layer on both pure titanium and its alloy which can vary depending on surface
properties [18]. The techniques for casting titanium and alloys are limited because
of high melting points and high chance of hydrogen, nitrogen, and oxygen absorp-
tion. Different purity levels can be achieved through an ultrapure protective gas
environment or a high vacuum [18].
1.2.1.2 Cobalt-chromium-molybdenum-based alloy
This alloy is made up of cobalt, chromium, and molybdenum. Alloys containing
cobalt are usually used as they are cast and are sometimes additionally annealed.
This allows custom designs otherwise unachievable. The named elements with
minor additions of nickel, manganese, and carbon provide strength four times
greater than compact bone and chromium provides resistance to corrosion. These
concentrations are critical so the fabrication processes must be carefully controlled
and followed. Cobalt-based alloys are the least ductile of the ones used in dental
implants [12]. Excellent biocompatibility has been observed with implants from
cobalt-based alloys when they are manufactured properly.
1.2.1.3 Iron-chromium-nickel-based alloys
Stainless steel alloys are one of the oldest materials to be used in the medical
field. The alloy is most often used in a wrought and heat treated condition, same as
titanium alloys, which gives the material high strength and ductility. Among all
alloys used in implant fabrication steel alloys are the ones most susceptible to
biocorrosion so the applied oxide surface must be protected. Another concerning











Titanium 99+Ti 97 (14) 240–550 (25–70) >15
Titanium-aluminum-
vanadium






235 (34) 655 (95) >8
Stainless steel (316 L) 70Fe-18Cr-
12Ni
193 (28) 480–1000 (70–145) >30
Zirconium 99+Zr 97 (14) 552 (80) 20
Tantalum 99+Ta — 690 (100) 11
Gold 99+Au 97 (14) 207–310 (30–45) >30
Platinum 99+Pt 166 (24) 131 (19) 40
Table 1.
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contacted a bridge containing a noble metal, for example, a circuit would be
formed. This would not be a cause of concern if these units function without
contact [19, 20].
1.2.1.4 Other metals and alloys
Several other metals been used in implant manufacturing. Notably, among
these, gold and platinum have been evaluated but the low strength of these mate-
rials limit implant design.
1.2.2 Ceramics
Ceramics are non-metal, non-polymer, inorganic materials. Oxide ceramic den-
tal implants were fabricated to make use of their resistance to biodegradation,
strength, color, low conductivity, and elastic properties [21, 22]. Despite their low
ductility and brittle nature, ceramics are being used both as coatings on other
materials and in bulk form.
1.2.2.1 Aluminum, titanium, and zirconium oxides
Main properties of these materials are listed in Table 2 [12]. High strength oxide
ceramics have been used as several implant forms including root form implants
[23]. Ceramics have approximately 3–5 times the strength of compact bone. Creat-
ing a different implant design for these materials is necessary because of their high
strength and high modulus of elasticity. Metallic oxide ceramics generally have a
white hue of color which makes them a viable option for implants in the esthetic
area in cases where gingival recession leaves implants visible. When compared with
other materials, minimal reactivity with oral tissues paired with low electrical and
thermal conductivity are notable benefits.
As with titanium implants, bone growth directly adjacent to the implant surface
has been observed. Going a step further, areas of bonding have been reported in
gingival attachment zones of sapphire dental implants in animal studies [24–26].
There are also special requirements for sterilization of metallic oxide ceramic
implants. Since steam and chemical solutions can lead to micro weaknesses which
can lead to fractures or leftover residues; dry heat is the best choice for sterilization
of ceramics. Their improved strength and excellent biocompatibility make ceramics
a viable choice as an implant material.
Modulus of elasticity












392 (56) 640 (93) 0 Al2O3
Zirconium oxide
zirconia (PSZ)
195–210 (28–30) 500–650 (72–94) 0 ZrO2
Titanium oxide
(titania)
280 (41) 69–103 (10–15) 0 TiO2
Table 2.
Mechanical properties of various inert ceramics [13, 14].
42
Biomaterials
1.2.2.2 Calcium phosphate ceramics (CPC)
First implants manufactured from CPCs aimed to reduce bone resorption after
tooth extractions by filling the bone socket with cone-shaped implants [27]. The
materials limited strength led researchers to either reinforcing the material inter-
nally with metal parts or to coat other materials with CPCs [28]. Out of these
techniques, coating metal implants via flame or plasma spraying was more widely
used with the intent of making metal implants more biocompatible [29].
The advantages of the application are the materials chemical similarity to living
tissues, biocompatibility, and low conductivity which means it can act as a barrier
to metallic ion transport between bone and metal implants. Disadvantages are its
low strength and the materials possibility to dissolve or alter in time. Main proper-
ties of these materials can be found in Table 3 [12]. Generally, bioceramics are
characterized by lower hardness, strength, and elasticity modulus than ceramics
like zirconia or aluminum oxide. Overall, CPCs are one of the most widely accepted,
studied, and used biomaterials developed in the last decades and could find its
applications expanding further as future implant surfaces as they evolve themselves
through technology and research [30].
1.2.2.3 Carbon and carbon silicon compounds
Carbon and carbon silicon materials are regarded as ceramics for their non-
reactive nature, but they conduct electricity and heat. Its elasticity is close to bone,
and it is a biocompatible material. Clinical trials of carbon-based dental implants
were carried out. Limitations in material properties, design, and applications led to
clinical failures in trials which resulted in withdrawal of carbon-based materials in
dental implant designs.
1.3 Influence of dental implant materials on soft and hard tissue
1.3.1 Implant surgery
Implant surgery begins with an incision on the edentulous ridge and flap elevation
to expose the alveolar bone. At the end of the surgery, the same flap will be sutured
and a primary wound healing of masticatory mucosa will follow. If a submerged
(placed under oral mucosa level) implant is being used, a recovery surgery will be
performed after a period of healing. If a non-submerged (placed on the same level as
oral mucosa) implant is being used, no recovery surgery is necessary.
Modulus of elasticity






Hydroxyapatite 40–120 (6–17) 40–300 (6–43) 0 Ca10(PO4)6(OH)2
Tricalcium
phosphate
30–120 (4–17) 15–120 (2–17) 0 Ca3(PO4)2
Bioglass or
Ceravital
40–140 (6–20) 20–350 (3–51) 0 CaPO4
Carbon 25–40 (4–6) 150–250 (22–36) 0 C
Carbon-silicon
(LTI)
25–40 (4–6) 200–700 (29–101) 0 CSi
Table 3.
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Most implant systems available today allow creation of a recipient intrabony site
for implant placement via rotary instruments. A tight fit is crucial for primary
stabilization of the implant and for preventing soft tissue from penetrating the gap
between the implant and the bone, effectively preventing the implant
osseointegration.
Most important negative influence of the surgery stage can be creation of exces-
sive heat with rotary instruments. It has been shown that bringing of the temperature
of bone to 47°C for 1 minute is enough to kill osteogenic cells which can compromise
necessary healing. As a safety measure, several sharp drills must be used at low speeds
with low hand pressure and proper irrigation for cooling the site [31].
1.3.2 Long-term influences on peri-implant tissues
Following surgery if no infection or inflammatory response takes place to pre-
vent healing, primary wound healing defines the long-term properties of surround-
ing tissues. Regardless of the dental implant material, the general outcome of bone
healing around an implant is osseointegration which is defined by Brånemark as “a
direct structural and functional connection between ordered, living bone and the
surface of a load-carrying implant [11].” Throughout several weeks of healing,
woven bone which forms during early stages of healing starts to become more
compact lamellar bone. This formation can be observed both from the cut bone and
from the implant surface [32].
Titanium’s corrosion rate in tissues is well documented [33]. In older studies, the
presence of titanium has been detected in peri-implant tissues and internal organs,
presumed to be caused by corrosion, mechanical wear, and peri-implant inflamma-
tion, but the compositions of the implant alloys were not strictly controlled, and in
same studies, the diffusion is very slow and since titanium has little to no toxicity, it
should be considered biocompatible [34, 35]. In a recent study, titanium particles
have been detected in healthy and inflamed mucosa and even in patients with no
titanium implants [36]. The increased amount of particles is likely the effect of the
inflammation rather than its cause. Since then, higher strength alloys of titanium have
emerged [37]. Recently, applications of these materials have been successful and have
not resulted in significant negative effects. Titanium allergy has been studied and is
known to be rare, but research is insufficient to give an accurate incidence rate [38].
The oxide surface of titanium as previously discussed exists through reacting
with oxygen at normal temperatures and will rapidly reform if removed mechani-
cally. It minimizes biocorrosion in tissues [15]. The oxide layer consists of mostly
TiO2 and to a lesser degree Ti2O3 and TiO [39]. While in normal temperatures, the
oxide layer is less than 20 nm in thickness, when processed at high temperatures or
anodized at high voltages, the layer can be 10–100 times thicker in a crystalline
structure [40]. The macro and micro architecture of dental implants achieved via
sand blasting, acid etching, or mechanical milling has no significant effect over the
thickness of the oxide layer [41]. Naturally occurring oxidants in tissues such as
hydrogen peroxide has been shown to form a complex gel with titanium on a
molecular level. This layer is found to have a very low toxicity, anti-inflammatory,
and bactericidal properties [42].
Coating titanium implants by hydroxyapatite via plasma spraying is a method
developed to help minimize ion transfer and accelerate bone formation between the
bone-implant interface [43]. The disadvantages of this coating are its possibility of
partial resorption during bone remodeling, after in vivo function, or in inflamma-
tion areas [44]. A recent study tested titanium and cobalt implants coated with
zirconium nitride and found the product to be cytocompatible and the red color
range can potentially minimize the visibility of implants under the gingiva [45].
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Aluminum oxide ceramics are used as implant bulk materials one advantage is
having the oxide layer properties throughout the entire body of the implant. As a
result, any removal of surface has no effect on the electrochemical properties
underneath the surface. Ceramic coatings aim to give the same biocompatibility
advantages to metals or alloys to be coated [46]. A systematic review including six
randomized controlled trials (RCTs) studied implants consisting of 85% Ti and 15%
Zr found that narrow Ti-Zr implants have comparable performance to regular
diameter Ti implants noting further research is necessary [47]. Some studies tested
alloys consisting of Ti-Nb and found the material to be cytocompatible and a good
candidate for implantology in future research due to its very low elasticity
modulus [48, 49].
1.4 Success of dental implant materials
There have been different criteria for measuring success of dental implants. The
two most commonly used in literature is survival and success. Survival of an
implant states whether the implant is simply still functioning in the mouth or it has
been removed. Success on the other hand is concerned with the condition of peri-
implant tissues and teeth as well as patients comfort and satisfaction [50].
A systematic review evaluating 23 published articles and 7711 implants over a
minimum of 10 and a mean of 13.4 years found a survival rate of 94.6% and a mean
bone loss of 1.3 mm around implants [51].
An article on zirconia dental implants stated zirconium dioxide is a promising
alternative for titanium, but studies found significantly more early failures com-
pared to titanium. Technical advances and innovation are found to be promising;
however, there is insufficient evidence for a final verdict at present [52]. An ITI
consensus report from 2018 states one-piece zirconia implants are safe in appropri-
ate conditions but cautions against two-piece zirconia implants due to insufficient
data. Same report stated that throughout different implant loading protocols and
implant materials, survival rates are above 96% [53]. A meta-analysis evaluating 17
studies reviewing clinical outcomes of zirconium dioxide implants states that the
survival rate was 95% over 1–7 years of follow-up [54]. A study on properties of
porous tantalum found the materials similarity to bone in terms of mechanical
properties and that it has less cytotoxicity than titanium. The authors claim bone
growth into the implant surface to form a unique interface pattern but state tanta-
lums safety and performance as an implant material should be further tested [55].
The lack of long-term follow-ups for zirconia implants result in researchers
advising caution and stating the information in insufficient even when high survival
rates are found and zirconium dioxide implants are becoming a viable alternative to
metal implants.
Titanium implants in contrast have very well-documented success with follow-
ups exceeding 25 years [56]. The current research in titanium implants is not
concerned of success of the material but rather its viability and applications in
diabetics, smokers, patients who underwent radiotherapy or anti-resorptive drugs
as well as timing of implantation and loading.
1.5 Potential impacts of titanium
Titanium and its alloys have been widely and safely used in the field of oral
implantology for 40 years. In the early years, researchers have argued that titanium
is a bio-inert material, but with recent studies, it has been found that titanium
degradation, as particle or ion release may penetrate surrounding tissues. This
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years after loading, during maintenance. The surface of an implant is covered with
many atomic-sized titanium oxide layers for its benefit in osseointegration and
corrosion resistance. Degradation of this layer over time may cause ion release from
the implant surface. The compressive and frictional forces generated during
osteotomy in surgical phase may disrupt this structure and cause titanium particle
release. It is also possible that the biofilm formed in the abutment-implant connec-
tion, which is the weakest component of an implant, acts as a lubricant, and thus
results in micro-movement and wear on the inner surface of the implant. Finally,
with the exposure of the implant surface during maintenance, chemical changes
may occur on the surface of the implant with factors such as saliva and bacteria.
Cleaning of implants surface with various instruments may also cause titanium
release [57]. Titanium release, which may occur due to the reasons listed above, has
been held responsible for peri-implant diseases such as mucositis and
periimplantitis in recent years. Oliviera et al. reported that titanium particles
increase osteoclast activity and cause mutational changes in cells. As a result, it was
argued that titanium release from the implant surface is responsible for peri-
implant tissue destruction with its cytotoxic and genotoxic effect [58]. In many
studies, titanium nanoparticles phagocytosed by macrophages were found in histo-
logical examination of specimens taken from the surrounding infected tissue. In a
study by Wennerberg et al., implants with moderately rough surfaces emit much
more titanium than other implant surfaces. The same study argues that the titanium
oxide layer oscillates more easily in additive surfaces than the surfaces formed by
subtraction [59]. In the light of all this information, it is not possible to say that
titanium used in dental implant applications is bio-inert. Due to the surface struc-
ture of the implant, bone density, overloading, and various many different factors,
potential influences in degradation of the implant surface come in sight and harmful
effects on the surrounding tissues can occur [60]. On the other hand, the peripheral
organ impacts of titanium are still controversial. Although it is not possible to
completely eliminate the titanium particle release, there are some ways to minimize
titanium release. Today, the use of different materials that are more resistant to
abrasion (such as zirconium, tantalium, etc.) has come to the fore in order to
protect against the possible harmful effects of titanium.
1.5.1 Implant macrogeometry
Implant macrogeometry, which can also be defined as implant design, has been
one of the most researched topics in recent years. However, before examining
thoroughly into this topic, it is necessary to know the two popular hypotheses that
implant success and survival are based on. The first one is the “Biological Hypoth-
esis” which declares, marginal bone loss mostly depends on bacterial plaque and the
host response. “Biomechanical Hypothesis,” which became a current factor, advo-
cates the effect of occlusal excessive forces on the bone surrounding implants and
compression, tension, and shear forces during and after osseointegration are crucial
in implant survival and success. According to the biomechanical hypothesis,
implant design is the key that provides primary stability of the implant and resis-
tance of the implant to forces during and after osseointegration. Primary and sec-
ondary osseointegration degrees and durations of the implant have been correlated
with macrogeometry in many studies. The reason for this fact is that implant
macrogeometry affects the host-implant response [61]. According to these studies,
the healing time of implants was shortened with the development of implant
macrogeometries, and the possibility of immediate or early loading of implants
came to the fore. Especially in recent years within the scope of macrogeometry,
many studies have been examining implant abutment connection, implant neck
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design, and their effects on long-term preservation of crestal bone. Nowadays, the
aim should be to achieve an ideal implant macrogeometry to put the implants into
function in the shortest time and to ensure their long-term function. The body
shape, groove design, or groove geometry (groove shape, groove spacing, groove
depth, groove width, implant groove surface angle, and helix angle), prosthetic
interface, and implant neck design forms the macrogeometry of an implant.
1.5.2 Implant microgeometry
The concept of implant microgeometry was first described by Geng et al. in
2004 consists of implant surface topography, implant surface coating, and implant
material [62]. In addition, Albrektsson et al. identified six factors for reliable
osseointegration. Surface quality is one of the six factors that plays a key role in the
host’s response to the implant.
1.5.2.1 Implant surface topography and implant surface coating
The term implant surface refers to an outer layer of 1–2 nm which includes
several outermost atomic layers different from the body material. This outermost
layer is seen as the thickness of the titanium oxide layer and the structure that can
be responsible for the reactions that occur on the surface. Implant surface modifi-
cation can be performed in two ways by forming concave or convex surface tissue.
Various methods such as sandblasting, turning, chemical and electrochemical pick-
ling, laser application, and anodizing are used for roughening of surfaces. The
amount of roughness of the resulting surface can range from nanometers to milli-
meters [63]. A number of studies have shown that rough surface implants have a
stronger connection with bone; this structure stops the migration of epithelial
attachment to the apical, thus preventing crestal bone resorption [64].
2. Conclusion
The discipline of oral implantology has come a long way from its state in 1960s.
This is largely due to the rapid evolution of biomaterials discipline in 1970s. With
new biomaterials and advances in surgical techniques, dental implantology is a
highly successful field, consistently publishing articles reporting success rates of
90% and above over long follow-ups. Biomaterials are now manufactured and
provided as sterile, standardized devices with high predictability which is essential
in the field of medicine. This requirement of predictability is the reason titanium
implants with widely used, well-documented surface properties are the gold stan-
dard and are the most common biomaterial of choice in dental implant devices. In
recent years, zirconium implants have been rising in popularity and dependable
short-term clinical outcomes look promising, but future research of long-term clin-
ical outcomes is necessary to safely recommend and expand the indications of
zirconia implants.
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provided as sterile, standardized devices with high predictability which is essential
in the field of medicine. This requirement of predictability is the reason titanium
implants with widely used, well-documented surface properties are the gold stan-
dard and are the most common biomaterial of choice in dental implant devices. In
recent years, zirconium implants have been rising in popularity and dependable
short-term clinical outcomes look promising, but future research of long-term clin-
ical outcomes is necessary to safely recommend and expand the indications of
zirconia implants.
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Composite Scaffolds for Bone 
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Abstract
The hydroxyapatite [HAp, Ca10(PO4)6(OH)2] has a variety of applications in bone 
fillers and replacements due to its excellent bioactivity and osteoconductivity. It com-
prises the main inorganic component of hard tissues. Among the various approaches, 
a composite approach using several components like biopolymer, gelatin, collagen, 
and chitosan in the functionalization of scaffolds with HAp has the prospective to 
be an engineered biomaterial for bone tissue engineering. HAp composite scaffolds 
have been developed to obtain a material with different functionalities such as surface 
reactivity, bioactivity, mechanical strength, and capability of drug or growth fac-
tor delivery. Several techniques and processes for the synthesis and fabrication of 
biocompatible HAp composite scaffolds suitable for bone regeneration are addressed 
here. Further, this chapter described the excellences of various HAp composite scaf-
folds used in in vitro and in vivo experiments in bone tissue engineering.
Keywords: hydroxyapatite, scaffolds, tissue engineering, bioceramics, composite, 
stem cell
1. Introduction
Recently, regenerated bone grafts have drawn attention as a promising new bone 
grafting technology for use in tissue engineering [1]. Bone tissue engineering offers 
an alternative approach for repairing bone defects caused by trauma, malignancies, 
and congenital diseases [2]. Scaffolds are one of the key factors for bone tissue engi-
neering. The scaffolds act as substrates by providing a temporary home for growth 
and proliferation of cells. The scaffolds also provide structural and mechanical 
support for cell growth. Therefore, scaffolds should possess sufficient mechanical 
strength to provide structural support and a porous structure to guide new bone tis-
sue in-growth [1, 3, 4]. Hydroxyapatite (HAp) has been used in regenerative science 
dates back to the 1950s as an inert scaffold for filling of the bone defects [5]. It is a 
calcium phosphate bioceramic [Ca10(PO4)6(OH)2] that has widely been applied as 
scaffolds in bone tissue engineering because of high osteoconductivity and biocom-
patibility. It is a well-known bioceramic found as a major component of bone and 
tooth [6, 7]. HAp is one of the popular bioceramics used in bone tissue engineering 
because it possesses chemical structure very similar to carbonate apatite which is 
the major inorganic component of bone [8, 9]. HAp bioceramics have been widely 
application in dental implantology.
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strength to provide structural support and a porous structure to guide new bone tis-
sue in-growth [1, 3, 4]. Hydroxyapatite (HAp) has been used in regenerative science 
dates back to the 1950s as an inert scaffold for filling of the bone defects [5]. It is a 
calcium phosphate bioceramic [Ca10(PO4)6(OH)2] that has widely been applied as 
scaffolds in bone tissue engineering because of high osteoconductivity and biocom-
patibility. It is a well-known bioceramic found as a major component of bone and 
tooth [6, 7]. HAp is one of the popular bioceramics used in bone tissue engineering 
because it possesses chemical structure very similar to carbonate apatite which is 
the major inorganic component of bone [8, 9]. HAp bioceramics have been widely 
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used as artificial bone substitutes because of their favorable biological properties, 
which include biocompatibility, bioaffinity, bioactivity, and osteoconduction [10]. 
HAp bioceramics contain only calcium and phosphate ions, and therefore, no 
adverse local or systemic toxicity has been reported in any study.
In tissue engineering, the interactions between tissue and HAp are impor-
tant. Therefore, it is necessary to understand the in vivo host responses for HAp. 
Generally, the mechanism of action of a biomaterial is considered to be biocompat-
ible, bioinert, biotolerant, and bioactive and includes bioresorbable materials. 
Bioactive materials form a chemical bond. The roughness and biomaterial porosity 
is considered to be an important factor for bonding. In this connection, HAp has 
displayed an ability to bond directly with the bone. It also exhibits the property of 
osteoinductivity [10, 11]. HAp scaffolds are very much recognized because of their 
osteoconduction and osteoinduction properties. Due to the provocation of the host 
mesenchymal stem cells, osteoinduction takes place in bone graft implantation. 
Therefore, these stem cells are then distinguished into bone-developing osteo-
blasts. Wide-ranging researches from worldwide have been accompanied several 
researches to recognize the osteoinduction potential of HAp over the past numerous 
years. As a result, through a number of independent studies in several hosts such 
as dogs, goats, and baboons osteoinduction has been finally detected [11–14]. In 
relation to the previous development, recently, comprehensive studies have been 
performed to construct biomimetic scaffolds materials for bone tissue engineer-
ing utilizations. Three-dimensional structure of these biomaterials is very much 
necessary for proper functioning. Few excellent properties of these scaffolds such 
as a high volume of open and interconnected pores, a bioresorbable scaffold with 
controlled resorption, appropriate mechanical properties, biocompatibility, and 
bioactivity are highly recommended in bone tissue engineering [15].
Various permeable scaffolds can be assembled by using both bioactive ceramics and 
biocompatible polymers for the application in bone tissue engineering [1]. The bioac-
tivity of graft substitutes is mostly governed by the degree of porosity of the fabricated 
biomaterials, which controls the rate of bone regeneration, local environment, and 
equilibrium of new bone at the repair site. Therefore, the osteoconductivity of the 
inductivity potential of the bone graft is synergistically promoted by the pore intercon-
nectivity, geometry, topography, and porosity modulate osteogenesis of the fabricated 
scaffolds [16–18]. Bioactive ceramics have a chemical composition resembling that of 
natural bone, allowing osteogenesis and providing bony contact and bonds with host 
bone [6, 19]. HAp is a typical bioceramic clinically used as a bone substitute, and it has 
also been used as scaffold materials in bone tissue engineering owing to its bioactivity, 
biocompatibility, and osteoconductivity. However, the low strength and toughness of 
HAp has limited its wide application in orthopedic implants [20]. The main reason for 
these low mechanical properties is thought to be the decomposition of HAp into differ-
ent calcium phosphate phases, such as tricalcium phosphate (TCP) and even tetra-
calcium phosphate (TTCP) [21]. Therefore, the mechanical properties of the HAp 
porous scaffold must be enhanced to use effectively in load-bearing compartments and 
tissue engineering applications. Various kinds of natural polymers, synthetic polymers 
(chitosan), protein (collagen), and bioceramics have been used along with HAp to 
develop composite porous scaffolds for bone tissue engineering in recent years.
2. Synthesis and fabrication processes
Scaffold fabricated by various methods acts as a substrate to stimulate cell 
adhesion, maintenance of differentiated cell function without hampering prolif-
eration. It is also a template to establish and direct the growth of cells and help in 
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the construction of extracellular matrix (ECM) [22]. Therefore, a biodegradable 
scaffold serves as a temporary skeleton in bone tissue engineering. Generally, 
when such scaffolds are inserted into the sites of faulty or lost bone to support and 
stimulate bone tissue regeneration, they gradually degrades and is replaced by new 
bone tissue [23–25]. The use of HAp as a scaffold material has been introduced in 
bone tissue engineering mainly due to its unique properties and similarity with bone 
components. The low strength and toughness of HAp has limited its wide applica-
tion in bone tissue engineering. Therefore, improved mechanical properties of the 
HAp porous scaffolds are required for the extensive range of applications and effec-
tive utilization in load-bearing compartments [1]. To overcome the brittleness of 
HAp porous body, biodegradable synthetic polymers such as poly (lactic co-glycolic 
acid) (PLGA), para-Methoxy-N-methylamphetamine (PMMA), poly(L-lactic acid) 
PLLA, and poly(ε-caprolactone) PCL are used as composites [26–29]. Even some 
attempts have been made to introduce bioceramics into polymer-based scaffolds or 
to combine synthetic polymers with natural polymers to enhance their biological 
capacity [30]. Recently, several studies are focusing on the development of HAp-
COL and HAp-COL/HAp composite scaffolds or HA-CNT nanocomposites with 
improved mechanical properties [31, 32]. HAp-COL and HAp-COL/HAp composite 
scaffolds or HA-CNT nanocomposites for orthopedic implants are synthesizing 
through template method, plasma spraying, laser surface alloying, electrophoretic 
deposition, and aerosol deposition [31, 33–37]. In addition to conventional sintering 
and hot isostatic pressing, spark plasma sintering (SPS) has also been employed to 
fabricate freestanding HA-CNT composites [38–41]. HAp-COL and HAp-COL/HAp 
composite scaffolds are also fabricated in a specific freeze-drying procedure [31].
2.1 Synthesis of HAp porous scaffolds by the template method
A template method (using polyurethane foam [PU]) was applied to prepare 
HAp porous scaffolds from HAp slurry. The HAp slurry was synthesized from 
HAp nanopowder and a 5 wt% solution of polyvinyl alcohol (PVA) (Wako Pure 
Chemical Industries, Ltd.). The HAp slurry was prepared by mixing the HAp 
powder and PVA solution at a mixing ratio of 1:1 (1 g of HAp to 1 ml of PVA) using 
a centrifuge mixing machine (Imoto Co, Ltd.). The machine was kneading for 
10 minutes and degassing (removal of gas bubbles) for 8 minutes to obtain the best 
outcome. A PU sponge sheet (HR-30, Bridgestone) was cut into cubic templates 
with dimensions of 10 × 10 × 10 mm. These cubes were then immersed into the 
ready HAp slurry. To escape blockage of the pores by the slurry, the additional 
slurry was removed by pressing the cubes at compression ratios of 50, 75, and 95%. 
To eliminate water content and to attach the HAp powders to the surface of the 
sponge framework, the cubes were then dried out at room temperature for 24 hours. 
The dried cubes were then calcined at 400°C for 6 hours and further sintered at 
1000, 1100, or 1200°C for 3 hours. The heating rate was set to 10°C/minute. The 
solidified samples were termed “pure HAp scaffolds” thereafter. The sintering 
process is illustrated schematically in Figure 1(a) [1].
2.2 Fabrication of HAp porous scaffolds with collagen and HAp particles
In a collagen-1 solution prepared, pure HAp scaffolds were dipped (Nippon Meat 
Packers Inc., Osaka, Japan) and then it was vacuumed for at least 30 minutes to 
eliminate the excess air. To synthesize HAp scaffolds with collagen coating, firstly, the 
surplus collagen solution was removed manually by pipette, and then the samples were 
dried at room temperature for at least 48 hours. On the other hand, a milk-like slime 
of HAp particles was formulated by mixing it accurately with the collagen-1 solution 
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used as artificial bone substitutes because of their favorable biological properties, 
which include biocompatibility, bioaffinity, bioactivity, and osteoconduction [10]. 
HAp bioceramics contain only calcium and phosphate ions, and therefore, no 
adverse local or systemic toxicity has been reported in any study.
In tissue engineering, the interactions between tissue and HAp are impor-
tant. Therefore, it is necessary to understand the in vivo host responses for HAp. 
Generally, the mechanism of action of a biomaterial is considered to be biocompat-
ible, bioinert, biotolerant, and bioactive and includes bioresorbable materials. 
Bioactive materials form a chemical bond. The roughness and biomaterial porosity 
is considered to be an important factor for bonding. In this connection, HAp has 
displayed an ability to bond directly with the bone. It also exhibits the property of 
osteoinductivity [10, 11]. HAp scaffolds are very much recognized because of their 
osteoconduction and osteoinduction properties. Due to the provocation of the host 
mesenchymal stem cells, osteoinduction takes place in bone graft implantation. 
Therefore, these stem cells are then distinguished into bone-developing osteo-
blasts. Wide-ranging researches from worldwide have been accompanied several 
researches to recognize the osteoinduction potential of HAp over the past numerous 
years. As a result, through a number of independent studies in several hosts such 
as dogs, goats, and baboons osteoinduction has been finally detected [11–14]. In 
relation to the previous development, recently, comprehensive studies have been 
performed to construct biomimetic scaffolds materials for bone tissue engineer-
ing utilizations. Three-dimensional structure of these biomaterials is very much 
necessary for proper functioning. Few excellent properties of these scaffolds such 
as a high volume of open and interconnected pores, a bioresorbable scaffold with 
controlled resorption, appropriate mechanical properties, biocompatibility, and 
bioactivity are highly recommended in bone tissue engineering [15].
Various permeable scaffolds can be assembled by using both bioactive ceramics and 
biocompatible polymers for the application in bone tissue engineering [1]. The bioac-
tivity of graft substitutes is mostly governed by the degree of porosity of the fabricated 
biomaterials, which controls the rate of bone regeneration, local environment, and 
equilibrium of new bone at the repair site. Therefore, the osteoconductivity of the 
inductivity potential of the bone graft is synergistically promoted by the pore intercon-
nectivity, geometry, topography, and porosity modulate osteogenesis of the fabricated 
scaffolds [16–18]. Bioactive ceramics have a chemical composition resembling that of 
natural bone, allowing osteogenesis and providing bony contact and bonds with host 
bone [6, 19]. HAp is a typical bioceramic clinically used as a bone substitute, and it has 
also been used as scaffold materials in bone tissue engineering owing to its bioactivity, 
biocompatibility, and osteoconductivity. However, the low strength and toughness of 
HAp has limited its wide application in orthopedic implants [20]. The main reason for 
these low mechanical properties is thought to be the decomposition of HAp into differ-
ent calcium phosphate phases, such as tricalcium phosphate (TCP) and even tetra-
calcium phosphate (TTCP) [21]. Therefore, the mechanical properties of the HAp 
porous scaffold must be enhanced to use effectively in load-bearing compartments and 
tissue engineering applications. Various kinds of natural polymers, synthetic polymers 
(chitosan), protein (collagen), and bioceramics have been used along with HAp to 
develop composite porous scaffolds for bone tissue engineering in recent years.
2. Synthesis and fabrication processes
Scaffold fabricated by various methods acts as a substrate to stimulate cell 
adhesion, maintenance of differentiated cell function without hampering prolif-
eration. It is also a template to establish and direct the growth of cells and help in 
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the construction of extracellular matrix (ECM) [22]. Therefore, a biodegradable 
scaffold serves as a temporary skeleton in bone tissue engineering. Generally, 
when such scaffolds are inserted into the sites of faulty or lost bone to support and 
stimulate bone tissue regeneration, they gradually degrades and is replaced by new 
bone tissue [23–25]. The use of HAp as a scaffold material has been introduced in 
bone tissue engineering mainly due to its unique properties and similarity with bone 
components. The low strength and toughness of HAp has limited its wide applica-
tion in bone tissue engineering. Therefore, improved mechanical properties of the 
HAp porous scaffolds are required for the extensive range of applications and effec-
tive utilization in load-bearing compartments [1]. To overcome the brittleness of 
HAp porous body, biodegradable synthetic polymers such as poly (lactic co-glycolic 
acid) (PLGA), para-Methoxy-N-methylamphetamine (PMMA), poly(L-lactic acid) 
PLLA, and poly(ε-caprolactone) PCL are used as composites [26–29]. Even some 
attempts have been made to introduce bioceramics into polymer-based scaffolds or 
to combine synthetic polymers with natural polymers to enhance their biological 
capacity [30]. Recently, several studies are focusing on the development of HAp-
COL and HAp-COL/HAp composite scaffolds or HA-CNT nanocomposites with 
improved mechanical properties [31, 32]. HAp-COL and HAp-COL/HAp composite 
scaffolds or HA-CNT nanocomposites for orthopedic implants are synthesizing 
through template method, plasma spraying, laser surface alloying, electrophoretic 
deposition, and aerosol deposition [31, 33–37]. In addition to conventional sintering 
and hot isostatic pressing, spark plasma sintering (SPS) has also been employed to 
fabricate freestanding HA-CNT composites [38–41]. HAp-COL and HAp-COL/HAp 
composite scaffolds are also fabricated in a specific freeze-drying procedure [31].
2.1 Synthesis of HAp porous scaffolds by the template method
A template method (using polyurethane foam [PU]) was applied to prepare 
HAp porous scaffolds from HAp slurry. The HAp slurry was synthesized from 
HAp nanopowder and a 5 wt% solution of polyvinyl alcohol (PVA) (Wako Pure 
Chemical Industries, Ltd.). The HAp slurry was prepared by mixing the HAp 
powder and PVA solution at a mixing ratio of 1:1 (1 g of HAp to 1 ml of PVA) using 
a centrifuge mixing machine (Imoto Co, Ltd.). The machine was kneading for 
10 minutes and degassing (removal of gas bubbles) for 8 minutes to obtain the best 
outcome. A PU sponge sheet (HR-30, Bridgestone) was cut into cubic templates 
with dimensions of 10 × 10 × 10 mm. These cubes were then immersed into the 
ready HAp slurry. To escape blockage of the pores by the slurry, the additional 
slurry was removed by pressing the cubes at compression ratios of 50, 75, and 95%. 
To eliminate water content and to attach the HAp powders to the surface of the 
sponge framework, the cubes were then dried out at room temperature for 24 hours. 
The dried cubes were then calcined at 400°C for 6 hours and further sintered at 
1000, 1100, or 1200°C for 3 hours. The heating rate was set to 10°C/minute. The 
solidified samples were termed “pure HAp scaffolds” thereafter. The sintering 
process is illustrated schematically in Figure 1(a) [1].
2.2 Fabrication of HAp porous scaffolds with collagen and HAp particles
In a collagen-1 solution prepared, pure HAp scaffolds were dipped (Nippon Meat 
Packers Inc., Osaka, Japan) and then it was vacuumed for at least 30 minutes to 
eliminate the excess air. To synthesize HAp scaffolds with collagen coating, firstly, the 
surplus collagen solution was removed manually by pipette, and then the samples were 
dried at room temperature for at least 48 hours. On the other hand, a milk-like slime 
of HAp particles was formulated by mixing it accurately with the collagen-1 solution 
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(1:9) at 30°C and stirred continuously by a magnetic stirrer. To fabricate HAp scaffolds 
with collagen-HAp coating, the prepared slime was then poured over the pure HAp 
scaffolds. After that, the additional slime was removed and the scaffolds were dried 
out for at least 48 hours to get fabricate HAp scaffolds. The two distinct types of fabri-
cated composite scaffolds were thereafter termed as “HAp-COL” and “HAp-COL/HAp 
particle-coated scaffolds,” respectively. The detail fabrication processes of the HAp-
COL and HAp-COL/HAp scaffolds are illustrated schematically here in Figure 1(b) 
[1]. Further, a specific freeze-drying procedure was applied to fabricate coated HAp 
scaffolds form both types. The pure HAp porous composite scaffolds were frozen at 
−20°C for 24 hours and then freeze-dried at −50°C for 24 hours. These samples were 
termed “HAp-Collagen or HAp-Collagen/HAp particles two-phase scaffolds” [31].
2.3 Fabrication of HAp composite by Nd-YAG laser
HAp composite scaffolds were fabricated by a unique process where HAp pow-
ders were coated on titanium substrates at low temperature, and this coating/sub-
strate interfacing was enhanced by a laser surface engineering. In this technology, 
Nd-YAG laser was transmitted to HAp powders and the laser power was absorbed 
by titanium substrate to produce a thin layer of the molten region. Finally, in this 
procedure, HAp powders were kept at low temperature before they were entrapped 
in the metallic layer during coating [35].
Figure 1. 
Schematic of the (a) sintering processes and (b) synthesis to the fabrication of HAp porous composite scaffolds [1].
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2.4 Fabrication of HAp composite by electrophoretic deposition (EPD)
Usually, various bioactive ceramics like HAp are coated containing carbon 
nanotubes on metallic substrates through electrophoretic deposition. The EPD 
technique is described by Sing et al.. Using EPD, a variety of potentially bioactive 
ceramic coatings constructed on combinations of either HAp or titanium oxide 
nanoparticles with carbon nanotubes (CNTs) have been deposited on metallic sub-
strates. Further, sol-gel-derived ultrafine HAp powders (10–70 nm) were dispersed 
in multi-wall nanotube-containing ethanol suspensions maintained at pH = ∼3.5 
and successfully coated onto Ti alloy wires at 20 V for 1–3 minutes. Commercially 
available TiO2 nanopowders and surface-treated CNTs in aqueous suspensions were 
co-deposited on stainless steel planar substrates for TiO2/CNT coatings. A field 
strength of 20 V/cm and a deposition time of 4 minutes were used in this process to 
work at pH = 5 [36].
2.5 Fabrication of HAp composite by aerosol deposition
Hahn et al. developed an aerosol deposition technique to fabricate HAp-carbon 
nanotube (CNT) composite coatings on Ti plate. Through this aerosol deposition 
technique, authors fabricating HAp-CNT powders composites for biomedical 
applications. For the deposition process, HAp-CNT powder mixtures with CNT 
contents of 1 and 3 wt.% were used. Dense coatings with a thickness of 5 μm were 
fabricated, irrespective of the content of CNTs. The propagation and alkaline 
phosphatase (ALP) activity of MC3T3-E1 pre-osteoblast cells grown on the HAp-
CNT composite coatings was estimated. A higher propagation and alkaline phos-
phatase (ALP) activity of MC3T3-E1 pre-osteoblast cells grown on the fabricated 
HAp-CNT composite coatings was detected than those on the bare Ti and pure 
HAp coating. It was also found that by increasing the CNT content of the compos-
ite materials, an enhanced ALP activity of the composite coatings was obtained. 
Therefore, the findings suggested that for the improvement both the mechani-
cal and biological performances of HAp coatings, CNTs would be an effective 
 fortifying agent [37].
2.6 Fabrication of HAp composite by in situ chemical vapor deposition
Li et al. described a novel process to fabricate carbon nanotubes (CNTs) (Fe)/
HAp composite. By this novel process (CNTs), (Fe)/HAp composite was success-
fully prepared where CNTs homogeneously dispersed. In this procedure, at first 
Fe2O3/HAp precursor was produced and then calcined in an atmosphere of N2 gas. 
The reduction reaction was done in the presence of hydrogen of the Fe2O3/HAp 
precursor to yield Fe/HAp catalyst, and finally, in situ synthesis of nanotubes by 
chemical vapor deposition over Fe/HAp catalyst was performed. To yield CNTs 
(Fe)/HAp bulk composites, these outstanding CNTs (Fe)/HAp composite powder 
was utilized. These CNTs (Fe)/HAp bulk composites further pressed and sintered 
to produce CNTs (Fe)/HAp nanocomposites. It was analyzed that the CNTs distrib-
uted homogenously and bonded strongly with the HAp matrix [39].
2.7  Fabrication of HAp composite by poly(ε-caprolactone) (PCL) and  
poly(L-lactide) (PLLA)
PCL pallets with the molecular formula (CH2)5CO2, molecular weight (Mw) 
of 105g.mol−1, glass transition temperature Tg = −62.62°C, and melting point 
Tm = 65.4°C (Celgreen PH7, Daicel Chemistry Industries Co., Ltd.) were dissolved 
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(1:9) at 30°C and stirred continuously by a magnetic stirrer. To fabricate HAp scaffolds 
with collagen-HAp coating, the prepared slime was then poured over the pure HAp 
scaffolds. After that, the additional slime was removed and the scaffolds were dried 
out for at least 48 hours to get fabricate HAp scaffolds. The two distinct types of fabri-
cated composite scaffolds were thereafter termed as “HAp-COL” and “HAp-COL/HAp 
particle-coated scaffolds,” respectively. The detail fabrication processes of the HAp-
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strate interfacing was enhanced by a laser surface engineering. In this technology, 
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2.4 Fabrication of HAp composite by electrophoretic deposition (EPD)
Usually, various bioactive ceramics like HAp are coated containing carbon 
nanotubes on metallic substrates through electrophoretic deposition. The EPD 
technique is described by Sing et al.. Using EPD, a variety of potentially bioactive 
ceramic coatings constructed on combinations of either HAp or titanium oxide 
nanoparticles with carbon nanotubes (CNTs) have been deposited on metallic sub-
strates. Further, sol-gel-derived ultrafine HAp powders (10–70 nm) were dispersed 
in multi-wall nanotube-containing ethanol suspensions maintained at pH = ∼3.5 
and successfully coated onto Ti alloy wires at 20 V for 1–3 minutes. Commercially 
available TiO2 nanopowders and surface-treated CNTs in aqueous suspensions were 
co-deposited on stainless steel planar substrates for TiO2/CNT coatings. A field 
strength of 20 V/cm and a deposition time of 4 minutes were used in this process to 
work at pH = 5 [36].
2.5 Fabrication of HAp composite by aerosol deposition
Hahn et al. developed an aerosol deposition technique to fabricate HAp-carbon 
nanotube (CNT) composite coatings on Ti plate. Through this aerosol deposition 
technique, authors fabricating HAp-CNT powders composites for biomedical 
applications. For the deposition process, HAp-CNT powder mixtures with CNT 
contents of 1 and 3 wt.% were used. Dense coatings with a thickness of 5 μm were 
fabricated, irrespective of the content of CNTs. The propagation and alkaline 
phosphatase (ALP) activity of MC3T3-E1 pre-osteoblast cells grown on the HAp-
CNT composite coatings was estimated. A higher propagation and alkaline phos-
phatase (ALP) activity of MC3T3-E1 pre-osteoblast cells grown on the fabricated 
HAp-CNT composite coatings was detected than those on the bare Ti and pure 
HAp coating. It was also found that by increasing the CNT content of the compos-
ite materials, an enhanced ALP activity of the composite coatings was obtained. 
Therefore, the findings suggested that for the improvement both the mechani-
cal and biological performances of HAp coatings, CNTs would be an effective 
 fortifying agent [37].
2.6 Fabrication of HAp composite by in situ chemical vapor deposition
Li et al. described a novel process to fabricate carbon nanotubes (CNTs) (Fe)/
HAp composite. By this novel process (CNTs), (Fe)/HAp composite was success-
fully prepared where CNTs homogeneously dispersed. In this procedure, at first 
Fe2O3/HAp precursor was produced and then calcined in an atmosphere of N2 gas. 
The reduction reaction was done in the presence of hydrogen of the Fe2O3/HAp 
precursor to yield Fe/HAp catalyst, and finally, in situ synthesis of nanotubes by 
chemical vapor deposition over Fe/HAp catalyst was performed. To yield CNTs 
(Fe)/HAp bulk composites, these outstanding CNTs (Fe)/HAp composite powder 
was utilized. These CNTs (Fe)/HAp bulk composites further pressed and sintered 
to produce CNTs (Fe)/HAp nanocomposites. It was analyzed that the CNTs distrib-
uted homogenously and bonded strongly with the HAp matrix [39].
2.7  Fabrication of HAp composite by poly(ε-caprolactone) (PCL) and  
poly(L-lactide) (PLLA)
PCL pallets with the molecular formula (CH2)5CO2, molecular weight (Mw) 
of 105g.mol−1, glass transition temperature Tg = −62.62°C, and melting point 
Tm = 65.4°C (Celgreen PH7, Daicel Chemistry Industries Co., Ltd.) were dissolved 
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in 1,4 dioxane (Kishida Chemical Co., Ltd., Osaka, Japan) to get the solution with a 
concentration of 1, 3, 5, 7 and 10 wt% by stirring at 60°C for 2 hours. HAp porous 
scaffolds were dipped into the solution, and it was then vacuumed for 1 hour to 
eliminate the air. For drying of these scaffolds, two different conditions were 
applied. The drenched HAp porous scaffolds were taken out from the PCL solution 
and then dried in an air oven at room temperature for 24 hours in the first drying 
process. These specimens were named as “HAp/PCL-coated scaffolds.” On the other 
hand, in the second drying process, the freeze-drying procedure was employed to 
obtain a two-phase porous construction. After excess PCL solution was removed 
from the soaked HAp porous materials, the samples were frozen at −20°C for 
24 hours and then freeze-dried at −50°C for 24 hours. These specimens were named 
as “HAp/PCL 2-phase scaffolds.” The summary of the reinforcement process is 
shown in Figure 2 [42].
3. Excellences in bone tissue engineering
The scaffolds act as a temporary substitute in bone tissue engineering and the 
interest of researchers in it as it permits mechanical support until the tissue has 
regenerated and remodeled itself naturally. It is well established that biopolymers 
such as collagen [43], chitosan [44], and hyaluronic acid [45]; biodegradable 
synthetic polymers such as poly(L-lactic acid) [46], poly(ε-caprolactone) [47], and 
polyglycolic acid (PGA) [48]; and bioactive ceramics such as hydroxyapatite [49], 
α-tricalcium phosphates [50], and β-tricalcium phosphates (β-TCP) [51] are used as 
the raw materials for the preparation of the scaffolds suitable for tissue engineering. 
These materials have been independently used to develop scaffolds, but composite 
materials have also been considered as ideal materials having mechanical stability, 
biocompatibility, cell proliferation, and easy proccessability [52–55]. However, HAp 
grows interested in scientists and researchers due to its mechanical and biological 
response and its efficiency in repairing a hard tissue defect in the composite state. 
This section will summarize the excellence of different HAp composite scaffolds for 
bone substitutes and hard tissue repair.
Figure 2. 
Schematic of biopolymer-reinforced HAp porous materials.
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3.1 In vitro experiments using HAp composite scaffolds
Phanny (in our lab) conducted a study using HAp/PCL-coated scaffold and 
HAp/PCL two-phase scaffold to investigate the mechanical properties variation, 
biocompatibility, and differentiation efficiency within 4 weeks of cell culture in a 
standard medium and osteoblast differentiation medium [42]. Human mesenchy-
mal stem cells (hMSCs) were seeded in both types of scaffold for 1–4 weeks with an 
α-minimum essential medium eagle with L-glutamine and phenol red (MEMα) for 
the growth and with osteoblast differentiation medium for cellular differentiation. 
The author reported that both HAp/PCL-coated scaffold (Figure 3, left) and HAp/
PCL two-phase scaffolds were biocompatible where hMSCs have grown and prolif-
erated rapidly (Figure 3, right). The level of p-nitrophenol obtained via ALP assay 
of both types of scaffolds are almost the same because the cells tended to proliferate 
in standard medium rather than differentiation. The cells cultured in osteoblast 
differentiation medium were able to differentiate into an osteoblastic lineage with 
an increasing level of p-nitrophenol and density of ARS staining. It was also found 
that specimens without cell seeding continuously decreased in both elastic modulus 
and compressive strength in both standard medium and osteoblast differentiation 
medium and remained lower than that of specimens with cell culture.
Therefore, it was concluded that the ability to allow cells to grow, proliferate, dif-
ferentiate, and maintain mechanical properties of HAp/PCL-coated and two-phase 
scaffolds are a high potential candidate for bone tissue engineering applications [42].
Figure 3. 
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eliminate the air. For drying of these scaffolds, two different conditions were 
applied. The drenched HAp porous scaffolds were taken out from the PCL solution 
and then dried in an air oven at room temperature for 24 hours in the first drying 
process. These specimens were named as “HAp/PCL-coated scaffolds.” On the other 
hand, in the second drying process, the freeze-drying procedure was employed to 
obtain a two-phase porous construction. After excess PCL solution was removed 
from the soaked HAp porous materials, the samples were frozen at −20°C for 
24 hours and then freeze-dried at −50°C for 24 hours. These specimens were named 
as “HAp/PCL 2-phase scaffolds.” The summary of the reinforcement process is 
shown in Figure 2 [42].
3. Excellences in bone tissue engineering
The scaffolds act as a temporary substitute in bone tissue engineering and the 
interest of researchers in it as it permits mechanical support until the tissue has 
regenerated and remodeled itself naturally. It is well established that biopolymers 
such as collagen [43], chitosan [44], and hyaluronic acid [45]; biodegradable 
synthetic polymers such as poly(L-lactic acid) [46], poly(ε-caprolactone) [47], and 
polyglycolic acid (PGA) [48]; and bioactive ceramics such as hydroxyapatite [49], 
α-tricalcium phosphates [50], and β-tricalcium phosphates (β-TCP) [51] are used as 
the raw materials for the preparation of the scaffolds suitable for tissue engineering. 
These materials have been independently used to develop scaffolds, but composite 
materials have also been considered as ideal materials having mechanical stability, 
biocompatibility, cell proliferation, and easy proccessability [52–55]. However, HAp 
grows interested in scientists and researchers due to its mechanical and biological 
response and its efficiency in repairing a hard tissue defect in the composite state. 
This section will summarize the excellence of different HAp composite scaffolds for 
bone substitutes and hard tissue repair.
Figure 2. 
Schematic of biopolymer-reinforced HAp porous materials.
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3.1 In vitro experiments using HAp composite scaffolds
Phanny (in our lab) conducted a study using HAp/PCL-coated scaffold and 
HAp/PCL two-phase scaffold to investigate the mechanical properties variation, 
biocompatibility, and differentiation efficiency within 4 weeks of cell culture in a 
standard medium and osteoblast differentiation medium [42]. Human mesenchy-
mal stem cells (hMSCs) were seeded in both types of scaffold for 1–4 weeks with an 
α-minimum essential medium eagle with L-glutamine and phenol red (MEMα) for 
the growth and with osteoblast differentiation medium for cellular differentiation. 
The author reported that both HAp/PCL-coated scaffold (Figure 3, left) and HAp/
PCL two-phase scaffolds were biocompatible where hMSCs have grown and prolif-
erated rapidly (Figure 3, right). The level of p-nitrophenol obtained via ALP assay 
of both types of scaffolds are almost the same because the cells tended to proliferate 
in standard medium rather than differentiation. The cells cultured in osteoblast 
differentiation medium were able to differentiate into an osteoblastic lineage with 
an increasing level of p-nitrophenol and density of ARS staining. It was also found 
that specimens without cell seeding continuously decreased in both elastic modulus 
and compressive strength in both standard medium and osteoblast differentiation 
medium and remained lower than that of specimens with cell culture.
Therefore, it was concluded that the ability to allow cells to grow, proliferate, dif-
ferentiate, and maintain mechanical properties of HAp/PCL-coated and two-phase 
scaffolds are a high potential candidate for bone tissue engineering applications [42].
Figure 3. 




It was reported in our previous study that hMSCs could be successfully cultured 
over HAp-COL and HAp-COL/HAp scaffolds. It was confirmed from that evalua-
tion that the scaffolds exhibited the best performance in terms of mechanical prop-
erties at a 50% compressive ratio. Figure 4 represents the FE-SEM micrographs of 
the surface regions of composite scaffolds with hMSCs [1]. In this figure, hMSCs’s 
adhesion and proliferation behaviors up to 7 days of culturing were observed on 
the surfaces. The FE-SEM micrographs of hMSCs cultivated over the fabricated 
composite scaffolds of HAp-COL and HAp-COL/HAp sintered at 1000, 1100, and 
1200°C are shown in figures (a), (c), and (e), and (b), (d), and (f), respectively. 
Most cells adhered tightly to the surface and were well disseminated. These results 
indicated that the composite scaffolds had favorable bioactivity for the promotion 
of cell adhesion and proliferation far excelling than that of pure HAp scaffolds. The 
effects of the compressive ratio and sintering temperature on cell-scaffold interac-
tions were evaluated through a cell proliferation assay using a cell-counting kit up to 
14 days of culture.
The growth performance of hMSCs over the constructed porous composite 
scaffolds is exhibited in Figure 5. Primarily, 1 × 104 cells were seeded on the fabri-
cated porous composite scaffolds. After the cells seeding well, the cell proliferation 
Figure 4. 
The FE-SEM images of 7 days culture period of hMSCs over HAp-COL and HAp-COL/HAp porous composite 
scaffolds fabricated at a 50% compressive ratio and sintered at (A) 1000C, (B) 1100°C, and (C) 1200°C. the 
FE-SEM images HAp-COL and HAp-COL/HAp porous composite scaffolds are represented by (a), (c), and 
(e) and (b), (d), and (f) at sintering temperature 1000°C, 1100°C, and 1200°C, respectively [1].
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behavior was recorded at 7 and 14 days of culture. It was noteworthy that the cell 
number increased until 7 days of culture for all types of scaffolds, while cell mul-
tiplication declined as the culturing days continued. The growth performance of 
hMSCs over the HAp-COL scaffolds sintered at 1000, 1100, and 1200°C displayed 
distinctive trend over their counterparts [1].
Wahl and Czernuszka summarized and compared a few excellent reports of in vitro 
experiments using HAp composite scaffolds and are listed here in Table 1 [56].
3.2 In vivo experiments using HAp composite scaffolds
Cai et al. fabricated coral hydroxyapatite (CHAp) as a cuboid of 
5 mm × 5 mm × 10 mm with an inclined groove. In this study, the prepared CHAp 
biomaterials was highly porous (porosity: 30–70%) with a fully interconnected 
pore with an average pore diameter of 100–600 μm. Here, the induced BMSCs 
Figure 5. 
The proliferation of hMSCs in HAp-COL and HAp-COL/HAp composite scaffolds fabricated at a 50% 
compressive ratio and sintered at 1000, 1100, and 1200°C with up to 14 days of culture. Each set of data 
represents the mean ± SD, n = 6, *p < 0.05 [1].
Composites Cell culturing or implantation Period (new tissue formed)
HA-Collagen (Du et al.) [57] Bone extract wrapped around 
composite osteogenic cells
21 days (mineralized bone)
HA-Collagen (Clarke et al.) [58] Human-derived bone cell culture 32 days (connective tissue and 
mineralized bone)
HA-Collagen (Wu et al.) [59] Osteoblasts from rat calvaria 21 days (mineralized bone)
HA-Collagen (Wang et al.) [60] Chondrocytes in a closed chamber 49 days (cartilage)
HA-Collagen-Elastin (Rovira 
et al.) [61]
Osteoblasts from trabecular bone 15 days (mineralized bone)
Table 1. 
In vitro experiments in bone tissue engineering using different HAp composites.
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It was reported in our previous study that hMSCs could be successfully cultured 
over HAp-COL and HAp-COL/HAp scaffolds. It was confirmed from that evalua-
tion that the scaffolds exhibited the best performance in terms of mechanical prop-
erties at a 50% compressive ratio. Figure 4 represents the FE-SEM micrographs of 
the surface regions of composite scaffolds with hMSCs [1]. In this figure, hMSCs’s 
adhesion and proliferation behaviors up to 7 days of culturing were observed on 
the surfaces. The FE-SEM micrographs of hMSCs cultivated over the fabricated 
composite scaffolds of HAp-COL and HAp-COL/HAp sintered at 1000, 1100, and 
1200°C are shown in figures (a), (c), and (e), and (b), (d), and (f), respectively. 
Most cells adhered tightly to the surface and were well disseminated. These results 
indicated that the composite scaffolds had favorable bioactivity for the promotion 
of cell adhesion and proliferation far excelling than that of pure HAp scaffolds. The 
effects of the compressive ratio and sintering temperature on cell-scaffold interac-
tions were evaluated through a cell proliferation assay using a cell-counting kit up to 
14 days of culture.
The growth performance of hMSCs over the constructed porous composite 
scaffolds is exhibited in Figure 5. Primarily, 1 × 104 cells were seeded on the fabri-
cated porous composite scaffolds. After the cells seeding well, the cell proliferation 
Figure 4. 
The FE-SEM images of 7 days culture period of hMSCs over HAp-COL and HAp-COL/HAp porous composite 
scaffolds fabricated at a 50% compressive ratio and sintered at (A) 1000C, (B) 1100°C, and (C) 1200°C. the 
FE-SEM images HAp-COL and HAp-COL/HAp porous composite scaffolds are represented by (a), (c), and 
(e) and (b), (d), and (f) at sintering temperature 1000°C, 1100°C, and 1200°C, respectively [1].
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behavior was recorded at 7 and 14 days of culture. It was noteworthy that the cell 
number increased until 7 days of culture for all types of scaffolds, while cell mul-
tiplication declined as the culturing days continued. The growth performance of 
hMSCs over the HAp-COL scaffolds sintered at 1000, 1100, and 1200°C displayed 
distinctive trend over their counterparts [1].
Wahl and Czernuszka summarized and compared a few excellent reports of in vitro 
experiments using HAp composite scaffolds and are listed here in Table 1 [56].
3.2 In vivo experiments using HAp composite scaffolds
Cai et al. fabricated coral hydroxyapatite (CHAp) as a cuboid of 
5 mm × 5 mm × 10 mm with an inclined groove. In this study, the prepared CHAp 
biomaterials was highly porous (porosity: 30–70%) with a fully interconnected 
pore with an average pore diameter of 100–600 μm. Here, the induced BMSCs 
Figure 5. 
The proliferation of hMSCs in HAp-COL and HAp-COL/HAp composite scaffolds fabricated at a 50% 
compressive ratio and sintered at 1000, 1100, and 1200°C with up to 14 days of culture. Each set of data 
represents the mean ± SD, n = 6, *p < 0.05 [1].
Composites Cell culturing or implantation Period (new tissue formed)
HA-Collagen (Du et al.) [57] Bone extract wrapped around 
composite osteogenic cells
21 days (mineralized bone)
HA-Collagen (Clarke et al.) [58] Human-derived bone cell culture 32 days (connective tissue and 
mineralized bone)
HA-Collagen (Wu et al.) [59] Osteoblasts from rat calvaria 21 days (mineralized bone)
HA-Collagen (Wang et al.) [60] Chondrocytes in a closed chamber 49 days (cartilage)
HA-Collagen-Elastin (Rovira 
et al.) [61]
Osteoblasts from trabecular bone 15 days (mineralized bone)
Table 1. 
In vitro experiments in bone tissue engineering using different HAp composites.
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were seeded on sterilized CHAp scaffold by a concentration of 20 × 106 cells/ml 
(200 ± 17 μL/scaffold, about 4 × 106 cells/scaffold) and were 3D cultured for 1 week 
before implantation. The growth behavior of BMSCs on the CHAp scaffold was 
assessed by using a scanning electron microscope and confocal laser electronic 
microscope [62]. The authors described an effective methodology to generate bone 
tissue and healing bone defect in ectopic and orthotopic sites. In this methodology, 
a tissue-engineered bone flap with a vascular pedicle of saphenous arteriovenous 
with an organized vascular network was observed after 4 weeks of implantation 
and followed by a successful repair of the fibular defect in beagle dogs (Figure 6).
Engineered bone formation in ectopic and orthotopic sites after implantation 
of 9 months over four CHAp scaffold groups were evaluated by CT (computed 
tomography) analysis. The stimuluses of vascularization and micro-environment 
on tissue-engineered bone were quantitatively analyzed by the comparison of bone 
formation and scaffold degradation between different groups (Figure 7). The 
results indicated that in the first 3 months, vascularization improved engineered 
bone formation by 2 times of non-vascular group and bone defect micro-environ-
ment improved it by 3 times the ectopic group, and the CHAp scaffold degradation 
was enhanced as well [62]. In the VSC group, the HE staining of decalcified paraf-
fin sections after 3 months embedding exhibited that there was a minor volume 
of bone-like tissue developed at the surface of the CHAp scaffold (Figure 7(B)). 
Figure 7(C) and (D) indicates the gradual improvement of engineered bone tissue 
after 6 months and a well-developed Haversian system with little residual scaffold 
remaining after 9 months, respectively. In the SC group, after 3 months of implan-
tation, only the osteoid was shown and until 6 months of implantation, there was 
no significant bone formation, but after 9 months of implantation, engineered bone 
tissue enlarged with much residual scaffold (Figure 7(E)–(H)). Figure 7(I)–(P) 
denotes the gradual degradation of the CHAp scaffolds without bone formation in 
both VS and S groups, the pores of the majority of CHAp scaffold fill with fibrous 
connective tissue and a large number of inflammatory cells. Moreover, more typical 
vascular structures and less inflammatory cells were seen in the VS group than that 
in the S group (Figure 7L and P).
In another study, Kikuchi et al. (2001) fabricated a biodegradable hydroxyapa-
tite/collagen (HAp/Col) nanocomposite [63]. In this method, through the lyophili-
zation of the precipitate of HAp/Col composites, HAp/Col powder was formulated. 
About 0.5 g of the prepared HAp/Col powder was well mixed with 3 ml of 0.9% 
NaCl solution (Wako, Japan) and 35 Al of 5 M CaCO3 (Wako). In a 0.9% NaCl 
Figure 6. 
Representation of the vascularization over MSC coral hydroxyapatite scaffold using cell-CHA constructs at 
4 weeks post-implantation. Here, (A) and (B) represent CT angiography and (C) and (D) indicate ultrasonic 
inspection. Further, (E) and (F) indicate X-ray before and after vascular corrosion cast and (G) represent 
vascular corrosion cast. HE and Masson’s trichrome staining of cell-CHA constructs in undecalcification 
sections and decalcification sections is indicated by (H), (I), and (J), respectively. Scale bars: 10 mm (F), (G), 
50 mm (H)–(J) [62].
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solution, 1.5 ml of 3% sodium alginate (Wako) was added, dissolved, and mixed. 
D-gluconic acid lactone (60 mg, Sigma, USA) was added to the HAp/Col-alginate 
mixture to initiate gelation, and the mixture was injected into a mold and left for 
45 minutes at room temperature. The composite has a bone-like nanostructure; the 
length of the HAp crystals is up to 50 nm. The authors investigated the capability 
of HAp/Col-alginate as a bone filler in the rat femur and as a carrier of BMP using 
an ectopic bone formation model (Figure 8). Vigorous bone growth around the 
fabricated scaffolds and tissue invasion into these scaffolds was observed during the 
experiment. A comparison was made between those observed for simple alginate 
and porous HAp. Furthermore, HAp/Col-alginate was investigated as a carrier of 
recombinant human bone morphogenetic protein 2 (rh-BMP2). It was revealed that 
bone formation throughout the implant 5 weeks after implantation without obvious 
deformation of the material was obtained by using the HAp/Col-alginate (20 μl) 
with the rh-BMP2 (100 μg/ml, 15 μl), whereas bone development was detected 
only in a part of a squashed collagen sponge [64]. In Figure 8 (A–C), prominent 
bone formation of the HAp/Col-alginate treated with the 100 μg/ml BMP solu-
tion was remarkably extended throughout almost the whole implant, and bone 
marrow-like tissue also developed. It was noticed that the implants shrank when 
there was no bone formation. Further, it was observed that ectopic bone formation 
was obtained using collagen sponge treated with the 100 μg/ml of rh-BMP2 solu-
tion, but new bone had not extended all through the implant even after 5 weeks 
(Figure 8(D)) [64].
Figure 7. 
Histological observation of different CHAp-scaffold constructs implanted into spatium intramuscular of the 
hind limb at 1, 3, 6, and 9 months post-implantation (HE staining; S, CHA scaffold; TB, tissue-engineered 
bone). Scale bars: 50 mm. Here, HE staining of decalcified paraffin sections is showed. In VSC group, bone-like 
tissue formation at the surface of the CHA scaffold after 1 and 3 months implantation are indicated by plate 
(A) and (B), respectively; gradual increase of engineered bone tissue after 6 months and visible well-developed 
Haversian system after 9 months implantation are indicated by plate (C) and (D), respectively. In SC group, 
visible osteoid after 3 months, no significant bone formation until 6 months and engineered bone tissue 
increased with much residual scaffold remaining after 9 months implantation are represented by (E), (F), (G), 
and (H), respectively. Filling the pores of the CHA scaffolds in both VS and S groups with fibrous connective 
tissue and a large number of inflammatory cells indicated by (I–P).
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were seeded on sterilized CHAp scaffold by a concentration of 20 × 106 cells/ml 
(200 ± 17 μL/scaffold, about 4 × 106 cells/scaffold) and were 3D cultured for 1 week 
before implantation. The growth behavior of BMSCs on the CHAp scaffold was 
assessed by using a scanning electron microscope and confocal laser electronic 
microscope [62]. The authors described an effective methodology to generate bone 
tissue and healing bone defect in ectopic and orthotopic sites. In this methodology, 
a tissue-engineered bone flap with a vascular pedicle of saphenous arteriovenous 
with an organized vascular network was observed after 4 weeks of implantation 
and followed by a successful repair of the fibular defect in beagle dogs (Figure 6).
Engineered bone formation in ectopic and orthotopic sites after implantation 
of 9 months over four CHAp scaffold groups were evaluated by CT (computed 
tomography) analysis. The stimuluses of vascularization and micro-environment 
on tissue-engineered bone were quantitatively analyzed by the comparison of bone 
formation and scaffold degradation between different groups (Figure 7). The 
results indicated that in the first 3 months, vascularization improved engineered 
bone formation by 2 times of non-vascular group and bone defect micro-environ-
ment improved it by 3 times the ectopic group, and the CHAp scaffold degradation 
was enhanced as well [62]. In the VSC group, the HE staining of decalcified paraf-
fin sections after 3 months embedding exhibited that there was a minor volume 
of bone-like tissue developed at the surface of the CHAp scaffold (Figure 7(B)). 
Figure 7(C) and (D) indicates the gradual improvement of engineered bone tissue 
after 6 months and a well-developed Haversian system with little residual scaffold 
remaining after 9 months, respectively. In the SC group, after 3 months of implan-
tation, only the osteoid was shown and until 6 months of implantation, there was 
no significant bone formation, but after 9 months of implantation, engineered bone 
tissue enlarged with much residual scaffold (Figure 7(E)–(H)). Figure 7(I)–(P) 
denotes the gradual degradation of the CHAp scaffolds without bone formation in 
both VS and S groups, the pores of the majority of CHAp scaffold fill with fibrous 
connective tissue and a large number of inflammatory cells. Moreover, more typical 
vascular structures and less inflammatory cells were seen in the VS group than that 
in the S group (Figure 7L and P).
In another study, Kikuchi et al. (2001) fabricated a biodegradable hydroxyapa-
tite/collagen (HAp/Col) nanocomposite [63]. In this method, through the lyophili-
zation of the precipitate of HAp/Col composites, HAp/Col powder was formulated. 
About 0.5 g of the prepared HAp/Col powder was well mixed with 3 ml of 0.9% 
NaCl solution (Wako, Japan) and 35 Al of 5 M CaCO3 (Wako). In a 0.9% NaCl 
Figure 6. 
Representation of the vascularization over MSC coral hydroxyapatite scaffold using cell-CHA constructs at 
4 weeks post-implantation. Here, (A) and (B) represent CT angiography and (C) and (D) indicate ultrasonic 
inspection. Further, (E) and (F) indicate X-ray before and after vascular corrosion cast and (G) represent 
vascular corrosion cast. HE and Masson’s trichrome staining of cell-CHA constructs in undecalcification 
sections and decalcification sections is indicated by (H), (I), and (J), respectively. Scale bars: 10 mm (F), (G), 
50 mm (H)–(J) [62].
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solution, 1.5 ml of 3% sodium alginate (Wako) was added, dissolved, and mixed. 
D-gluconic acid lactone (60 mg, Sigma, USA) was added to the HAp/Col-alginate 
mixture to initiate gelation, and the mixture was injected into a mold and left for 
45 minutes at room temperature. The composite has a bone-like nanostructure; the 
length of the HAp crystals is up to 50 nm. The authors investigated the capability 
of HAp/Col-alginate as a bone filler in the rat femur and as a carrier of BMP using 
an ectopic bone formation model (Figure 8). Vigorous bone growth around the 
fabricated scaffolds and tissue invasion into these scaffolds was observed during the 
experiment. A comparison was made between those observed for simple alginate 
and porous HAp. Furthermore, HAp/Col-alginate was investigated as a carrier of 
recombinant human bone morphogenetic protein 2 (rh-BMP2). It was revealed that 
bone formation throughout the implant 5 weeks after implantation without obvious 
deformation of the material was obtained by using the HAp/Col-alginate (20 μl) 
with the rh-BMP2 (100 μg/ml, 15 μl), whereas bone development was detected 
only in a part of a squashed collagen sponge [64]. In Figure 8 (A–C), prominent 
bone formation of the HAp/Col-alginate treated with the 100 μg/ml BMP solu-
tion was remarkably extended throughout almost the whole implant, and bone 
marrow-like tissue also developed. It was noticed that the implants shrank when 
there was no bone formation. Further, it was observed that ectopic bone formation 
was obtained using collagen sponge treated with the 100 μg/ml of rh-BMP2 solu-
tion, but new bone had not extended all through the implant even after 5 weeks 
(Figure 8(D)) [64].
Figure 7. 
Histological observation of different CHAp-scaffold constructs implanted into spatium intramuscular of the 
hind limb at 1, 3, 6, and 9 months post-implantation (HE staining; S, CHA scaffold; TB, tissue-engineered 
bone). Scale bars: 50 mm. Here, HE staining of decalcified paraffin sections is showed. In VSC group, bone-like 
tissue formation at the surface of the CHA scaffold after 1 and 3 months implantation are indicated by plate 
(A) and (B), respectively; gradual increase of engineered bone tissue after 6 months and visible well-developed 
Haversian system after 9 months implantation are indicated by plate (C) and (D), respectively. In SC group, 
visible osteoid after 3 months, no significant bone formation until 6 months and engineered bone tissue 
increased with much residual scaffold remaining after 9 months implantation are represented by (E), (F), (G), 
and (H), respectively. Filling the pores of the CHA scaffolds in both VS and S groups with fibrous connective 
tissue and a large number of inflammatory cells indicated by (I–P).
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Ripamonti et al. conducted spontaneous induction research of bone forma-
tion in heterotopic rectus abdominis and orthotopic calvarial sites by coral-derived 
biomimetic matrices of different chemical compositions. The authors conducted a 
long-term study in the non-human primate Papio ursinus. In this methodology, rods 
(diameter 20 mm × and 7 mm) were implanted in heterotopic rectus abdominis sites; 
discs (diameter 25 mm) were implanted in orthotopic calvarial defects of six adult 
non-human primates, P. ursinus. Fully converted hydroxyapatite replicas sintered 
at 1100°C were used as heterotopic samples. These fully converted hydroxyapatite 
replicas were coated with the synthetic peptide P15 known to increase the adhesion 
of fibroblasts to an organic bovine mineral to further enhance the spontaneous 
osteoinductive activity. Thereafter, bone induction was evaluated by a histologi-
cal examination, alkaline phosphatase, and osteocalcin expression, as well as by 
the expression of BMP-7, GDF-10, and collagen type IV mRNAs at 60, 90, and 
365 days. Bone induction occurred in the concavities of the scaffolds matrices at 
all time points. It was evident of bone marrow formation in the P15-coated and 
uncoated implants at 365 days. Moreover, resorption of partially converted calcium 
carbonate/hydroxyapatite and remodeling of the newly formed bone was apparent. 
The northern blot analyses of samples from heterotopic specimens indicated high 
levels of expression of BMP-7 and collagen type IV mRNA in all samples at 60 days. 
Therefore, it was correlating with the induction of the osteoblastic phenotype 
in invading fibrovascular cells. Expanded bone formation across the different 
implanted constructs of the orthotopic samples was also observed (Figure 9).
The concavities of the biomimetic matrices and the remodeling cycle of the osteo-
genic primate cortico-cancellous bone stimulate the ripple-like cascade of the induction 
of bone formation. It is demonstrated for the first time through this study that sponta-
neous differentiation of bone was induced by partially converted HAp/CC constructs. 
It was noted that this bone induction was only seen 1 year post-implantation [12].
Figure 8. 
BMP2 (100 μg/ml) induced ectopic bone formation after 5 weeks of implantation. Here, (A–C) denote HAp/
col-alginate with BMP; (A), (B), (C), and (D) stand for HE section of the whole implant, immunostaining 
section with antiosteocalcin, higher magnification, and collagen sponge with BMP, respectively. Here, bone 
marrow-like tissue was indicated by white arrows. Further, black arrowheads and white arrowheads indicate 
soft and bone, respectively [64].
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Ripamonti et al. also fabricated osteoinductive titanium implants for the induc-
tion of bone formation. The experimental titanium implants were prepared with 
a sequence of 36 repetitive concavities. The estimated diameter, depth, and space 
distance of these concavities was 1600, 800, and 1000 μm, respectively. To prepare 
edentulous mandibular ridges for later implantation, mandibular molars and pre-
molars were taken out. After a healing period of 7–8 months, in the left and right, 
edentulized hemi-mandibles planar and geometric hydroxyapatite-coated titanium 
constructs were entrenched, respectively. In this study, three planar and three 
geometric implants were implanted in the left and right tibiae, respectively; addi-
tionally, planar and geometric constructs were also inserted in the rectus abdominis 
muscle. A total of six animals were euthanized at 30 and 90 days after implantation 
for this study; one animal was euthanized 5 days after surgery, and the remaining 
animal was euthanized 31 months after implantation. Undecalcified longitudinal 
Figure 9. 
Demonstration of calvarial incorporation of 13% hydroxyapatite/calcium carbonate paradigms collected on 
60 (A, E, F), 90 (B, F, G, H), and 365 days (C, D, and I) after implantation in calvarial defects of Papio 
ursinus. Here, (a) stands for islands of newly formed bone (blue arrows) scattered within the internal and 
central regions of the implanted coral-derived construct; (E and F) stand for the induction of bone formation 
within the porous spaces of the implanted biomimetic matrices; (B, F, G, and H) stand for induction of 
bone formation in porous biomimetic constructs harvested 90 days after implantation in calvarial defects. 
Further, (C, D, and I) denote calvarial constructs harvested on day 365 after implantation showing significant 
induction of bone formation with solid blocks (I) of newly formed bone [12].
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Ripamonti et al. conducted spontaneous induction research of bone forma-
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at 1100°C were used as heterotopic samples. These fully converted hydroxyapatite 
replicas were coated with the synthetic peptide P15 known to increase the adhesion 
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genic primate cortico-cancellous bone stimulate the ripple-like cascade of the induction 
of bone formation. It is demonstrated for the first time through this study that sponta-
neous differentiation of bone was induced by partially converted HAp/CC constructs. 
It was noted that this bone induction was only seen 1 year post-implantation [12].
Figure 8. 
BMP2 (100 μg/ml) induced ectopic bone formation after 5 weeks of implantation. Here, (A–C) denote HAp/
col-alginate with BMP; (A), (B), (C), and (D) stand for HE section of the whole implant, immunostaining 
section with antiosteocalcin, higher magnification, and collagen sponge with BMP, respectively. Here, bone 
marrow-like tissue was indicated by white arrows. Further, black arrowheads and white arrowheads indicate 
soft and bone, respectively [64].
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Ripamonti et al. also fabricated osteoinductive titanium implants for the induc-
tion of bone formation. The experimental titanium implants were prepared with 
a sequence of 36 repetitive concavities. The estimated diameter, depth, and space 
distance of these concavities was 1600, 800, and 1000 μm, respectively. To prepare 
edentulous mandibular ridges for later implantation, mandibular molars and pre-
molars were taken out. After a healing period of 7–8 months, in the left and right, 
edentulized hemi-mandibles planar and geometric hydroxyapatite-coated titanium 
constructs were entrenched, respectively. In this study, three planar and three 
geometric implants were implanted in the left and right tibiae, respectively; addi-
tionally, planar and geometric constructs were also inserted in the rectus abdominis 
muscle. A total of six animals were euthanized at 30 and 90 days after implantation 
for this study; one animal was euthanized 5 days after surgery, and the remaining 
animal was euthanized 31 months after implantation. Undecalcified longitudinal 
Figure 9. 
Demonstration of calvarial incorporation of 13% hydroxyapatite/calcium carbonate paradigms collected on 
60 (A, E, F), 90 (B, F, G, H), and 365 days (C, D, and I) after implantation in calvarial defects of Papio 
ursinus. Here, (a) stands for islands of newly formed bone (blue arrows) scattered within the internal and 
central regions of the implanted coral-derived construct; (E and F) stand for the induction of bone formation 
within the porous spaces of the implanted biomimetic matrices; (B, F, G, and H) stand for induction of 
bone formation in porous biomimetic constructs harvested 90 days after implantation in calvarial defects. 
Further, (C, D, and I) denote calvarial constructs harvested on day 365 after implantation showing significant 
induction of bone formation with solid blocks (I) of newly formed bone [12].
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sections were precision-sawed, ground, and polished to 40–60 μm; all sections 
were stained with a modified Goldner’s trichrome. By the EXAKT precision cutting 
and grinding system, undecalcified specimen block preparation was accomplished. 
Histomorphometric analyses of bone in contact (BIC) revealed that there was no 
difference between the geometric vs. planar control implants on day 30; on the 
other hand, on day 90, the ratio of BIC to surface within the geometric implants 
was greater than that of the standard planar implants in both mandibular and tibial 
sites. Further, selected concavities cut into the geometric implants harvested from 
the rectus abdominis muscle 31 months after implantation exhibited the spontane-
ous induction of bone formation with mineralized bone surfaced by osteoid seams 
(Figure 10). Therefore, these data in non-human primates indicate that geo-
metrically constructed plasma-sprayed titanium implants are per se osteogenic, the 
concavities providing a unique microenvironment to initiate bone differentiation by 
induction [65].
Figure 10. 
Tissue evolution, induction, remodeling, and osteointegration within the in vivo bioreactor of the concavities 
90 days after implantation within the edentulized hemi-mandibles of the non-human primate Papio ursinus. 
Here, (A) denotes the instrumental for the preparation of the geometric implants, attachment, orientation, 
and alignment of MC 3 T3-E1 cells in vitro within the geometric cue of the concavity of the coral-derived 
calcium phosphate macroporous construct. (B) Indicates insertion into the edentulous ridge of the non-human 
primate P. ursinus, the concavities of the in vivo bioreactor adsorb plasma and plasma products during the 
surgical procedure (blue arrow) but not the planar linear inter-concavity spaces. Further, osteointegration 
along the geometric implant with marrow spaces within the concavity osteointegrated space is denoted by 
(C) and (D) (blue arrow), whereas mineralized remodeled bone tightly integrated with the hydroxyapatite 
coating, remodeling, and blending into the highly crystalline hydroxyapatite layer are denoted by E, F, G, H, 
respectively (H blue arrow) [65].
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In a previous study, porous composite biomaterial of hydroxyapatite (HAp) 
and periosteal graft was used to repair an induced maxillary bone defect where a 
defect was created in the premaxillary bone of rats. In this study, four groups were 
used: (1) those treated with the mucoperiosteal graft from the premaxilla, (2) those 
treated with HAp combined with a mucoperiosteal graft from the premaxilla, (3) 
those treated with HAp combined with a periosteal graft from the femur, and (4) 
those treated with a periosteal graft from the femur. It was revealed from the radio-
graphic evaluation from all groups that no signs of bone formation after 2 weeks 
were detected but radiolucency was found inside the HAp implants after 16 weeks. 
It was clear that cell proliferation occurred from the periosteum covering the defect. 
Moreover, bone tissue formation was detected from the defect margin to inside the 
defect in all cases. Interestingly, after 8 and 16 weeks of implantation, mature bone 
was observed around the HAp implants (Figure 11). Therefore, it was concluded 
that the periosteal graft provides reasonable support to the HAp implant, allowing 
the development of new bone [66].
Figure 11. 
A histologic frontal section through bone defect covered with mucoperiosteum from the premaxilla combined 
with HA (group 2). After 16 weeks, the defect in the premaxilla was partially occupied by newly formed bone 
(white stars) with a mature appearance and by the HA blocks, while there were spaces filled by connective 
tissue. The mucoperiosteum from the premaxilla remained the HA blocks in the defect (black arrow). 
(Original magnification 32; hematoxylin-eosin stain).
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Moreover, Wahl and Czernuszka (2006) summarized and compared a few excel-
lent reports of in vivo experiments using HAp composite scaffolds and are listed 
here in Table 2 [56].
The biodegradable porous scaffolds of HAp synthesized and fabricated by the 
mentioned methods showed several advantages and disadvantages. The porosity 
of the HAp scaffolds plays an important role in tissue engineering to control cell 
functions and to guide the formation of new tissues and organs. Therefore, no 
matter what the materials are, scaffolds must have sufficient porosity to allow for 
cellular infiltration and proper cell function [31]. The fabricated pore structures 
of HAp scaffolds facilitated cell seeding, cell penetration, and distribution in 
the scaffolds. On the other hand, the bottleneck of the mentioned methods was 
time-consuming.
4. Conclusion
Recently, bone and cartilage generation by autogenous cell/tissue transplanta-
tion has become one of the most promising techniques in orthopedic surgery and 
biomedical engineering. Several scaffold materials have been investigated for tissue 
engineering bone and cartilage. Hydroxyapatite (HAp) composite is an eminent 
one among them. It has been investigated for its clinical viability in various bone 
defects since the mid-1980s. Synthetic HAp exhibits good properties as a biomate-
rial, such as biocompatibility, bioactivity, and osteoconductivity. Therefore, it has 
been widely used as a bone substitute, coating on metallic implants, and scaffold 
for tissue engineering. HAp along with other biopolymers, ceramics, and metals 
produced composite scaffolds to enhance the ease of application of tissue engineer-
ing. HAp-COL and HAp-COL/HAp composite scaffolds or HAp-CNT nanocom-
posites for orthopedic implants are synthesized and fabricated through template 
method, plasma spraying, laser surface alloying, electrophoretic deposition, aerosol 
deposition, and a specific freeze-drying procedure. Several in vitro and in vivo 
experiments conducted worldwide demonstrated and proved the inevitabilities and 
excellences of HAp composite scaffolds in bone tissue regeneration and engineering.
Composites Cell culturing or implantation Period (new tissue formed)
CO3Appatite-Collagen 
(Okazaki et al.) [67]
Implantation in rat periosteum cranii 21 days (mineralized bone)
PCCA-TCP-Collagen  
(Du et al.) [68]
Implantation in rat thigh muscle 7 days (connective tissue and 
capillary vessels)
HA-Collagen (Kikuchi et al.) 
[69]
Implantation in beagle tibia 54 days (mineralized bone)
HA-Collagen (Itoh et al.) [70] Implantation in beagle cervical spine 14 days (start of callus formation)
FGMgCO3Ap-Collagen 
(Yamasaki et al.) [71]
Implantation in rat periosteum cranii 14–28 days (mineralized bone)
HA-Collagen Alginate 
(Sotome et al.) [64]
Implantation in the rat femur 14 days (mineralized bone)
nHA-Anionic Collagen 
(Martins and Goissis) [72]
Implantation in rat infraorbital bone 60 days (mineralized bone)
cAP-Collagen (Suh et al.) [73] Implantation in rabbit skin 98 days (mineralized bone)
Table 2. 
In vivo experiments in bone tissue engineering using different HAp composites.
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Development of New Advanced 
Ti-Mo Alloys for Medical 
Applications
Petrică Vizureanu, Mădălina Simona Bălțatu  
and Andrei Victor Sandu
Abstract
The use of titanium and titanium-based alloys with applications in implantology 
and dentistry has made remarkable progress in the promotion of new technologies 
and new materials that have been developed in recent years. This is justified thanks 
to their excellent mechanical, physical, and biological performance. Today’s genera-
tion promotes new titanium alloys, with nontoxic elements and long-term perfor-
mance and without rejection of the human body. This book chapter describes new 
original compositions of Ti-based alloys for medical applications, with improved 
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1. Introduction
Materials with the possibility of performing a biological function are increas-
ingly sought. In the medical field, implants require a high compatibility with the 
hard tissue for osteointegration and bone formation and a compatibility with the 
soft tissue for the adhesion of the epithelium to them and the acquisition of anti-
bacterial properties for inhibiting or forming the biofilm at the interface. These 
biofunctional characteristics have two contradictory properties: inhibition and 
enhancement of protein adsorption, respectively, and cell adhesion [1, 2].
The usual classification of synthetic biomaterials is carried out structurally, 
according to the classes of materials used. The main types of synthetic biomaterials 
are metallic, ceramic, polymeric, composite, and of natural origin, but they can also 
be divided into several categories, as can be seen in Figure 1.
Biocompatible materials are intended to “work under biological constraint” and 
thereby become adapted to various medical applications.
When a metallic material is implanted in a human body, immediate reactions 
occur between their surface and the living tissues. In other words, an immediate 
reaction during the introduction period is determined and defines the biofunction-
ality of the metallic material [3].
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The quality of a material used in the construction of an implant must respect the 
following two criteria: the biochemical criterion and the biomechanical criterion. 
According to the biochemical criterion, the applicability of a material is determined 
by its biocompatibility, and from the biomechanical point of view of fatigue resis-
tance, it is the most important parameter but not the only one.
The most used metallic biomaterials are stainless steels, Co-Cr alloys, titanium 
alloys, and magnesium-based alloys. Each class of biomaterials has its advantages 
and disadvantages (Figure 2), their use in the execution of different implants being 
influenced by both the properties of the biomaterials and the functional require-
ments imposed to the implants [5].
Among the most important factors that intervene on a biomaterial successfully 
integrated in the human body, we mention the physical-chemical properties, the 
design, the biocompatibility, the surgical technique applied to the implantation, 
and last but not least, the patient’s health.
The selection of materials used in contact with living cells or tissues for implanta-
tion in the human body, as biomaterials, is determined primarily by their acceptance 
by the human tissues with which they interact (biocompatibility) and by the ability to 
perform their functional role for which they were implanted (biofunctionality) [6].
Out of the metallic biomaterials, a special interest is for those with osteotropic 
structure, of which the titanium belongs. These biomaterials, thanks to the chemi-
cal and micromorphological biocompatibility with the bone tissue, achieve with this 
physical-chemical connection, the interface phenomenon being assimilated with 
the linking osteogenesis.
Titanium alloys are frequently used, due to the need of replacing stainless steels 
and cobalt-based alloys that have limitations in use, causing some deficiencies of 
biocompatibility with human tissues. These deficiencies are caused by some ele-
ments present in their chemical composition (e.g., nickel), which have a toxic effect 
Figure 1. 
The main types of biomaterials [4].
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on human tissues, causing inflammatory allergic reactions or implant rejection 
reactions [7].
The properties of the titanium are as follows:
• melting point—the titanium melts at 1660°, and it can be sterilized without 
risk at 300°;
• resistance—the implants are made from a single pure titanium bar by mechani-
cal processing, giving them maximum resistance;
• hardness—the titanium has a hardness comparable to that of steel, giving it 
special mechanical quality;
• rigidity—the implants do not deform when applying, mounting, or milling 
forces nor in the biomechanics of chewing;
• nonmagnetic—the titanium has no magnetic effect, resulting in good tissue 
supportability;
• regenerative and therapeutic action—research and practical experience have 
highlighted the healing qualities of titanium oxide;
• neutral pH—titanium dioxide, TiO2, which is formed immediately around the 
metal molecules, has a pH of 7, completely neutral;
• biological immunity—the implant can be stimulated in contact with the bone, 
surrounding tissues and the oral cavity environment;
• excellent resistance to electric shock—the titanium has a very low thermal 
conductivity; and
• light weight—the density of titanium is close to that of light alloys [4, 8].
Figure 2. 
Main characteristics of metallic orthopedic implants [6].
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The biocompatibility of titanium is a consequence of the presence of the super-
ficial oxide layer. The chemical properties and therefore the chemical processes on 
the interface are determined precisely by this layer of oxide and not by the metal 
itself. This feature is applicable to all metal materials used in the manufacturing 
of implants and prosthetic parts. Among the metal materials used for hard tissue 
repair in human body, the elastic modulus of titanium (about 80–110 GPa) is the 
closest to hard human tissue, which can reduce the mechanical incompatibility 
between metal implants and bone tissue [9].
Titanium alloys are used for medical applications in multiple fields in human 
body and became the first choice for orthopedic products. Figure 3 shows the main 
applications of titanium alloys used in orthopedic applications [2–8].
In conclusion, it can be said that titanium biomaterials, by its properties, 
respond to almost all the requirements necessary for the achievement of osteogen-
esis, osteointegration, and durability over time. The pure titanium implant offers 
perfect compatibility, correct and concrete osteogenesis, and demonstrable time-
lapse viability.
Adding the alloying elements gives titanium a wide range of properties through 
different microstructures and properties.
After microstructure, the alloys are grouped into three categories depending on 
the type of stabilizing elements added to the titanium alloy. The mechanical proper-
ties and corrosion resistance of the alloys depend on the morphology and structure 
of the α or β phase particles in the alloy matrix.
Thus, the alloying elements are divided into three categories as follows:
• α stabilizers: C, N2, O2, and Al;
• β stabilizers: V, Nb, Mo, Ta, Fe, Mn, Cr, Co, W, Ni, Cu, Si, and H2; and
• neutral elements: Zr, Sn, Hf, Ge, and Th [1, 5, 8].
Over the years, many titanium alloys have been developed and investigated 
for the implantation of implants for medical applications, of which few have been 
accepted by the human body, namely those that have certain properties necessary 
for long-term success.
The biocompatibility of an alloy depends on the alloying elements. Alloying 
elements such as Zr, Ta, Nb, and Sn do not affect cell viability and have shown a 
reduced amount of ions released into the body, but Al and V contribute to reducing 
cell viability. Other elements such as Ag, Co, Cr, and Cu have moderate cytotoxic 
behavior, but their presence in these alloys significantly reduces their toxicity [1–5]. 
By analyzing the current research, these alloys were studied in order to develop 
Figure 3. 
Orthopedic products made by titanium and titanium alloys: (a) endoprosthesis for joint replacement; (b) 
system plate screws for bone fracture repair; (c) screws for bone repair; and (d) intramedullary nail [2, 9].
81
Development of New Advanced Ti-Mo Alloys for Medical Applications
DOI: http://dx.doi.org/10.5772/intechopen.91906
new recipes of titanium-based alloys with elements with high biocompatibility on 
human tissue such as Mo, Ta, Zr, and Si [10, 11].
2. Characterization of the obtained titanium alloys
The experimental tests aim at a characterization of new developed titanium 
alloys by chemical, structural, surface, and mechanical analyses.
This chapter describes the following investigations for the new alloys developed:
• Development of alloys was carried out using a Vacuum Arc Remelting instal-
lation for the elaboration of homogeneous alloys.
• Elemental composition is necessary to determine the percentages of the 
chemical elements that make up the elaborated titanium alloys.
• Structural characterization is necessary for the study of the microstructure, 
the crystallographic orientation, the texture, and the identification of the 
constituent phases.
• Mechanical characterization highlights the mechanical properties of the 
developed titanium alloys: hardness and elasticity module.
• Corrosion resistance determines the stability of the proposed alloys in the 
simulated body fluids.
• Surface characterization takes into account the measurement of the contact 
angle of the surface of the alloys for achieving/optimizing the adhesion and cell 
proliferation.
2.1 Vacuum arc remelting
In order to obtain the titanium alloys, the MRF ABJ 900 Vacuum Arc Remelting 
has been used. Vacuum arc remelting is a commonly used process in the develop-
ment of alloys. The process itself is used to refill the ingots and refine the structure 
by using nonconsumable mobile electrode of thorium tungsten. The process itself 
can also be used to obtain special alloys, superalloys, and titanium alloys.
In principle, the process of remelting with a vacuum arc is a process based on 
continuous melting with the use of the electric arc and nonconsumable mobile 
electrode.
Advantages of using this equipment are as follows:
• It can achieve very high melting temperatures.
• It ensures the possibility of melting the metallic vacuum samples under a pro-
tective atmosphere by means of a nonconsumable mobile electrode of thorium 
tungsten.
• It creates alloys with uniform composition, through repeated remeltings.




The biocompatibility of titanium is a consequence of the presence of the super-
ficial oxide layer. The chemical properties and therefore the chemical processes on 
the interface are determined precisely by this layer of oxide and not by the metal 
itself. This feature is applicable to all metal materials used in the manufacturing 
of implants and prosthetic parts. Among the metal materials used for hard tissue 
repair in human body, the elastic modulus of titanium (about 80–110 GPa) is the 
closest to hard human tissue, which can reduce the mechanical incompatibility 
between metal implants and bone tissue [9].
Titanium alloys are used for medical applications in multiple fields in human 
body and became the first choice for orthopedic products. Figure 3 shows the main 
applications of titanium alloys used in orthopedic applications [2–8].
In conclusion, it can be said that titanium biomaterials, by its properties, 
respond to almost all the requirements necessary for the achievement of osteogen-
esis, osteointegration, and durability over time. The pure titanium implant offers 
perfect compatibility, correct and concrete osteogenesis, and demonstrable time-
lapse viability.
Adding the alloying elements gives titanium a wide range of properties through 
different microstructures and properties.
After microstructure, the alloys are grouped into three categories depending on 
the type of stabilizing elements added to the titanium alloy. The mechanical proper-
ties and corrosion resistance of the alloys depend on the morphology and structure 
of the α or β phase particles in the alloy matrix.
Thus, the alloying elements are divided into three categories as follows:
• α stabilizers: C, N2, O2, and Al;
• β stabilizers: V, Nb, Mo, Ta, Fe, Mn, Cr, Co, W, Ni, Cu, Si, and H2; and
• neutral elements: Zr, Sn, Hf, Ge, and Th [1, 5, 8].
Over the years, many titanium alloys have been developed and investigated 
for the implantation of implants for medical applications, of which few have been 
accepted by the human body, namely those that have certain properties necessary 
for long-term success.
The biocompatibility of an alloy depends on the alloying elements. Alloying 
elements such as Zr, Ta, Nb, and Sn do not affect cell viability and have shown a 
reduced amount of ions released into the body, but Al and V contribute to reducing 
cell viability. Other elements such as Ag, Co, Cr, and Cu have moderate cytotoxic 
behavior, but their presence in these alloys significantly reduces their toxicity [1–5]. 
By analyzing the current research, these alloys were studied in order to develop 
Figure 3. 
Orthopedic products made by titanium and titanium alloys: (a) endoprosthesis for joint replacement; (b) 
system plate screws for bone fracture repair; (c) screws for bone repair; and (d) intramedullary nail [2, 9].
81
Development of New Advanced Ti-Mo Alloys for Medical Applications
DOI: http://dx.doi.org/10.5772/intechopen.91906
new recipes of titanium-based alloys with elements with high biocompatibility on 
human tissue such as Mo, Ta, Zr, and Si [10, 11].
2. Characterization of the obtained titanium alloys
The experimental tests aim at a characterization of new developed titanium 
alloys by chemical, structural, surface, and mechanical analyses.
This chapter describes the following investigations for the new alloys developed:
• Development of alloys was carried out using a Vacuum Arc Remelting instal-
lation for the elaboration of homogeneous alloys.
• Elemental composition is necessary to determine the percentages of the 
chemical elements that make up the elaborated titanium alloys.
• Structural characterization is necessary for the study of the microstructure, 
the crystallographic orientation, the texture, and the identification of the 
constituent phases.
• Mechanical characterization highlights the mechanical properties of the 
developed titanium alloys: hardness and elasticity module.
• Corrosion resistance determines the stability of the proposed alloys in the 
simulated body fluids.
• Surface characterization takes into account the measurement of the contact 
angle of the surface of the alloys for achieving/optimizing the adhesion and cell 
proliferation.
2.1 Vacuum arc remelting
In order to obtain the titanium alloys, the MRF ABJ 900 Vacuum Arc Remelting 
has been used. Vacuum arc remelting is a commonly used process in the develop-
ment of alloys. The process itself is used to refill the ingots and refine the structure 
by using nonconsumable mobile electrode of thorium tungsten. The process itself 
can also be used to obtain special alloys, superalloys, and titanium alloys.
In principle, the process of remelting with a vacuum arc is a process based on 
continuous melting with the use of the electric arc and nonconsumable mobile 
electrode.
Advantages of using this equipment are as follows:
• It can achieve very high melting temperatures.
• It ensures the possibility of melting the metallic vacuum samples under a pro-
tective atmosphere by means of a nonconsumable mobile electrode of thorium 
tungsten.
• It creates alloys with uniform composition, through repeated remeltings.




• It can use various crucibles for elaboration and ensure the possibility of obtain-
ing the samples under specific conditions in the form of a pill of different 
shapes and sizes.
• Loading and unloading is done in a simple way by lifting the cover that is 
caught in the hinge to the rest of the camera.
• It is illuminated with a halogen lamp, thus helping to control the melting of the 
alloying elements in the process [12].
Figure 4 shows all stages of titanium alloying, which includes the weighing of 
the raw material, the loading of the alloying elements, and the final semi-finished 
obtained products.
The load calculation has considered the characteristics of the different alloying 
elements and their physical-chemical properties.
Elaboration of the alloys was carried out in two charges to obtain two alloys in 
each charge. Table 1 shows alloys proposed the cavities used for each alloy.
Elaboration of the titanium alloys made with a vacuum arc melting system, took 
place by the melting of the elements, and followed by the remeltings of alloys for six 
times, a necessary operation for the refining and homogenization of the alloys. The 
melting of the elements took place uniformly, resulting alloys with a precise and 
homogeneous chemical composition. The samples had a homogeneous structure, 
which means that the installation, the elaboration protocol, and the elements were 
chosen correctly.
After the solidification, two samples of each alloy were obtained in the form 
of ingots, shapes, and different masses but with sufficient quantity for taking the 
specimens required for all proposed laboratory tests.
2.2  Determination of the chemical composition of titanium alloys by EDAX 
analysis
A complete characterization of a metallic material consists in knowing its com-
position, the concentration of the various elements, or the impurities in the mass of 
the alloy. An extremely important aspect is the determination as precisely as pos-
sible of the chemical composition of the titanium alloys obtained after elaboration.
The EDAX system is a microanalysis detector, equipped with an electron micro-
scope, which uses the resulting X-ray energy on the surface of the samples.
Determination of chemical composition can be performed, both punctually and 
in a well-defined region on the surface of the analyzed sample.
This method is a variant of X-ray fluorescence spectroscopy, in which the sample 
investigation is based on the interactions between the electromagnetic radiation 
and the sample, analyzing the X radiation emitted by the sample as a response to the 
charging of particles loaded with electric charges. The characterization possibilities 
are largely according to the fundamental principle that each chemical element has a 
unique atomic structure that allows the characteristic X-rays of the atomic structure 
of an element to characterize it uniquely from another.
In order to achieve the structural and thermal characterization, it is necessary to 
identify the chemical composition of the alloys obtained. EDAX microanalysis with 
energy dispersion of X radiation was used to determine the chemical composition 
of the TiMo alloys developed. Determination of the chemical composition by EDAX 
microanalysis is the first laboratory investigation required to highlight the propor-
tions obtained between the pure chemical elements and was performed on titanium 
alloys obtained.
83
Development of New Advanced Ti-Mo Alloys for Medical Applications
DOI: http://dx.doi.org/10.5772/intechopen.91906
In order to validate the results regarding the concentration, for each sample, 10 
measurements on five different areas were done.
To determine the chemical composition of the obtained titanium alloys, the Vega 
Tescan LMH II equipment was performed using the EDAX by Bruker attached to 
the SEM equipment.
For the determination of the chemical composition of alloys obtained from the 
TiMo system, samples having dimensions of 10 mm × 10 mm × 5 mm were used. 
Before being examined, the samples were ground on abrasive paper to remove 
impurities and titanium oxide film on the surface of the alloy.
Table 2 shows the mass percentages of the elements identified in the alloy 
composition, the percentages of the elements varying slightly with the theoretical 
batch calculation.
Figures 5–8 highlight EDX spectrum and element mapping of titanium  
alloys.
Alloy element Ti Mo Si Zr Ta
(% weight)
Ti15Mo0.5Si 84.50 15.00 0.50 — —
Ti20Mo0.5Si 79.50 20.00 0.50 — —
Ti15Mo7Zr10Ta 68.00 15.00 — 7.00 10.00
Ti20Mo7Zr10Ta 63.00 20.00 — 7.00 10.00
Table 1. 
Chemical composition proposed of the new titanium alloys.
Figure 4. 
Stages of titanium alloying obtaining process: (a) weighing of raw materials and gravimetric dosing;  
(b) loading of the raw material; and (c) titanium semi-products obtained after solidification [12].
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The analysis of the chemical composition obtained revealed that the main 
elements identified in the alloys elaborated are Ti, Mo, Zr, Ta, and Si, without the 
presence of other inclusions.
2.3 Structural characterization of titanium alloys by optical microscopy
Microscopic methods of structural analysis are used to characterize the materials 
based on their structure, constituents and phases present (nature, shape, dimen-
sions, and distribution), and possible structural defects (pores, cracks, structural 
inhomogeneities, etc.). Structural analysis was performed using the OPTIKA 
XDS-3 MET microscope.
In order to investigate the metallographic structure, the preparation of the 
metallographic samples of the experimental titanium alloys included a sequence 
of steps: cutting to appropriate dimensions (e.g., 10 mm × 10 mm × 5 mm), incor-
poration in epoxy resin, grinding and polishing, and chemical attack with specific 
reagents (a solution with 10 mL of HF, 5 mL of HNO3, and 85 mL of H2O) for 
30 s. After the preparation of the samples, this was analyzed at the optical micro-
scope at various magnification powers in order to obtain detailed images on the 
microstructure.
Figure 9 highlights images obtained by optical microscopy for titanium alloys at 
100× magnification.
In Figure 9, the structure of titanium alloys with aspects of the specific grains of 
titanium is presented. The images obtained by optical microscopy for the elaborated 
alloys show a dendritic structure with irregular grain boundaries. These coarse 
structures are specific to β alloys.
The variation of the α, α + β, and β type phases consists of the differences 
in chemical composition of the constituent elements. The high percentage of 
β-stabilizing elements (Mo, Ta, and Si) led to the formation of a β-type structure, 
very well highlighted in the elaborated TiMo alloys.
2.4 Mechanical characterization
2.4.1 Microindentation method
The measurement of the longitudinal elastic modulus for the obtained titanium 
alloys was achieved by the microindentation method. This method consists of 
penetrating the surface of the sample with a conical palpate at a certain force.
From a practical point of view, the indentation characterization presents a major 
advantage over the standard methods of testing on standardized tests, namely, the 
testing can be done directly on the finished pieces.
Alloy element Ti Mo Si Zr Ta
(% weight)
Ti15Mo0.5Si 79.28 19.95 0.77 — —
Ti20Mo0.5Si 78.98 20.06 0.96 — —
Ti15Mo7Zr10Ta 75.40 10.41 — 7.69 6.50
Ti20Mo7Zr10Ta 71.51 14.05 — 7.04 7.40
Table 2. 
Chemical compositions of titanium alloys, expressed as a mass percentage, according to the EDX measurements.
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During the microindentation test, the values of the loading forces are recorded 
relative to the penetration depth of the indenter in the material. Based on the 
loading-unloading curve, a number of sizes can be determined that allow the 
characterization of the materials.
Figure 10 shows the response of the alloys during the indentation tests in the 
form of force-depth dependencies. The values of the modulus of elasticity for the 
titanium alloys resulting from the indentation test are shown in Table 3.
Among the mechanical properties that are considered when evaluating a bioma-
terial is the longitudinal elasticity module. If the biomaterial is used for orthopedic 
implants, it must have a modulus of longitudinal elasticity equivalent to that of the 
bone, which varies between 4 and 30 GPa, depending on the type of bone and the 
direction of measurement [13–15].
A low modulus is reliable in inhibiting the bone resorption and enhancing the 
remodeling of bones, which may be due to the excellent stress transmission between 
the bone and the implant. A biomedical orthopedic implant should have a Young 
modulus matching or closer to that of human bone to avoid the stress shielding effect.
Figure 5. 
EDX spectrum and mapping for Ti15Mo0.50Si alloy.
Figure 6. 
EDX spectrum and mapping for Ti20Mo0.50Si alloy.
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The analysis of the chemical composition obtained revealed that the main 
elements identified in the alloys elaborated are Ti, Mo, Zr, Ta, and Si, without the 
presence of other inclusions.
2.3 Structural characterization of titanium alloys by optical microscopy
Microscopic methods of structural analysis are used to characterize the materials 
based on their structure, constituents and phases present (nature, shape, dimen-
sions, and distribution), and possible structural defects (pores, cracks, structural 
inhomogeneities, etc.). Structural analysis was performed using the OPTIKA 
XDS-3 MET microscope.
In order to investigate the metallographic structure, the preparation of the 
metallographic samples of the experimental titanium alloys included a sequence 
of steps: cutting to appropriate dimensions (e.g., 10 mm × 10 mm × 5 mm), incor-
poration in epoxy resin, grinding and polishing, and chemical attack with specific 
reagents (a solution with 10 mL of HF, 5 mL of HNO3, and 85 mL of H2O) for 
30 s. After the preparation of the samples, this was analyzed at the optical micro-
scope at various magnification powers in order to obtain detailed images on the 
microstructure.
Figure 9 highlights images obtained by optical microscopy for titanium alloys at 
100× magnification.
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titanium is presented. The images obtained by optical microscopy for the elaborated 
alloys show a dendritic structure with irregular grain boundaries. These coarse 
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alloys was achieved by the microindentation method. This method consists of 
penetrating the surface of the sample with a conical palpate at a certain force.
From a practical point of view, the indentation characterization presents a major 
advantage over the standard methods of testing on standardized tests, namely, the 
testing can be done directly on the finished pieces.
Alloy element Ti Mo Si Zr Ta
(% weight)
Ti15Mo0.5Si 79.28 19.95 0.77 — —
Ti20Mo0.5Si 78.98 20.06 0.96 — —
Ti15Mo7Zr10Ta 75.40 10.41 — 7.69 6.50
Ti20Mo7Zr10Ta 71.51 14.05 — 7.04 7.40
Table 2. 
Chemical compositions of titanium alloys, expressed as a mass percentage, according to the EDX measurements.
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During the microindentation test, the values of the loading forces are recorded 
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bone, which varies between 4 and 30 GPa, depending on the type of bone and the 
direction of measurement [13–15].
A low modulus is reliable in inhibiting the bone resorption and enhancing the 
remodeling of bones, which may be due to the excellent stress transmission between 
the bone and the implant. A biomedical orthopedic implant should have a Young 
modulus matching or closer to that of human bone to avoid the stress shielding effect.
Figure 5. 
EDX spectrum and mapping for Ti15Mo0.50Si alloy.
Figure 6. 
EDX spectrum and mapping for Ti20Mo0.50Si alloy.
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The developed titanium alloys have a low modulus of elasticity, close to that of 
the bone, with the exception of the Ti15Mo7Zr10Ta alloy and significantly lower 
values than CoCr alloys.
If the balance between mechanical properties and biocompatibility is achieved 
by both the implant and the bone tissue, the risk of negative effects is very small. 
The use of titanium materials with a low modulus of elasticity seems to be a 
good solution, and the chances of using the material for medical purposes are 
increasing.
2.4.2 Determination of hardness for titanium alloys
Hardness is a property of materials that express their ability to resist the action 
of mechanically penetrating a tougher body into its surface. When determining the 
hardness of the materials, the size of the traces produced by a penetration body, 
characterized by a certain shape and size, and the force acting on it is taken into 
account.
Figure 7. 
EDX spectrum and mapping for Ti15Mo7Zr10Ta alloy.
Figure 8. 
EDX spectrum and mapping for Ti20Mo7Zr10Ta alloy.
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Figure 9. 
Optical microstructure of alloys investigated at 100× magnification power: (a) Ti15Mo0.5Si,  
(b) Ti20Mo0.5Si, (c) Ti15Mo7Zr10Ta, and (d) Ti20Mo7Zr10Ta.
Figure 10. 
The force-depth curve of the micro-indentation test for the investigated alloys: (a) Ti15Mo0.5Si,  
(b) Ti20Mo0.5Si, (c) Ti15Mo7Zr10Ta, and (d) Ti20Mo7Zr10Ta.
Biomaterials
86
The developed titanium alloys have a low modulus of elasticity, close to that of 
the bone, with the exception of the Ti15Mo7Zr10Ta alloy and significantly lower 
values than CoCr alloys.
If the balance between mechanical properties and biocompatibility is achieved 
by both the implant and the bone tissue, the risk of negative effects is very small. 
The use of titanium materials with a low modulus of elasticity seems to be a 
good solution, and the chances of using the material for medical purposes are 
increasing.
2.4.2 Determination of hardness for titanium alloys
Hardness is a property of materials that express their ability to resist the action 
of mechanically penetrating a tougher body into its surface. When determining the 
hardness of the materials, the size of the traces produced by a penetration body, 
characterized by a certain shape and size, and the force acting on it is taken into 
account.
Figure 7. 
EDX spectrum and mapping for Ti15Mo7Zr10Ta alloy.
Figure 8. 
EDX spectrum and mapping for Ti20Mo7Zr10Ta alloy.
87
Development of New Advanced Ti-Mo Alloys for Medical Applications
DOI: http://dx.doi.org/10.5772/intechopen.91906
Figure 9. 
Optical microstructure of alloys investigated at 100× magnification power: (a) Ti15Mo0.5Si,  
(b) Ti20Mo0.5Si, (c) Ti15Mo7Zr10Ta, and (d) Ti20Mo7Zr10Ta.
Figure 10. 
The force-depth curve of the micro-indentation test for the investigated alloys: (a) Ti15Mo0.5Si,  






















































































































































































































Development of New Advanced Ti-Mo Alloys for Medical Applications
DOI: http://dx.doi.org/10.5772/intechopen.91906
The methods for determining the hardness, depending on the speed of the force 
on the penetrator, are classified into static methods, where the drive speed is below 
1 mm/s, and dynamic methods for which the drive speed exceeds this value.
The Vickers hardness determination method uses a diamond penetrator in the 
form of a pyramid with a square base and consists in pressing it at a reduced speed 
and with a certain predetermined force F on the surface of the test material. The 
Vickers hardness, symbolized by HV, is expressed by the ratio of the applied force 
F to the area of the lateral surface of the residual trace produced by the penetrator. 
The trace is considered to be a straight pyramid with a square base, with diagonal d, 
having the same angle as the penetrator at the top.
For the Vickers hardness determination method, at least three attempts are made 
on the test material. For each trace, the average diagonal value is calculated based on 
the magnitude of the two diagonals measured. It is recognized that the difference in 
diagonal dimensions is within an error margin of not more than 2%.
The hardness measurements highlight resistance and provide information on the 
behavior of the studied materials. In this way, we can analyze titanium alloys devel-
oped for the purpose of fitting them into a specific medical application (Table 4).
HV hardness measurements on titanium alloys were performed with Wilson 
Wolpert 751N.
Both systems studied have different hardness results. Compared to other 
titanium biomaterials, TMZT alloys have a higher hardness, but close to the Ti6Al4V 
alloy, which are most commonly used in implantology. An important aspect that 
might have contributed to the increased hardness is the amount of stabilizing β 
elements. It can be observed that as the amount of stabilizing β elements increases 
(Mo and Ta), it decreases the hardness values.
2.5 Corrosion resistance
Corrosion represents the physical-chemical, spontaneous, reversible, and 
undesirable destruction of metals and alloys under the chemical, electrochemical, 
or biological action of the environment.
Corrosion monitoring is the practice of qualitative assessment and quantitative 
measurement of the corrosivity of an environment on a metal or an alloy immersed 
in this environment. Monitoring tests can be performed using mechanical, electrical, 
electrochemical, or chemical methods [18–20]. The nature of the monitoring sensor 
depends on the technique chosen for the study, the purpose pursued, and the particular 
characteristics of the sample used. In the older methods, the electrical measurements 
were often used, the monitoring technique and the methods of processing the experi-
mental data being generally very laborious. The advances in the field of microelectron-
ics have allowed the signals of the electrochemical sensors to be strictly conditioned, 
appropriately amplified, and processed based on complex data processing programs.
Some techniques and methods of measurement allow continuous monitoring of 
corrosion—the sample is permanently exposed in the corrosion environment, while 
the discontinuous methods are done only in specialized laboratories.
Alloy Ti15Mo0.5Si Ti20Mo0.5Si Ti15Mo7Zr10Ta Ti20Mo7Zr10Ta C.P. Ti Ti6Al4V CoCr alloys
HV 233.37 165.18 462.33 321.31 128 381 600
The bold values represent the values of the classical alloys used in implantology, values that do not belong to us and 
are for a comparative points. They were bold to see the good results of our alloys.
Table 4. 






















































































































































































































Development of New Advanced Ti-Mo Alloys for Medical Applications
DOI: http://dx.doi.org/10.5772/intechopen.91906
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on the penetrator, are classified into static methods, where the drive speed is below 
1 mm/s, and dynamic methods for which the drive speed exceeds this value.
The Vickers hardness determination method uses a diamond penetrator in the 
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and with a certain predetermined force F on the surface of the test material. The 
Vickers hardness, symbolized by HV, is expressed by the ratio of the applied force 
F to the area of the lateral surface of the residual trace produced by the penetrator. 
The trace is considered to be a straight pyramid with a square base, with diagonal d, 
having the same angle as the penetrator at the top.
For the Vickers hardness determination method, at least three attempts are made 
on the test material. For each trace, the average diagonal value is calculated based on 
the magnitude of the two diagonals measured. It is recognized that the difference in 
diagonal dimensions is within an error margin of not more than 2%.
The hardness measurements highlight resistance and provide information on the 
behavior of the studied materials. In this way, we can analyze titanium alloys devel-
oped for the purpose of fitting them into a specific medical application (Table 4).
HV hardness measurements on titanium alloys were performed with Wilson 
Wolpert 751N.
Both systems studied have different hardness results. Compared to other 
titanium biomaterials, TMZT alloys have a higher hardness, but close to the Ti6Al4V 
alloy, which are most commonly used in implantology. An important aspect that 
might have contributed to the increased hardness is the amount of stabilizing β 
elements. It can be observed that as the amount of stabilizing β elements increases 
(Mo and Ta), it decreases the hardness values.
2.5 Corrosion resistance
Corrosion represents the physical-chemical, spontaneous, reversible, and 
undesirable destruction of metals and alloys under the chemical, electrochemical, 
or biological action of the environment.
Corrosion monitoring is the practice of qualitative assessment and quantitative 
measurement of the corrosivity of an environment on a metal or an alloy immersed 
in this environment. Monitoring tests can be performed using mechanical, electrical, 
electrochemical, or chemical methods [18–20]. The nature of the monitoring sensor 
depends on the technique chosen for the study, the purpose pursued, and the particular 
characteristics of the sample used. In the older methods, the electrical measurements 
were often used, the monitoring technique and the methods of processing the experi-
mental data being generally very laborious. The advances in the field of microelectron-
ics have allowed the signals of the electrochemical sensors to be strictly conditioned, 
appropriately amplified, and processed based on complex data processing programs.
Some techniques and methods of measurement allow continuous monitoring of 
corrosion—the sample is permanently exposed in the corrosion environment, while 
the discontinuous methods are done only in specialized laboratories.
Alloy Ti15Mo0.5Si Ti20Mo0.5Si Ti15Mo7Zr10Ta Ti20Mo7Zr10Ta C.P. Ti Ti6Al4V CoCr alloys
HV 233.37 165.18 462.33 321.31 128 381 600
The bold values represent the values of the classical alloys used in implantology, values that do not belong to us and 
are for a comparative points. They were bold to see the good results of our alloys.
Table 4. 
The hardness values of titanium alloys measured by the Vickers method [5, 13, 14].
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Some techniques give direct information on material degradation or corrosion 
rate, while others are used to determine if a corrosive environment may exist. Also, 
some techniques are “destructive” altering more or less the surface of the metal, 
while others are nondestructive. The true methods of monitoring the corrosion 
are considered very sensitive measurements, which give a practical instantaneous 
signal, simultaneously with the change of the corrosion speed.
To obtain a more complete picture of the corrosion process, it is often necessary 
to obtain complementary data, from other sources or sensors, which are purchased 
simultaneously with those obtained from the corrosion sensor.
Three main aspects are pursued in the study of corrosion of alloys in various 
environments: (1) the type of corrosion involved in the process; (2) the corrosion 
rate; and (3) the nature of the corrosion products and their properties (chemical, 
structural, and protective). For this, numerous study methods can be used, which 
can be divided into three main classes: analytical methods, electrochemical meth-
ods, and optical methods. But in special cases, other methods are used (acoustic, 
nuclear, etc.).
Electrochemical impedance spectroscopy (SIE) data, were processed with the 
ZSimpWin software [8], in which the spectra are interpreted by the fit procedure 
developed by Boukamp - by the smallest squares method. In order to process with 
this software the data acquired by the VoltaMaster 4 program, this were converted 
by using the EIS file converter program.
The polarization resistance method was used to evaluate the corrosion rate. This 
method serves to determine the corrosion current, at the corrosion potential of 
the metal or alloy, from the linear polarization curve obtained for relatively small 
overvoltages. The corrosion current determined by this method therefore represents 
the current that appears at the metal/corrosive medium interface when the metal is 
immersed in the solution and represents the instantaneous corrosion current.
All measurements were made on freshly cleaned surfaces. Each sample was 
polished on SiC abrasive paper until granulation 2000, degreased with acetone, 
washed with distilled water, and kept in bidistilled water until introduced into the 
electrochemical cell.
Figure 11 shows the linear polarization curves in semi-logarithmic coordinates 
for the samples studied in the Ringer solution, and in Table 5, the parameters of 
instantaneous corrosion in the same physiological environment are presented.
The corrosion potential, Ecor, measured in relation to the potential of the satu-
rated calomel electrode, is the potential at which the oxidation-reduction reactions 
on the surface of the alloy are at equilibrium; the speed of the oxidation reaction is 
equal to the rate of the reduction reaction, and the total current intensity is zero. 
As the potential increases toward more positive values, the speed of the oxidation 
reaction increases, while the movement of the potential toward negative values, the  
oxidation process is reduced and the metal is passivized. As a qualitative aspect, 
the TiMoSi alloy series has a higher corrosion tendency than the TiMoZrTa alloys. 
The differences are significant, and the presence of zirconia and tantalum seems to 
cause a decrease in the corrosion rate.
The polarization resistors have high values, which are reflected in very low 
corrosion rates. The product of “corrosion” in the case of these alloys is mainly 
titanium oxide, TiO2, which is insoluble and adherent to the surface of the alloy. 
The oxide layer on the surface protects the alloy from the ages of the electrolytic 
media. In view of this, it can be admitted that in the artificial physiological envi-
ronment, Ti-based alloys do not corrode but in fact undergo a passivation process. 
Under these conditions, the parameter Vcor—called corrosion rate—is actually 
passivation speed.
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2.6 Surface characterization
One of the requirements of biomaterials is cellular adhesion on the surface of 
the material, depending on surface energy. The contact angle between a drop of 
liquid and a solid surface is a sensitive indicator of changes in surface energy and 
of the chemical and supramolecular structure on the surface. Specialty studies in 
domain indicated that contact angle measurement is important for the study of cell 
adhesion to the surface, being the one that characterizes the hydrophobicity of the 
studied material [21, 22].
Measurement of the contact angle (Figure 12) is an experimental technique used 
to evaluate the hydrophilic or hydrophobic character of the surfaces. Surfaces can 
be classified as hydrophilic or hydrophobic reported at 90°. If the angle of contact 
is between 0 and 90°, the material is hydrophilic, and if the angle of contact is 
between 90 and 180°, material is hydrophobic.
Figure 11. 
Linear polarization curves in semi-logarithmic coordinates for titanium alloys developed in Ringer’s solution: 
(a) Ti15Mo0.5Si, (b) Ti20Mo0.5Si, (c) Ti15Mo7Zr10Ta, and (d) Ti20Mo7Zr10Ta.
Alloy element Ecor [mV] Rp [kΩ/cm2] Jcor [μA/cm2] Vcor [μm /an] βa [mV] βc [mV]
Ti15Mo0.5Si −266 14.91 2.131 20.59 200 −192
Ti20Mo0.5Si −227 17.71 2.089 20.19 310 −142
Ti15Mo7Zr10Ta −400.10 46.22 0.37 4.31 92.10 −91.20
Ti20Mo7Zr10Ta −425.50 50.33 0.38 4.47 130.20 −10.430
Table 5. 
Instantaneous corrosion parameters for titanium alloys developed in Ringer’s solution.
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The equipment used allows the determination of the surface tension of the 
liquids and of the free surface energy of the solid. The principle of measuring the 
angle of contact consists in placing a drop of water with a microsurgery syringe with 
the drop volume of 4 μl. Drop lighting is made from behind and recorded from the 
opposite side with a digital camera. The image obtained is further analyzed through 
the FAMAS program, a KYOWA integrated goniometer software.
Ten measurements of the contact angle (θ) for each experimental alloy were 
performed, and the value presented is the average of the measurements made, with 
a maximum error of ±1°. The average value of the contact angle for each alloy is 
shown in Table 6.
All investigated alloys have a contact angle of less than 90°, thus having a 
hydrophilic character, which means a high adhesion of the cells to the surface of 
the alloys.
From the data obtained for the analyzed titanium alloy surfaces, it follows that 
the value of the highest arithmetic mean of the alloys is recorded at the level of 
contact angle with water on the surface of the Ti15Mo7Zr10Ta alloy, and the small-
est level was Ti20Mo7Zr10Ta alloy, this alloy having a more pronounced hydrophilic 
character.
Alloy Ti15Mo0.5Si Ti20Mo0.5Si Ti15Mo7Zr10Ta Ti20Mo7Zr10Ta
Liquid used water water water water
Contact angle (°) 64.40 50.00 45.64 70.72
Table 6. 
Water contact angle values on the surface of elaborated titanium alloys.
Figure 12. 
Images of water droplet on the surface of the elaborated alloys: (a) Ti15Mo0.5Si, (b) Ti20Mo0.5Si,  
(c) Ti15Mo7Zr10Ta, and (d) Ti20Mo7Zr10Ta.
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3. Conclusions
Metals have traditionally been used to make implants subjected to high loads 
in the human body, used in various applications. They are known for their high 
resistance to wear, ductility, hardness, corrosion, and biocompatibility.
For a biomaterial to be functional for an extended period of time in the body, it 
should be nontoxic and engage in an adequate response with the body, so that it can 
fulfill its purpose.
The preliminary investigations presented in this chapter for the elaborated 
titanium alloys revealed the beneficial influence of some stabilizing β elements 
(Mo, Ta, and Si).
The alloys developed by the proposed method have the advantage of a modulus 
of elasticity close to that of the human bone and a good corrosion resistance in the 
simulated biological fluids. According to the obtained values for corrosion and the 
mechanical properties, the newly developed alloys, for a Young modulus, the value 
is the closest to the bone (from 19 to 77 GPa our alloys, C.p. Ti is 105 GPa, and the 
rest are higher, where the bone is 17 GPa) from all the commercial known alloys, 
and TMZT systems have the lowest corrosion rate. Also, according to the contact 
angle, the surfaces of the obtained alloys are susceptible for cell development.
Because improving the properties of biomaterials is a necessity to reduce the 
failure rate of implants in human tissue, we can say that the alloys developed in this 
chapter can be successful candidates for orthopedic implants, thanks to the stabiliz-
ing β elements.
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titanium alloys revealed the beneficial influence of some stabilizing β elements 
(Mo, Ta, and Si).
The alloys developed by the proposed method have the advantage of a modulus 
of elasticity close to that of the human bone and a good corrosion resistance in the 
simulated biological fluids. According to the obtained values for corrosion and the 
mechanical properties, the newly developed alloys, for a Young modulus, the value 
is the closest to the bone (from 19 to 77 GPa our alloys, C.p. Ti is 105 GPa, and the 
rest are higher, where the bone is 17 GPa) from all the commercial known alloys, 
and TMZT systems have the lowest corrosion rate. Also, according to the contact 
angle, the surfaces of the obtained alloys are susceptible for cell development.
Because improving the properties of biomaterials is a necessity to reduce the 
failure rate of implants in human tissue, we can say that the alloys developed in this 
chapter can be successful candidates for orthopedic implants, thanks to the stabiliz-
ing β elements.
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Abstract
This chapter deals with the effect of alternating electrical current on hydroxy-
apatite [HAp, Ca10(PO4)6(OH)2] and doped HAp along with their optical response 
and the processes involved. The dielectric constant, permittivity and ac conductivity 
were analyzed to have an insight into the surface charge polarization phenomenon. 
Further, the magnitude and the polarity of the surface charges, microstructure, and 
phases also play significant role in the cell proliferation and growth on the implants. 
Besides, the mechanism behind the electrical properties and the healing of bone 
fracture are discussed. The influence of various dopants on the optical properties of 
HAp viz., absorbance, transmission, band gaps and defects energy levels are ana-
lyzed along with the photoluminescence and excitation independent emission. In 
the future outlook, the analysis of effect of doping is summarized and its impact on 
the next generation biomaterials are elucidated.
Keywords: doped hydroxyapatite, electrical, optical, luminescence
1. Introduction
Hydroxyapatite (HAp) is one of the phases of calcium phosphate having excellent 
biological properties. Human bone contains 75% of inorganic materials (HAp) and 
remaining organic contents (predominantly collagen) and water. The HAp is analogous 
to the inorganic compositions of bone. The drawbacks of HAp to be used as an implant 
(bone and dental replacement material) are its weak mechanical strength, resorbability 
and to an extent this could be overcome by doping with metal ions. However, there 
were no adequate new bone formation between living bone and the implants due to the 
slow osteoconductivity [1]. Even variations in shape, roughness of the implants did not 
enhance osteoconduction [2]. Some other routes say tissue engineering, even growth 
factors [bone morphogenic protein (BMP)] [3] etc., also possess some treatment issues. 
Further, these parameters could not improve the osteoconduction. So, the application 
of the electric field on the HAp nanoparticles to induce strongly or weakly oriented 
dipoles, depending on the polarization of the dopants and band gap of the HAp 
nanoparticles to improve its biocompatibility. Besides, the dopants modify the ionic 
and space charge polarizations which vary with the ionic size of the dopants.
Recently, many studies have been reported on the electrical properties of 
HAp/doped HAp. Das and Pamu suggested that HAp could be a suitable candidate 
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(bone and dental replacement material) are its weak mechanical strength, resorbability 
and to an extent this could be overcome by doping with metal ions. However, there 
were no adequate new bone formation between living bone and the implants due to the 
slow osteoconductivity [1]. Even variations in shape, roughness of the implants did not 
enhance osteoconduction [2]. Some other routes say tissue engineering, even growth 
factors [bone morphogenic protein (BMP)] [3] etc., also possess some treatment issues. 
Further, these parameters could not improve the osteoconduction. So, the application 
of the electric field on the HAp nanoparticles to induce strongly or weakly oriented 
dipoles, depending on the polarization of the dopants and band gap of the HAp 
nanoparticles to improve its biocompatibility. Besides, the dopants modify the ionic 
and space charge polarizations which vary with the ionic size of the dopants.
Recently, many studies have been reported on the electrical properties of 
HAp/doped HAp. Das and Pamu suggested that HAp could be a suitable candidate 
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for biosensing and micro-electromechanical system applications [4]. The fer-
roelectric properties of graphene-doped HAp samples were studied by Hendi and 
Yakuphanoglu [5]. Iron-doped calcium phosphate demonstrated hyperthermia 
(42°C) within 4 minutes [6]. Study on various metals ions (iron, manganese, and 
cobalt ions)-doped HAp revealed an increase in the ac conductivity. Further, the 
annealed iron-doped HAp revealed ferromagnetism, whereas the manganese 
and cobalt ions doped samples exhibited super-paramagnetic property [7]. The 
dielectric properties of the chromium-doped HAp were also studied [8]. Various 
anions such as nitrate, acetate, chloride, and egg shell precursors have been used 
to prepare HAp particles and their corresponding dielectric constant were 9.96, 
13.22, 9.92, and 10.86 at 5 MHz [9]. Porous HAp was prepared from Pila globosa 
shells which possessed high dielectric constant with low dielectric loss [10]. HAp-
barium titanate (BT) composite scaffolds having improved electric, compressive 
strength, toughness, density, and hardness were developed using cold isostatic 
pressing and sintering by Tavangar et al. [11]. Bismuth ions (10, 30 and 50 wt%) 
were substituted in the HAp matrix by the conventional solid-state reaction at 
1300°C and their ac conductivity was reduced with an increase in Bi content [12]. 
Space charge and dipolar polarization were the dominant polarization mechanisms 
in Na0.5K0.5NbO3 (NKN)-HAp as reported by Verma et al. [13]. La, Ba, Fe, and Zn 
ions doped HAp synthesized by sol-gel route displayed a space charge polariza-
tion at low frequency with negative temperature coefficient of resistance [14]. 
Different contents (e.g., 0, 1, 3, 6, 19, 12, and 15% [wt.]) of gallium ion-doped 
HAp by microwave-assisted sol-gel technique, illustrated a higher inhibition of 
bacteria and fungi. Further, gallium ions influence the dielectric properties of 
HAp [15]. Dielectric properties of chlorinated ethylene propylene diene mono-
mer/hydroxyapatite nanocomposites were robustly distorted at lower frequencies 
whereas above 103 Hz, it was frequency independent [16]. Horiuchi et al. reported 
that the polycrystalline HAp possesses conductive grains and insulating grain 
boundaries further, interfacial polarization was confirmed to be an electret [17]. 
In the case of chitosan/HAp composite, the concentration of chitosan plays a 
predominant role in regulating its hardness, conductivity and dielectric constant 
[18]. HAp particles were permanently polarized by both electric potential (500 V 
direct current) and thermal treatment (at 1000°C) leading to the high adsorption 
of inorganic bioadsorbates compared to the as prepared HAp [19]. Electric field 
assisted sintering such as spark plasma sintering (SPS) and flash sintering (FS) 
performed on HAp revealed nanovoids within HA grains. Further, in situ TEM 
heating produced nanovoids which remained stable up to 900°C and were not 
present at 1100°C [20]. Using sol-gel route, yttrium and strontium co-substituted 
nano-hydroxyapatite was prepared with a minor phase of β tricalcium phosphate, 
however the ac conductivity was enhanced with an increase in frequency [21]. 
Tungsten-doped hydroxyapatite (W-HAp) nanoparticles were prepared by chemi-
cal precipitation followed by thermal treatment (800, 1000 and 1200°C) leading 
to an enhancement in the mechanical strength, Young’s modulus and dielectric 
constant [22]. The synthesis routes, concentration of doping, and doping char-
acteristics affect the behavior of dielectrics as well as other correlated properties 
such as mechanical and biocompatibility. In the case of doping of semiconductors, 
the dielectric properties are robustly influenced due to the presence of holes and 
electrons. When the electric field is applied, the polarization varied in the matrix 
owing to the occurrence of both holes and electrons. The physical (pressure), 
chemical (electronic), and thermal treatment significantly alter the properties of 
HAp leading to the creation of porous, dense and bonded matrix. When electric 
field is applied to such systems, the electronic polarization, oxygen vacancies, 
dipole displacement, and atomic orientation are interrelated which alter the 
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permittivity and ac conductivity of HAp. In the case of polymer/HAp composites, 
the dielectric behavior is distinct due to the presence of carbon and hydrogen 
chains and the type of bonding. On annealing, the dielectric response of the com-
posites changes significantly due to the formation of voids and porous structures.
Yamashita et al. reported the chemical effects of the electrically polarized HAp 
in simulated body fluid [23] and in addition enhanced the in vitro bioactivity and in 
vivo osteoconductivity [24, 25]. Similarly, the bioactivity of HAp has been improved 
by doping of metal ions viz., iron [26, 27], silver [28, 29], magnesium [30, 31], 
strontium [32, 33], etc., in HAp. Co-dopants like magnesium-silver ions [34], iron-
zinc [35], etc., have also been used for augmenting physical and biological proper-
ties. Electrical and dielectric properties of HAp are crucial for understanding the 
dipole polarization and surface charge. Depending on the radius of metal ions, sub-
stitution or doping takes place in the matrix of HAp which in turn alters the local 
dielectric polarization leading to micro and macro polarization. Further, these types 
of polarization modify the surface charges to either positive or negative. In the case 
of co/tri doping, the basis of lattice has higher atomic and electronic polarization 
which alter local bonding of the atoms. When electromagnetic field is applied to 
the co-doped lattice, the wave dispersion is modified when compared to the pristine 
dielectric material. The ex situ electromagnetic fields enhance the bone fracture 
healing and bone mineralization [36]. Bowen et al. reported that an enhancement 
in the barium titanate incorporation in HAp lattice increases the permittivity and 
ac conductivity [37]. Nakamura et al. revealed the migration of protons along the 
columnar structure of HAp under electric field at high temperature [38]. Enhanced 
bone growth was noticed on the negatively charged surface whereas it was reduced 
on positively charged surface [39]. Osteogenesis was promoted in the dog’s jaw-
bones using HA-BaTiO3 composites without any change in phase [40]. Nakamura 
et al. augmented the osteoconduction of the canine bone owing to the bioactive 
HAp surface as well as accelerated surface charge by electrical polarization [41]. In 
the lattice of HAp, the hydroxyl atoms were projected along c-axis and charges are 
modified on application of the electric field and with an increase in temperature. 
The projection of hydroxyl groups alters to either abundant negative or positive 
charge that would aid the cell growth and cell proliferation.
The interaction of light with the HAp nanoparticles is another interesting phe-
nomenon, though an insulating material, the presence of phosphate ions aids the 
emission of photons of different wavelengths. Addition of metal ions in the lattice 
of HAp tunes the defect energy levels and alters the chemical potential. The dopants 
can affect the optical and photoluminescence (PL) of HAp. These properties depend 
on the absorption, transmission, and band gap as well. Further, these properties 
favor the use of the HAp nanostructure for bio-imaging and biosensing applications. 
The doped HAp facilitates the trapping of photons at defect sites or ease transmis-
sion which enables them for opto-electronic device applications. Popa and Ciobanu 
reported the enhanced PL by the cerium ions doped HAp without any structural 
change [42]. The band gap of erbium-doped HAp was reduced displaying red and 
green emissions [43]. The various emissions were possible due to the formation of 
defect energy levels coupled with the HAp energy levels which alters the rate of 
recombination of electron and hole pairs. Further, the doping concentration varies 
the active centers of recombination. Feng et al. reported that the Eu3+/Gd3+dual-
doped HAp nanorods show enhanced PL with a sustained ibuprofen (IBU) release. 
Further, the nanorods were injected into mice and demonstrated that these nanorods 
could be used for in vivo imaging [44]. Europium-doped HAp revealed high photolu-
minescence intensity at 900°C due to the migration of europium from Ca1 to Ca2 site 
[45]. Fluorescent europium-doped HAp nanowires were prepared by hydrothermal 
technique and in situ dispersion of them for dental applications [46]. Chang et al. 
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technique and in situ dispersion of them for dental applications [46]. Chang et al. 
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reported dual emission from nitrogen-doped carbon dots (N-CDs)/HAp:europium, 
gadolinium composite due to aggregation of N-CDs [47]. The nanostructures either 
one or zero dimensions significantly affect the electronic motion forming many 
energy levels due to the quantum confinement effect. Moreover, the optical proper-
ties of HAp vary on doping of quantum dots, nanowires, etc. When light is shone on 
the materials, various local emissions occurred that would be absorbed in the matrix 
subsequently leading to the partial emission of photons. In the case of cerium-doped 
HAp, the luminescence quenching occurred between the nearest cerium ions in the 
matrix as reported by Kolesnikov et al. [48]. Various fluoridated HAp doped with 
Eu3+ ion nanoparticles were prepared by hydrothermal technique and the fluorine 
ions could influence the crystal field environment for luminescence conversion [49]. 
Reddy et al. observed a strong green emission from Ni2+-doped Ca-Li HAp (CLHA) 
[50]. Erbium-ytterbium-molybdenum tri-doped HA/β-TCP phosphor was synthe-
sized using solid-state reaction by Van et al. They demonstrated 650 times higher 
green emission in the presence of molybdenum [51]. In the case of tri-doped HAp, 
each dopant generates its energy levels and active centers for recombination leading 
to different emissions. Further, the emission depends on the dopant concentration 
as well. The praseodymium-doped fluorapatite illustrated green emission at 545 nm 
and orange emission at 600 nm [52]. Europium/barium co-doped and F-substituted 
nHAp (HA@nFAp:Eu/Ba) showed high sensitivity in both computed tomography 
and fluorescence imaging [53]. Carbon dots/HAp/PVA (CDs/HA/PVA) dual-network 
(DN) hydrogel scaffold showed an excellent fluorescence in non-invasive monitoring 
field for the in vivo evaluation [54]. In vivo investigation is a challenging task; these 
advanced materials help in monitoring the cell viability and cell proliferation on 
implants without following supplementary way to understand cell interaction. Xing 
et al. developed heparin-coated Eu3+-doped HAp nanoparticles (SH-Eu:nHAP) for 
bioimaging [55]. HAp nanorods tune color from blue to red and also emit white colors 
depending on the temperature, excitation wavelengths, etc. [56]. Optical responses, 
band gap, and emission behavior of materials vary on thermal treatments; further, 
thermal defects and production of active centers were responsible for the rapid/slow 
recombination of the electron and hole pairs. Hence, thermal-based luminescence 
is a fascinating process of emission with respect to various temperatures. However, 
thermally induced defects are not stable and returned to the ground state by emitting 
photons. Further, doping modifies the interatomic and intra-atomic transition states 
of basis during thermoluminescence. For instance, thermoluminescence of HAp 
doped with different percentages of lanthanum (La), Eu, gadolinium (Gd), and dys-
prosium (Dy) has been examined under the gamma radiation and (1 m%) Dy-doped 
samples demonstrated its capability to be used for gamma radiation dosimetry [57]. 
Cathodoluminescence and thermoluminescence nature of calcium phosphates were 
also investigated in the UV-IR range with the wavebands due to hydroxyl groups, 
nonbridging oxygen, etc. [58]. HAp and YAG:Ce ceramics were synthesized by Huang 
et al. at 850°C to fabricate white light-emitting diodes with phosphor in ceramics 
(PiCs) color converters in transmission mode [59]. So, these green diodes are use-
ful in reducing the consumption of toxic materials (europium, cadmium etc.) and 
will guide researchers to develop various green-based diodes. Gd-dependent blue 
emission was observed on selenium (Se) and gadolinium (Gd) dual ions doped HAp 
nanoparticles under ultraviolet (UV) irradiation [60]. Copper-doped Sr-HAp was 
prepared by solid-state reaction Sr10(VO4)6-x(PO4)xO2CuyH2-y-δ (x = 0–6; y = 0–0.24) 
as the x value decreases; copper-doped samples show intense blue emission [61]. In 
most of the cases, the PL emission was reduced due to the concentration quenching 
and non-radiative recombination of electron and hole pairs which evidently showed 
the variation of active centers in the matrix.
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Europium-doped calcium phosphate apatite-based colloids possess narrow 
emission with long luminescence lifetimes suitable for nanoprobe as reported 
by Kattan et al. [62]. These colloids were stable over time and excite near visible 
or visible light domains. The excited states in the colloids were highly stable and 
electron decay time was slow. Further, non-radiative recombination centers might 
be far away from each other to reduce the bleaching effect. Mesoporous strontium 
ions doped HAp samples exhibited blue emission and sustained drug release [63]. 
The PL intensity of doped HAp was correlated to the amount of ibuprofen released 
[63]. Similarly, Yang et al. reported the red emission of europium-doped HAp 
and its PL intensity altered with the release of drug molecules [64]. This idea has 
many practical difficulties at in vivo level and could be addressed by developing 
advanced analysis. Thus, doped HAp nanostructures can be an ideal candidate for 
both bio-imaging and drug delivery. Still, there is a lack of fundamental and basic 
understanding of electrical and optical nature of doped HAp. The main focus of 
this chapter is to discuss few instances of metal ions doped HAp and its electrical 
and optical behavior. Further, the path that lead to the development of next genera-
tion advanced biomedical materials will also be examined.
2. Types of calcium phosphates
Calcium phosphates are found in the bone and teeth as the major inorganic 
constituent. Depending on the Ca/P ratio and structure, the phases of calcium 
phosphate are classified as tabulated in Table 1. Although these phases of calcium 
phosphate are different from each other by their chemical composition, but they 
are biocompatible, non-toxic, and osteoconductive in nature which have ability 
to stimulate tissue regeneration. The HAp and tricalcium phosphate (TCP) are 
the mostly used ceramics in biomedical applications among the phases of calcium 
phosphate. The combination of these two phases result in a new phase formation 
which was recognized as a biphasic calcium phosphate used in bone repair and 
replacement applications. The phases of calcium phosphate have their individual 
adsorption and resorption capacities.
S. No. Phase Abbreviation Empirical formula Ca/P 
ratio
1. Calcium phosphate monohydrate MCPM Ca(H2PO4)2.H2O 0.5
2. Monocalcium phosphate MCP Ca(H2PO4)2 0.5
3. Dicalcium phosphate DCP CaHPO4 1.0
4. Dicalcium phosphate dihydrate DCPD CaHPO4.2H2O 1.0
5. Octacalcium phosphate OCP Ca8H2(PO4)6.5H2O 1.33
6. Tricalcium phosphate TCP Ca3(PO4)2 1.5
7. Amorphous calcium phosphate ACP Ca10−xH2x(PO4)6(OH)2 1.2–2.2
8. Calcium-deficient hydroxyapatite CDHA Ca9(HPO4)(PO4)5(OH) 1.5–1.67
9. Hydroxyapatite HAp Ca10(PO4)6(OH)2 1.67
10. Oxyapatite OXA Ca10(PO4)6O 1.67
11. Tetracalcium phosphate TTCP Ca4O(PO4)2 2.0
Table 1. 
Phases of calcium phosphate [65].
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The solubility of calcium phosphate (CaPs) varies from each other 
and the in vivo degradation was foreseen in the order MCPM>TTCP>α-
TCP > DCPD>DCP > OCP > β-TCP > CDHA>HAp [29]. Monocalcium phosphate 
monohydrate (MCPM) is soluble in water and is acidic in nature. Therefore, it 
cannot be used in the bone repair applications. The MCPM combined with α-TCP or 
β-TCP, makes it less soluble [65, 66]. Usually the MCPM has been used as fertilizer 
and commonly known as superphosphate fertilizer. The Monocalcium phosphate 
(MCP) was prepared by heating the MCPM at 100–110°C and is similar to the 
MCPM. The MCP has been rarely used due to its highly hygroscopic nature [67].
Dicalcium phosphate (DCP) is biocompatible and bioresorbable and has been 
used as bone cement [68, 69]. Dicalcium phosphate dihydrate (DCPD) also known 
as brushite can be easily synthesized and has osteoconductive property. It is a 
metastable material and can be converted to other phases DCP, OCP, CDHA, and 
TCP by varying the pH of the reactant solutions. The octacalcium phosphate (OCP) 
is responsible for the formation of teeth and bone. It crystallizes very slowly and 
is not suitable for bone cement application. The α-TCP and β-TCP are polymorphs 
having same chemical composition with different structures [70, 71]. The α-TCP’s 
solubility is better than that of β-TCP but both are biocompatible, resorbable, 
and have been used as bone cement. Among the phases of CaPs, the HAp is more 
stable and highly crystalline in nature. When the HAp is heated above 900°C, it is 
converted to oxyapatite (OXA) in an inert atmosphere. The tetracalcium phosphate 
(TTCP) was prepared by heating the DCP and calcium carbonate at 1400°C with 
rapid cooling [72].
3. Electrical properties
HAp is a bioceramic having a high dielectric constant. Researchers have studied 
the impact of electric field on the HAp to understand the real part and imaginary 
part of the permittivity [37, 38]. These properties provide us an insight into the 
dielectric polarization of electric dipoles with respect to electric field. Further, the 
dielectric studies aid to understand in vitro electrical polarization. The respective 
real and imaginary part of permittivity grants dispersion of dipoles and energy 
dissipation. Some other parameters say temperature, experimental condition and 
dopants can influence and alter the dielectric properties. Doping sites and dopant’s 
radius alter the electronic and orientation polarization, whereas co or tri-doping 
significantly affects the structure and phase, further, the dielectric properties of 
these materials might vary due to the rate of dipole relaxation. Generally, at low 
frequency alternating field, the dielectric constant is high and varies with increase 
in frequency. Nakamura et al. studied the polarization of HAp using direct current 
and showed that proton migrates along the columnar OH channel [38]. The polar-
ized charge was high enough to improve biological activity. Usage of the electrical 
fields enabled the accelerated fracture healing in bones; however, it was slow in the 
case of long bone [72–74]. There are some reports on electrical stimulation which 
has been used to enhance the bone growth in spinal fusion [75, 76]. Further, it has 
been employed to treat osteonecrosis as well as osteoarthritis [77]. The dielectric 
constant of fluids and tissues in the bone and HAp is crucial for healing. The poros-
ity of HAp plays a vital role for the local electrical field strength [78, 79]. Human 
bones also contain many elements such as magnesium, zinc, and strontium etc., so, 
the impact of the elements in the bone also play a vital role in the dielectric constant 
of bone. Further, it as well depends on the elemental size, concentration, and inter-
related porosity.
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For instance, doping of magnesium ions on HAp enhances the dielectric constant 
(Figure 1A) [30]. At low frequency, the dielectric constant was high due to ionic 
polarization; however, it was reduced by lagging of dipoles with respect to electric 
field. At low magnesium ions doping, the dielectric constant was low and almost 
equal to the dielectric constant of HAp. So, the low level doping did not highly polar-
ize the ions in the direction of electric field and difficult to locate the dopant site posi-
tion either at calcium site 1 or calcium site 2. As the Mg concentration increases, both 
the sites might be occupied and at low frequency the dipoles were strongly oriented, 
whereas it was disturbed at high frequency. Similarly, the cadmium-doped HAp 
revealed a higher dielectric constant in comparison with pure HAp. However, 40% of 
cadmium-doped HAp shows a decrease in the dielectric property. At 1 kHz frequency,  
the dielectric constant of HAp, doped samples 10 at.% Cd, 20 at.% Cd, 25 at.%  
Cd, 30 at.% Cd, and 40 at.% Cd were 6.75, 7.12, 8.16, 7.13, 7.26, and 6.24 respectively. 
At 40 at.% Cd, the structural change from hexagonal to monoclinic with varying 
crystallinity was responsible for the reduction in the dielectric constant [80]. In the 
case of silver-doped HAp, the dielectric constant was enhanced due to a high dipole 
polarization [81]. The dopant size varies the phase of HAp leading to amorphous or 
partial amorphization which completely modifies the local coordination and chemical 
potential. Horiuchi et al. revealed the two step relaxations of fluorine substituted HAp 
(F-HAp) [82]. They depicted that one step from 600 to 60 Hz and other 60 to 20 Hz 
in HAp which were analogous to the F-HAp. At low frequency, the electric dipoles are 
largely (L) relaxed, whereas at high frequency, the relaxation was small (S). Further, 
they calculated the activation energy of HAp and F-HAp as 0.63 and 0.62 eV, respec-
tively, for one type of relaxation and it was independent of fluorine substitution. In 
case of other relaxation, the activation energy was significantly influenced by fluorine 
substitution due to the change in orientation of hydroxyl groups [82].
In the case of tungsten (W)-doped HAp, the relative permittivity was reduced 
up to 1 MHz and from 1 to 5 MHz the permittivity was constant [83]. The dielectric 
constant of W-doped HAp was high at low frequency due to the polarization of 
electronic, ionic, dipolar, and space charge. As the doping concentration increases, 
the dielectric constant was enhanced [83]. Thus, the dopants enhance spreading 
of the electromagnetic fields in the damaged bone sites or fractured area for rapid 
healing. Similarly, the other metal ions strontium [21], iron [26] etc., have been 
used as dopants in HAp to enhance dielectric property. A crucial and impressive 
part is how dielectric constant varies with concentration and with various dopants 
and the mechanism involved. The co-doping in HAp leads to the creation of many 
defects and alters the ionic polarization with respect to electric field. For instance, 
iron and zinc ions were co-doped in HAp at various concentrations (0.01, 0.05, 
Figure 1. 
(A) Real part of relative permittivity of HAp and Mg-doped HAp (reproduced from Ref. [30] with permission 
from Elsevier). (B) Dielectric constant of (a) FZH0, (b) FZH1 (0.01 M), (c) FZH2 (0.05 M) and (d) FZH3 
(0.1 M) (reproduced from [35] with permission from Elsevier) and (C) The real part of relative permittivity 
as a function of frequency for (a) Pristine, (b) 1HAp (1×1015 ions/cm2), (c) 2HAp (1×1016 ions/cm2) and  
(d) 3HAp (1×1017 ions/cm2) (reproduced from [84] with permission from Elsevier).
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Figure 1. 
(A) Real part of relative permittivity of HAp and Mg-doped HAp (reproduced from Ref. [30] with permission 
from Elsevier). (B) Dielectric constant of (a) FZH0, (b) FZH1 (0.01 M), (c) FZH2 (0.05 M) and (d) FZH3 
(0.1 M) (reproduced from [35] with permission from Elsevier) and (C) The real part of relative permittivity 
as a function of frequency for (a) Pristine, (b) 1HAp (1×1015 ions/cm2), (c) 2HAp (1×1016 ions/cm2) and  
(d) 3HAp (1×1017 ions/cm2) (reproduced from [84] with permission from Elsevier).
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and 0.1 M) by ultrasonication. At higher concentration (FZH3) (0.1M), dielectric 
constant was greater (Figure 1B) compared to the other samples owing to the 
enhanced ionic polarization and strong orientation of dipoles at low frequency. As 
the frequency increases, the dielectric constant was reduced in all the samples due 
to lagging of the dipoles [35]. Generally, at low frequency, the value of dielectric 
is high due to slow relaxation of dipoles with high orientation. At high frequency, 
the dielectric constant was reduced due to strong re-alignment of dipoles with field 
[30, 83]. Further, it depends on the size of dopants, crystal structure, and concen-
tration providing atomic site variations which enable the variations in the unit cell 
and crystal structure. Moreover, the dopants provide vacancies which affect space 
charge localization/delocalization. This facilitates the alterations in the dielectric 
constant. In case of the HAp structure, the hydroxyl ions aligned along c-axis paral-
lel to calcium and phosphate(PO4)3− ions favor high polarization of electric dipoles 
thereby increasing the ionic conduction [38]. Surface charge of HAp is another 
important parameter which assists the bone cell growth. The polarized surface of 
HAp had improved the osteobonding in canine bone tissues [39]. So, the electric 
properties have been employed to understand the cellular behavior on bone and to 
develop bone prostheses [38]. The surface charge of HAp depends on the poros-
ity and dielectric strength. It can vary on low energy ion implantation which are 
capable of altering the surface properties without affecting the bulk properties of 
the materials. Nitrogen ions (N+1) were implanted in HAp matrix with varying ion 
fluences 1 × 1015 (1HAp), 1 × 1016 (2HAp), and 1 × 1017 (3HAp) ions/cm2 [84].  
At higher ion fluence (3HAp), relative permittivity was significantly enhanced 
(Figure 1C) in comparison with other samples because of the higher ionic and space 
charge polarizations. The surface and subsurface of HAp were modulated on ion 
implantation altering the dipole polarization thereby leading to the variation in the 
surface charge of the samples. The polarization varies locally leading to dielectric 
strength modification at the surface, subsurface and at macro level. Hence, the 
surface charge can be tuned by different dopants, temperature, and frequency.
The variation of dielectric constant with frequency of pure and Fe-doped HAp, 
Mn-doped HAp, and Co-doped HAP sample at room temperature was examined by 
Panneerselvam et.al. [7]. The dielectric constant of the doped samples decreased 
sharply up to 10 kHz, and then reduced gradually with further increase in fre-
quency. This difference in dielectric constant is due to the four types of polariza-
tion such as electronic polarization (frequencies up to 1016 Hz), ionic polarization 
(1013 Hz), orientation polarization (up to 1010 Hz), and space charge polarization 
or interfacial (up to 103 Hz) [7]. In all the samples, as the doping concentration 
increases, the dielectric constant was enhanced due to ionic polarization. The high-
est dielectric constant was exhibited by 5% MnHAp and the lowest by 5% CoHAp 
[7]. The dopants such as Fe, Mn, and Co possess different ionic radii and electronic 
cloud density. The variation of dielectric constant of the different metal ions doped 
HAp is due to the change in dipole strength, rate of dipole relaxation, and space 
charge polarization apart from ionic polarization. Tavangar et al. fabricated HAp-
barium titanate (BT) scaffolds by cold isostatic pressing and sintering. As the BT 
concentration increases, the dielectric loss (D) of the composite was reduced due 
to the low porosities and higher densities of composite when compared with pure 
HAp. The 60 wt% BT had the lowest dielectric loss at 1 kHz. The dielectric constant 
of the 60 wt% BT–40 wt% HA composite was 46.50 which was the highest com-
pared to the other composites due to the coupling of low-dielectric constant of HA 
with BT leading to a parallel polarization in the presence of phases with different 
weight percentages and electrical conductivity [11]. The ac frequency facilitated 
the coupling of the phases of materials leading to a synergic effect on the dipole 
polarization and orientation. Verma et al. studied the effect of concentration of 
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piezoelectric Na0.5K0.5NbO3 (NKN) on dielectric and electrical properties of HAp 
in the range of temperature (30–500°C) at frequency 1 Hz to 1 MHz. The composite 
was prepared by solid state ceramic method and sintered at 1075°C for 2 h [13]. The 
experimental values of the dielectric constant are lower than those of calculated 
using theoretical models [13] due to the connectivity between HAp and NKN phases 
at the lower concentration of NKN in HAp matrix. The connectivity of matrix and 
secondary phase affects the electrical as well as mechanical properties of the com-
posites. At low content of NKN, the HAp phases were connected in three-dimension 
whereas, no connectivity between NKN phases and 0–3 connectivity between 
NKN and HAp phases were observed. With enhancing content of NKN in the HAp 
matrix, the interaction between piezoelectric phases was increased. The calculated 
dielectric values of HAp-10 NKN, HAp-20 NKN, and HAp-30 NKN were 30.54, 
38.71 and 50.29 respectively. The effective dielectric constant of HAp-10 NKN, 
HAp-20 NKN and HAp-30 NKN at 10 kHz (room temperature) were calculated 
to be 29.81, 35.32 and 42.046 respectively. The calculated and experimental values 
were significantly varied at high concentrations due to the combined involvement 
of complex parameters such as orientation and electronic The microstructure, 
densification, undetectable phases etc. play a vital role in determining the efficient 
dielectric constant of the composite system [13].
The ac conductivity measurements are used to study the mechanism of hop-
ping and it is a complex phenomenon. Further, it depends on frequency and 
temperature [30]. The ac conductivity of Mg-doped HAp was enhanced compared 
to HAp (Figure 2A). There was low ac conductivity at low frequency due to the 
weak turnaround of ions with the electric field. However, it was increased at higher 
frequency on Mg-doped samples due to the complex array of ions and proton seg-
regation along c-axis [30, 85]. Similar trend also noticed in W-doped HAp samples 
which linearly depend on the frequency range. Further, it obeyed the universal 
frequency power law. Towards understanding the mechanism of ac conductivity of 
the samples, the proverbial Jonscher equation (σac = σdc + Bωs) was used [86], where 
B-constant, ω-angular frequency and s-frequency exponent. Using the slope of lnσ 
vs. lnωac and the s values were calculated as 1.0622, 1.0600, 1.0623, 1.0501, 1.0518, 
1.0629, and 1.0534 for pure and 1, 5, 10, 20, 30, and 40% of W in HAp, respec-
tively. Here, s is almost ≤1, revealing no measureable direct current conductivity 
and displays prompt hopping with a translational motion [83]. In the case of the 
Cd-doped HAp samples, the alternating current conductivity was enhanced from 
10−10 to 10−5 s cm−1 with an increase in frequency. The frequency exponent(s) was 
Figure 2. 
(A) Ac conductivity as a function of frequency of HAp and Mg-doped HAp (reproduced from Ref. [30] with 
permission from Elsevier); and (B) The ac conductivity as a function of frequency for (a) Pristine,  
(b) 1HAp, (c) 2HAp and (d) 3HAp (reproduced from [84] with permission from Elsevier).
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(A) Ac conductivity as a function of frequency of HAp and Mg-doped HAp (reproduced from Ref. [30] with 
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determined from the slope of logσ vs. logω and its value equal to 1 for the samples 
[80]. Eventually, it displays a lack of direct current conductivity [87]. Similar, s 
value was realized for the Te-doped HAp samples however, their ac conductivity 
enhanced at low concentration due to s ≥ 1 leading to localized hopping. At higher 
concentration, it was reduced due to s ≤ 1 leading to translation motion with a 
rapid hopping motion [88]. Ion implantation could also be employed to alter the ac 
conductivity, without using expensive and toxic chemicals. It can precisely modu-
late the ac conductivity up to a particular depth. Nitrogen ions implanted samples 
demonstrated higher ac conductivity at higher frequency owing to the strong 
arrangement of complex ions compared to pristine (Figure 2B). However, it was 
less at low frequency due to the weak turnover of ions [84].
4. Optical properties
The interaction of light on materials leads to transmission, absorptions and 
reflection. These parameters depend on refractive index, wavelength, dielec-
tric constant, and dopants. Dopants play a vital role in creating the abundant 
defects/vacancies in the lattice of materials. When light interacts on the bound 
charges of the materials, they either transmit or reflect back. The structure and 
phase of HAp varied depending on the type of dopant [80] which also alters 
the optical properties of HAp. The optical properties of HAp were enhanced 
by developing smaller grains and low porosity in the HAp matrix. It is an opti-
cally anisotropic material and possesses a refractive index in the range 1.644 
and 1.651 depending on light polarization and direction of propagation [89]. A 
highly transparent HAp nanosized grains were used to observe in vivo interac-
tions with proteins/cells [90, 91]. For a proper insight of the optical properties, 
intrinsic correlated parameters/quantities say crystalline structure, dispersion of 
phonon, band structure, dielectric response, band gap, etc. are required. Density 
functional theory displays a local or semi local exchange-correlation interac-
tion of HAp providing a band gap between 4.5 and 5.4 eV depending on the 
type of valence states [92, 93]. However, the (semi) local exchange-correlation 
underestimates the band gap of HAp, and thus its value is above 5.5 eV [94]. So, 
the defect free HAp is transparent to visible light under middle or far ultraviolet 
illumination having a band gap >6 eV. Interesting point to note is that the dop-
ants produce defects level in between conduction band and valence band.
For instance, the thenoyltrifluoroacetonate (TTA)- and europium (Eu)-doped 
HAp were used to enhance transmission spectra by 20% compared to PMMA. The 
TTA shows a red shift and the transmission edge from 275 to 375 nm. Both the TTA 
and HAp mixture restrict the formation of PMMA clusters improving the trans-
parency. In this case, the absorption and scattering losses were introduced by the 
TTA and the HAp nanoparticles [95]. The other example, Cd-doped HAp showed 
enhanced reflectivity at the Cd (40 at.%) due to the structural transformation to the 
monoclinic phase. Further, it alters the refractive index of the samples as well [80]. 
At a particular atomic percentage, the structural transformation occurred affecting 
the electronic polarization thereby, altering the reflectivity. In the case of erbium 
doping in HAp, seven absorption bands were noticed [43]. The bands observed 
at 1520, 980, 803, 657, 524, 490, and 448 nm corresponding to the electronic 
transitions from ground state 4I15/2 → 4I13/2, 4I15/2 → 4I11/2, 4I15/2 → 4I9/2, 4I15/2 → 4F9/2, 
4I15/2 → 2H11/2, 4I15/2 → 4F7/2, and 4I15/2 → 4F3/2, respectively [92]. Among all the transi-
tions, the 4I15/2 → 2H11/2 transition had the highest intensity due to the hypersensitive 
transition [92]. Further, the peaks were broadened inhomogeneously due to the f-f 
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interactions of Er3+ ions [96]. As the erbium doping concentration increases, the 
intensity of the peaks increased due to the replacement of Ca2+ by Er3+ ions. Further, 
there was a blue shift observed on the doped HAp due to the reduced particle size 
[97]. The Er-HAp samples possess direct band gap (n = 1/2) so band to band transi-
tions was allowed. As the erbium doping concentration increased, the band gap was 
enhanced to 4.46 eV from 4.02 eV. Hence the structure, phase, defects and particle 
size of HAp are the key parameters to alter either the absorption or reflection. 
Further, the symmetry of the HAp also plays a predominant role in modifying the 
electronic polarization and dielectric constant.
Apurba et al. studied the optical response of HAp films of various thicknesses 
on amorphous SiO2 substrates [98]. All the films showed 75–96% transparency 
in the visible region. There are two regions noticed, one is absorption and other a 
transparent oscillating region. Below 300 nm, the transmittance of the HAp films 
displayed robust absorption. When the film thickness enhances, the absorption 
edge was shifted to higher wavelength in turn altering electronic polarization 
Thus, these films revealed a strong absorption in UV region and transparency 
in the visible regions as well. The band gap of the varying thickness of HAp thin 
films was in the range 5.25–4.67 eV due to an increase in crystallinity and grain 
size. The band gap of thin films is similar to the band gap of bulk HAp (in the 
range of 5.4 to 4.51) [99]. For annealed films, the refractive indices were aug-
mented with an increase in the film thickness [98]. Flores et al. reported that using 
the Kubelka-Munk function through the maximum of the first derivative, the 
absorption edge values were 5.62, 4.74 and 4.6 eV which correspond respectively to 
TbW0 [calcium-deficient (CD) HAp], TbW10 (terbium 10%-doped CDHA), and 
TbW12 (terbium 20%-doped CDHA) [100]. The optical band gap values of the 
TbW0, TbW10 and TbW12 samples were 5.41, 4.49 and 4.38 eV respectively. This 
demonstrates that as the Tb increases, the band gap was reduced. Here the host 
matrix having calcium vacancies was considered as n-type, whereas the Tb acts as 
a p-type dopant. When the Tb ions substitute at that calcium site then the elec-
trons were delocalized to conduction band. Further, in the case of the TbW10 and 
TbW12 samples, the band gap was reduced. From the UV photoelectron spectra, 
the valence band energies of Ev0 (TbW0), Ev1 (TbW10) and Ev2 (TbW12) were 
3.33, 2.55 and 2.40 eV, respectively [100]. It exhibits a decrease in the valence band 
at the higher concentration of Tb and varies Fermi level of the samples.
Feng et al. studied the drug adsorption capacity of HAp using absorption spectra 
[44, 101]. The respective drug adsorption capacity of the undoped HAp nanorod 
and the Eu3+/Gd3+ HAp was 653.5 and 841.4 mg/g. The interaction of the dopants 
with drug molecules might be strong due to the presence of oxygen vacancies and 
atomic defects which pave a path for sustained or rapid release of drug molecules. 
This revealed that the doped nanorods displayed a high drug adsorption compared 
to undoped sample with a reduced absorbance. The size of the dopant and its 
doping concentration play a predominant role in modifying the crystal structure 
thereby the Fermi level position gets altered leading to the enhancement or decrease 
of the band gap. When photon interacts with the material, either high absorbance 
or transmission of photons occurs due to the variation in energy levels of defects or 
vacancies. The optical response of the doped HAp is not only dependent on material 
property and type of dopant (drug or organic molecules) but also on the type of 
wavelength used. Moreover, different wavelengths have distinct capability of light 
reflection, absorbance, and transmission as well.
The carbon-based HAp showed enhanced optical absorption. N-doped carbon 
dots (N-CDs) revealed absorption at about 240 and 340 nm, due to the Π▬Π* 
transition of C〓C and Π▬Π* transition of C〓O and C▬N/C〓N, respectively [56]. 
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in the visible regions as well. The band gap of the varying thickness of HAp thin 
films was in the range 5.25–4.67 eV due to an increase in crystallinity and grain 
size. The band gap of thin films is similar to the band gap of bulk HAp (in the 
range of 5.4 to 4.51) [99]. For annealed films, the refractive indices were aug-
mented with an increase in the film thickness [98]. Flores et al. reported that using 
the Kubelka-Munk function through the maximum of the first derivative, the 
absorption edge values were 5.62, 4.74 and 4.6 eV which correspond respectively to 
TbW0 [calcium-deficient (CD) HAp], TbW10 (terbium 10%-doped CDHA), and 
TbW12 (terbium 20%-doped CDHA) [100]. The optical band gap values of the 
TbW0, TbW10 and TbW12 samples were 5.41, 4.49 and 4.38 eV respectively. This 
demonstrates that as the Tb increases, the band gap was reduced. Here the host 
matrix having calcium vacancies was considered as n-type, whereas the Tb acts as 
a p-type dopant. When the Tb ions substitute at that calcium site then the elec-
trons were delocalized to conduction band. Further, in the case of the TbW10 and 
TbW12 samples, the band gap was reduced. From the UV photoelectron spectra, 
the valence band energies of Ev0 (TbW0), Ev1 (TbW10) and Ev2 (TbW12) were 
3.33, 2.55 and 2.40 eV, respectively [100]. It exhibits a decrease in the valence band 
at the higher concentration of Tb and varies Fermi level of the samples.
Feng et al. studied the drug adsorption capacity of HAp using absorption spectra 
[44, 101]. The respective drug adsorption capacity of the undoped HAp nanorod 
and the Eu3+/Gd3+ HAp was 653.5 and 841.4 mg/g. The interaction of the dopants 
with drug molecules might be strong due to the presence of oxygen vacancies and 
atomic defects which pave a path for sustained or rapid release of drug molecules. 
This revealed that the doped nanorods displayed a high drug adsorption compared 
to undoped sample with a reduced absorbance. The size of the dopant and its 
doping concentration play a predominant role in modifying the crystal structure 
thereby the Fermi level position gets altered leading to the enhancement or decrease 
of the band gap. When photon interacts with the material, either high absorbance 
or transmission of photons occurs due to the variation in energy levels of defects or 
vacancies. The optical response of the doped HAp is not only dependent on material 
property and type of dopant (drug or organic molecules) but also on the type of 
wavelength used. Moreover, different wavelengths have distinct capability of light 
reflection, absorbance, and transmission as well.
The carbon-based HAp showed enhanced optical absorption. N-doped carbon 
dots (N-CDs) revealed absorption at about 240 and 340 nm, due to the Π▬Π* 
transition of C〓C and Π▬Π* transition of C〓O and C▬N/C〓N, respectively [56]. 
Biomaterials
108
In the case of HAp:Eu,Gd, the absorption at 200–280 nm due to the wide band gap 
of HAp with a peak (395 nm), was assigned to the intrinsic 4f-4f transition absorp-
tion of Eu [56] confirming the incorporation of Eu into HAp. The absorption of 
N-CDs/HAp:Eu,Gd was superior than single N-CDs and HAp:Eu,Gd and its band 
edge shifted to 550 nm due to the porous structure and multiple reflection [47]. 
The CDs based system could be used as a stable bioimaging candidate. Ni2+-doped 
calcium-lithium hydroxyapatite (CLHA) nanopowders were synthesized by mecha-
nochemical synthesis by Reddy et al. [50]. The spectra of these powder possess 
four absorption band at 420, 718, 794, and 1189 nm attributed to the transitions 
of 3A2g(F) → 3T1g(P), 3T1g(F), 1E1g(D) (spin-forbidden transition), and 3T2g(F), 
respectively [50]. The chemical potential of the CLHA is drastically affected leading 
to the modification of conductivity and dielectric properties. Iron, manganese, and 
cobalt ions doped HAp possess direct band gap (index number n = 1/2). The band 
gap of 5% Co-doped HAp was higher than Fe, Mn ions doped samples [7]. The band 
gaps were modified due to the presence of defect energy levels which shift Fermi 
level toward the valence or conduction band.
5. Photoluminescence
The PL of HAp depends on the defect energy level formation, structure, and 
size of the nanoparticle. Moreover, its band gap is above 5.5 eV, when dopants added 
to HAp matrix, the band gap perhaps vary due to the formation of many defects 
energy levels in between valence and conduction band. When the HAp nanostruc-
ture was excited by different wavelengths, electrons were accordingly excited to the 
higher states sometimes, these electrons recombine with holes promptly to produce 
radiative emission. However, in some cases, the emission might be non-radiative. 
Proper understanding of the effect of dopant is required to create either light active 
or inactive centers which enable emission at different wavelengths. However, it also 
depends on the excitation wavelength as well. The defects energy level formation 
is a complex phenomenon containing the associated band position and the band 
bending process. It as well depends on the size, phase and atomic arrangements. In 
order to reduce non-radiative emission, the doping concentration must be properly 
tuned to avoid the occurrence of concentration quenching; otherwise, abundant 
non-radiative centers are facilitated [34].
Addition of sodium hydroxide (NaOH) varies PL of Sr-HAp samples [102]. 
By varying NaOH content, the shape of the spectra did not change drastically; 
however, the intensities vary significantly. The Sr-HAp sample (0.15 g NaOH) 
displays the strongest emission and the weakest intensity was at 0.40 g NaOH due 
to the variation in luminescent centers. Here, neither Sr2+ nor PO43− is responsible 
for the luminescence but it was due to the carbon and oxygen related active elec-
tronic defect centers on the host matrix [102]. Some reports are available for the 
self-activated luminescence due to the addition of trisodium citrate which enables 
the creation of carbon monoxide impurities [103]. In the case of the Tb-doped 
samples, the excitation peaks of TbW10 (terbium 10% CDHA) and TbW12 
(terbium 20% CDHA) were matched with that of CDHA. Further, the vacancies 
and carbonate radicals act as acceptor chromophores and terbium ions as donor 
chromophores. The interaction of chromophores leads to a non-radiative relaxation 
through defects and impurities in each sample [100]. Two different wavelengths 
(255 and 264 nm) were used for excitation of the samples. The emission peaks were 
associated with 5D4 → 7F6 (489 nm), 5D4 → 7F6 (544 nm), 5D4 → 7F4 (585 nm), and 
5D4 → 7F3 (622 nm) due to intraconfigurational 4f-5d transitions of the Tb3+ ion. At 
the 544 nm, a high intense green light emission was noticed in the doped samples 
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(TbW10) [104, 105]. There was a weak contribution of the PL emission from the 
host matrix of both samples and displayed a deformation of the peak shape with 
a small shift in the peaks 5D4 → 7F6 and 5D4 → 7F4 transitions. The emission from 
TbW10 was high due to chemical composition, self-activated CDHA, whereas at 
higher Tb doping (TbW12), the intensity was reduced due to concentration quench-
ing leading to non-radiative relaxation [100].
Yang et al. reported the broad excitation spectrum at 250 nm due to the 
charge transfer between europium and oxygen ions and further, small peaks were 
noticed at longer wavelength due to f-f transitions of Eu3+ [28]. It was monitored 
by 5D0 → 7F2 transition at 612 nm. The two peaks were prominently noticed at 
5D0 → 7F1 (590 nm) and 5D0 → 7F2 (612 nm). Even the IBU-loaded europium-doped 
HAp samples display a clear PL spectrum and it can be tracked by the luminescence 
intensity. The fascinating part is how the PL intensity varies with release rate of 
drug molecules. As the cumulative release rate increases, the PL intensity enhances 
and reached maximum when all drug molecules were released completely. The 
organic groups of the IBU highly quenched the emission due to europium in the 
IBU-Eu:HAp. The IBU creates high non-radiative centers in the matrix. However, 
the release of IBU augments with a weakening of quenching effect which was 
confirmed by enhanced PL intensity. Thus, it was used as a potential probe for 
monitoring the drug release [28].
In the case of dual ions doped samples, the europium/gadolinium dual-doped 
HAp nanorods showed a maximum excitation peak at 394 nm [44]. There was 
no significant emission on the co-doping of europium (Eu3+)/gadolinium (Gd3+) 
compared to the lone europium doping. However, the PL intensity was altered and 
four emission peaks were noticed at 590, 615, 650, and 699 nm [44]. The prominent 
peak was identified at 615 nm due to 5D0 → 7F2 transition within Eu3+ ions. The 
other PL peaks were observed at 590, 650, and 699 nm owing to their respective 
5D0 → 7F1, 5D0 → 7F3, and 5D0 → 7F4 transitions. As the doping concentration of 
europium increases, the PL emission intensity was enhanced. The highest PL inten-
sity occurred in 5 mol% Eu3+ but with an enhanced intensity compared to the dual 
doped samples. The PL intensity was higher at the doping ratio of Eu3+ to Gd3+ (1:2) 
than the ratio 1:1. On UV irradiation, the dual doped samples displayed a robust red 
emission from powder as well as from powder dispersed solution [44]. So, the PL 
intensity depends on the phase, particle size and defect based active centers which 
absolutely alter either the inter- or intra band transition and emission.
In the case of Mg ions doping on HAp, the PL intensity was enhanced accom-
panied by a modification of the spectra. At higher Mg concentration, the peak was 
reduced due to weak radiative recombination [30]. Further, the defects create many 
active centers for non-radiative recombination and the centers might be very close 
to each other for a rapid decrease in the PL intensity. As the Mg and Ag ions in HAp 
augments, the PL intensity was enhanced, however, as the concentration raises, the 
intensity was reduced (Figure 3A) [34]. With further increase in co-doping, the PL 
intensity was enhanced but lesser than the lowest concentration of co-doping [34]. 
A similar emission was also seen in the iron and zinc co-incorporated HAp samples, 
but as the co-doping increases, the PL intensity was reduced (Figure 3B) [35]. So, 
the PL intensities were tuned by varying co-doping concentration which might alter 
the radiative recombination active center in the HAp matrix. Ion implantation is one 
of the effective routes to dope a particular element at the desired depth and varying 
defects energy level to tune the PL intensity. Nitrogen ion implantation enhanced the 
PL emission of HAp [84]. As the ion fluence increases, the PL intensity was enhanced 
due to the radiative recombination of electron-hole pair without the influence of 
concentration quenching effect (Figure 3C) [84]. There are reports on different 
synthesis routes for doping of various elements on HAp viz., microwave-assisted 
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In the case of HAp:Eu,Gd, the absorption at 200–280 nm due to the wide band gap 
of HAp with a peak (395 nm), was assigned to the intrinsic 4f-4f transition absorp-
tion of Eu [56] confirming the incorporation of Eu into HAp. The absorption of 
N-CDs/HAp:Eu,Gd was superior than single N-CDs and HAp:Eu,Gd and its band 
edge shifted to 550 nm due to the porous structure and multiple reflection [47]. 
The CDs based system could be used as a stable bioimaging candidate. Ni2+-doped 
calcium-lithium hydroxyapatite (CLHA) nanopowders were synthesized by mecha-
nochemical synthesis by Reddy et al. [50]. The spectra of these powder possess 
four absorption band at 420, 718, 794, and 1189 nm attributed to the transitions 
of 3A2g(F) → 3T1g(P), 3T1g(F), 1E1g(D) (spin-forbidden transition), and 3T2g(F), 
respectively [50]. The chemical potential of the CLHA is drastically affected leading 
to the modification of conductivity and dielectric properties. Iron, manganese, and 
cobalt ions doped HAp possess direct band gap (index number n = 1/2). The band 
gap of 5% Co-doped HAp was higher than Fe, Mn ions doped samples [7]. The band 
gaps were modified due to the presence of defect energy levels which shift Fermi 
level toward the valence or conduction band.
5. Photoluminescence
The PL of HAp depends on the defect energy level formation, structure, and 
size of the nanoparticle. Moreover, its band gap is above 5.5 eV, when dopants added 
to HAp matrix, the band gap perhaps vary due to the formation of many defects 
energy levels in between valence and conduction band. When the HAp nanostruc-
ture was excited by different wavelengths, electrons were accordingly excited to the 
higher states sometimes, these electrons recombine with holes promptly to produce 
radiative emission. However, in some cases, the emission might be non-radiative. 
Proper understanding of the effect of dopant is required to create either light active 
or inactive centers which enable emission at different wavelengths. However, it also 
depends on the excitation wavelength as well. The defects energy level formation 
is a complex phenomenon containing the associated band position and the band 
bending process. It as well depends on the size, phase and atomic arrangements. In 
order to reduce non-radiative emission, the doping concentration must be properly 
tuned to avoid the occurrence of concentration quenching; otherwise, abundant 
non-radiative centers are facilitated [34].
Addition of sodium hydroxide (NaOH) varies PL of Sr-HAp samples [102]. 
By varying NaOH content, the shape of the spectra did not change drastically; 
however, the intensities vary significantly. The Sr-HAp sample (0.15 g NaOH) 
displays the strongest emission and the weakest intensity was at 0.40 g NaOH due 
to the variation in luminescent centers. Here, neither Sr2+ nor PO43− is responsible 
for the luminescence but it was due to the carbon and oxygen related active elec-
tronic defect centers on the host matrix [102]. Some reports are available for the 
self-activated luminescence due to the addition of trisodium citrate which enables 
the creation of carbon monoxide impurities [103]. In the case of the Tb-doped 
samples, the excitation peaks of TbW10 (terbium 10% CDHA) and TbW12 
(terbium 20% CDHA) were matched with that of CDHA. Further, the vacancies 
and carbonate radicals act as acceptor chromophores and terbium ions as donor 
chromophores. The interaction of chromophores leads to a non-radiative relaxation 
through defects and impurities in each sample [100]. Two different wavelengths 
(255 and 264 nm) were used for excitation of the samples. The emission peaks were 
associated with 5D4 → 7F6 (489 nm), 5D4 → 7F6 (544 nm), 5D4 → 7F4 (585 nm), and 
5D4 → 7F3 (622 nm) due to intraconfigurational 4f-5d transitions of the Tb3+ ion. At 
the 544 nm, a high intense green light emission was noticed in the doped samples 
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(TbW10) [104, 105]. There was a weak contribution of the PL emission from the 
host matrix of both samples and displayed a deformation of the peak shape with 
a small shift in the peaks 5D4 → 7F6 and 5D4 → 7F4 transitions. The emission from 
TbW10 was high due to chemical composition, self-activated CDHA, whereas at 
higher Tb doping (TbW12), the intensity was reduced due to concentration quench-
ing leading to non-radiative relaxation [100].
Yang et al. reported the broad excitation spectrum at 250 nm due to the 
charge transfer between europium and oxygen ions and further, small peaks were 
noticed at longer wavelength due to f-f transitions of Eu3+ [28]. It was monitored 
by 5D0 → 7F2 transition at 612 nm. The two peaks were prominently noticed at 
5D0 → 7F1 (590 nm) and 5D0 → 7F2 (612 nm). Even the IBU-loaded europium-doped 
HAp samples display a clear PL spectrum and it can be tracked by the luminescence 
intensity. The fascinating part is how the PL intensity varies with release rate of 
drug molecules. As the cumulative release rate increases, the PL intensity enhances 
and reached maximum when all drug molecules were released completely. The 
organic groups of the IBU highly quenched the emission due to europium in the 
IBU-Eu:HAp. The IBU creates high non-radiative centers in the matrix. However, 
the release of IBU augments with a weakening of quenching effect which was 
confirmed by enhanced PL intensity. Thus, it was used as a potential probe for 
monitoring the drug release [28].
In the case of dual ions doped samples, the europium/gadolinium dual-doped 
HAp nanorods showed a maximum excitation peak at 394 nm [44]. There was 
no significant emission on the co-doping of europium (Eu3+)/gadolinium (Gd3+) 
compared to the lone europium doping. However, the PL intensity was altered and 
four emission peaks were noticed at 590, 615, 650, and 699 nm [44]. The prominent 
peak was identified at 615 nm due to 5D0 → 7F2 transition within Eu3+ ions. The 
other PL peaks were observed at 590, 650, and 699 nm owing to their respective 
5D0 → 7F1, 5D0 → 7F3, and 5D0 → 7F4 transitions. As the doping concentration of 
europium increases, the PL emission intensity was enhanced. The highest PL inten-
sity occurred in 5 mol% Eu3+ but with an enhanced intensity compared to the dual 
doped samples. The PL intensity was higher at the doping ratio of Eu3+ to Gd3+ (1:2) 
than the ratio 1:1. On UV irradiation, the dual doped samples displayed a robust red 
emission from powder as well as from powder dispersed solution [44]. So, the PL 
intensity depends on the phase, particle size and defect based active centers which 
absolutely alter either the inter- or intra band transition and emission.
In the case of Mg ions doping on HAp, the PL intensity was enhanced accom-
panied by a modification of the spectra. At higher Mg concentration, the peak was 
reduced due to weak radiative recombination [30]. Further, the defects create many 
active centers for non-radiative recombination and the centers might be very close 
to each other for a rapid decrease in the PL intensity. As the Mg and Ag ions in HAp 
augments, the PL intensity was enhanced, however, as the concentration raises, the 
intensity was reduced (Figure 3A) [34]. With further increase in co-doping, the PL 
intensity was enhanced but lesser than the lowest concentration of co-doping [34]. 
A similar emission was also seen in the iron and zinc co-incorporated HAp samples, 
but as the co-doping increases, the PL intensity was reduced (Figure 3B) [35]. So, 
the PL intensities were tuned by varying co-doping concentration which might alter 
the radiative recombination active center in the HAp matrix. Ion implantation is one 
of the effective routes to dope a particular element at the desired depth and varying 
defects energy level to tune the PL intensity. Nitrogen ion implantation enhanced the 
PL emission of HAp [84]. As the ion fluence increases, the PL intensity was enhanced 
due to the radiative recombination of electron-hole pair without the influence of 
concentration quenching effect (Figure 3C) [84]. There are reports on different 
synthesis routes for doping of various elements on HAp viz., microwave-assisted 
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route followed by ion implantation which is similar to dual ions doping [106]. 
However, the implantation was used to create/dope ions on the surface and subsurface 
with associated defects/vacancies without disturbing bulk properties of HAp. For 
instance, nitrogen ion implantation on magnesium ion incorporated HAp samples 
demonstrated that at low fluence of nitrogen, the PL intensity was enhanced [106]. 
However, at high fluence, the intensity was reduced due to concentration quenching 
and high non-radiative centers created on the surface. The PL intensity of unmodi-
fied Mg-doped HAp decreased drastically compared to the surface modified samples 
[106]. In the case of polymer (polyvinyl alcohol) doping in HAp, the PL intensity was 
raised [107] and the highest PL intensity was noticed at higher concentration due to 
the formation of abundant active sites created by the carbon and oxygen radicals in 
the polymer chains. So, the PL signal could be enhanced by optimizing the doping 
concentration, varying the band gap and creating active recombination defect sites 
and vacancies.
Machado et al. studied the photoluminescence of HAp nanorods at different 
excitation wavelengths (380 to 680 nm) [56]. They demonstrated a shift of emis-
sion from blue to red owing to the absence of the short wavelength emission with 
an increase in the excitation. Near-UV excitation, the intensity was higher with 
blue/green emissions. Eventually, the best emission intensity was in the range 330 
to 430 nm [56]. Erbium-ytterbium (Yb)-molybdenum (Mo) tri-doped HA/β-TCP 
phosphor prepared by solid-state reaction was examined for intense green upconver-
sion (UC) emission [51]. M5 ((0.5% mol) Er-(10% mol) Yb-(8% mol) Mo tri-doped 
HA/β-TCP) showed green emission intensity 650 times than that of the M1 (0.5% mol 
Er-doped HA/β-TCP), M2 ((0.5% mol) Er-(10% mol) Yb co-doped HA/β-TCP) due 
to energy transfer from 2F7/2, 3T2 > state of Yb3+ − MoO4 2− dimer to the 4F7/2 of Er3+ 
ions. Further, red emission was weak because of feeble absorption cross-section of 
4I13/2 and the green emission band can be controlled by the Mo6+ doping concentra-
tions. It aids to use the material for bioimaging application [51]. N-doped carbon 
dots/HAp:Eu,Gd (N-CDs/HAp:Eu,Gd) composite were studied [47] and the PL 
spectra of N-CDs/HAp:Eu,Gd simultaneously revealed the emission from N-CDs 
and HAp:Eu,Gd on single wavelength excitation. The PL emission depicted no shift 
under different wavelengths revealing excitation independent emission. It clearly 
shows that the electronic structure of N-CDs and Eu ions were not affected during 
the synthesis. So, both the N-CDs and HAp:Eu,Gd were preserved. The PL lifetime 
of both N-CDs/HAp:Eu,Gd and N-CDs illustrated a single exponential decay but the 
lifetime decreased from 11.7 ns (N-CDs) to 5.6 ns (N-CDs/HAp:Eu,Gd) owing to the 
photogenerated charges [47]. Further, it could be used for bioimaging with distinct 
differentiation of colors due to different emission from carbon dots and doped HAp 
samples. Polymer/inorganic based structures can also affect the PL. Karthikeyan et al.  
Figure 3. 
(A)Photoluminescence spectra of HAp and magnesium and silver ions co-incorporated HAp samples (reproduced 
from [34] with permission from Elsevier), (B) Photoluminescence spectra of (a) FZH0, (b) FZH1, (c) FZH2  
and (d) FZH3 (reproduced from [35] with permission from Elsevier) and (C) Photoluminescence of (a) pristine, 
(b) 1HAp, (c) 2HAp and (d) 3HAp (reproduced from [84] with permission from Elsevier).
111
Impact of Dopants on the Electrical and Optical Properties of Hydroxyapatite
DOI: http://dx.doi.org/10.5772/intechopen.93092
described the formation of core-shell structures on argon ion implanted polymer-
based zinc ions incorporated HAp and reported that the zinc ions and the polymer 
lead to formation of many defects which in turn produces additional energy states. 
The PL intensity at the lower fluence samples (1 × 1014 ions/cm2) showed enhance-
ment in the PL intensity due to the presence of higher radiative active centers. On 
increasing the fluence viz., 1 × 1015 ions/cm2 and 1 × 1016 ions/cm2, the PL intensity 
was decreased owing to the formation of more non-radiative centers [108]. The 
incorporation of metal ions such as iron not only play a major role in tailoring the 
optical properties but also when exposed to magnetic field, they tend to change their 
morphologies depending on the magnetic field strength and have potential biological 
application such as protein absorption [109]. It could also lead to the development of 
magnetic based prolonged PL emission. Hence, the structure and morphology play a 
prominent role in altering the radiative/non-radiative recombination sites which can 
be correlated to the PL intensity decay.
6. Summary and future outlook
The effect of electric field, electromagnetic dispersion, dielectric relaxation 
and correlated structural variation of the doped HAp samples was discussed. The 
role of hydroxyl ions, frequency exponent and the mechanism of ac conductivity 
by translation and hopping motion in the doped HAp samples were elaborated. 
Further, the electrical studies showed that the polarized surface charge either posi-
tive or negative, could alter the growth of bone cells on HAp. The surface charge, 
microstructure, densification, porosity, phase, electrical dipole reversal and its 
strong orientation were responsible for the enhancement in the dielectric constant 
of the doped HAp samples. The optical response depends on the dopant size and 
its concentration and associated phase transformation. The formation of different 
energy levels and electronic level transitions on doping enabled the tuning of the 
PL intensity and multi-color emissions which are independent of the excitation 
wavelength. The drug-loaded doped HAp samples and their PL intensity were 
correlated to the rate of drug release. Thus, the europium ion-doped HAp behaves 
as a one-dimensional nanoprobe for tracking the drug release. Further, different 
synthesis routes, doping, and co-doping are capable of generating new energy 
levels between conduction and valence band. Moreover, it was understood that the 
respective radiative and non-radiative emission were due to the activated lumines-
cent centers and the concentration quenching of the doped samples.
Electro-opto biomaterials could be developed for the rapid healing of bone 
defects and fracture owing to the enhanced bone cell proliferation and growth. 
Current, in vitro and in vivo analysis routes must be improved further to control 
infection and to enhance the cell growth after implantation. To have an exact 
biomimicking of the bone, multielemental incorporation of the HAp is essential. 
Still, there is a lack of advanced analysis technique to have an insight of the surface 
charge interaction with the bone cells and how these charges assist the precipita-
tion, mineralization, and growth of bone tissues. Solar/photon and magneto/light-
based advanced biomaterials need to be developed for rapid healing and recovery.
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route followed by ion implantation which is similar to dual ions doping [106]. 
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with associated defects/vacancies without disturbing bulk properties of HAp. For 
instance, nitrogen ion implantation on magnesium ion incorporated HAp samples 
demonstrated that at low fluence of nitrogen, the PL intensity was enhanced [106]. 
However, at high fluence, the intensity was reduced due to concentration quenching 
and high non-radiative centers created on the surface. The PL intensity of unmodi-
fied Mg-doped HAp decreased drastically compared to the surface modified samples 
[106]. In the case of polymer (polyvinyl alcohol) doping in HAp, the PL intensity was 
raised [107] and the highest PL intensity was noticed at higher concentration due to 
the formation of abundant active sites created by the carbon and oxygen radicals in 
the polymer chains. So, the PL signal could be enhanced by optimizing the doping 
concentration, varying the band gap and creating active recombination defect sites 
and vacancies.
Machado et al. studied the photoluminescence of HAp nanorods at different 
excitation wavelengths (380 to 680 nm) [56]. They demonstrated a shift of emis-
sion from blue to red owing to the absence of the short wavelength emission with 
an increase in the excitation. Near-UV excitation, the intensity was higher with 
blue/green emissions. Eventually, the best emission intensity was in the range 330 
to 430 nm [56]. Erbium-ytterbium (Yb)-molybdenum (Mo) tri-doped HA/β-TCP 
phosphor prepared by solid-state reaction was examined for intense green upconver-
sion (UC) emission [51]. M5 ((0.5% mol) Er-(10% mol) Yb-(8% mol) Mo tri-doped 
HA/β-TCP) showed green emission intensity 650 times than that of the M1 (0.5% mol 
Er-doped HA/β-TCP), M2 ((0.5% mol) Er-(10% mol) Yb co-doped HA/β-TCP) due 
to energy transfer from 2F7/2, 3T2 > state of Yb3+ − MoO4 2− dimer to the 4F7/2 of Er3+ 
ions. Further, red emission was weak because of feeble absorption cross-section of 
4I13/2 and the green emission band can be controlled by the Mo6+ doping concentra-
tions. It aids to use the material for bioimaging application [51]. N-doped carbon 
dots/HAp:Eu,Gd (N-CDs/HAp:Eu,Gd) composite were studied [47] and the PL 
spectra of N-CDs/HAp:Eu,Gd simultaneously revealed the emission from N-CDs 
and HAp:Eu,Gd on single wavelength excitation. The PL emission depicted no shift 
under different wavelengths revealing excitation independent emission. It clearly 
shows that the electronic structure of N-CDs and Eu ions were not affected during 
the synthesis. So, both the N-CDs and HAp:Eu,Gd were preserved. The PL lifetime 
of both N-CDs/HAp:Eu,Gd and N-CDs illustrated a single exponential decay but the 
lifetime decreased from 11.7 ns (N-CDs) to 5.6 ns (N-CDs/HAp:Eu,Gd) owing to the 
photogenerated charges [47]. Further, it could be used for bioimaging with distinct 
differentiation of colors due to different emission from carbon dots and doped HAp 
samples. Polymer/inorganic based structures can also affect the PL. Karthikeyan et al.  
Figure 3. 
(A)Photoluminescence spectra of HAp and magnesium and silver ions co-incorporated HAp samples (reproduced 
from [34] with permission from Elsevier), (B) Photoluminescence spectra of (a) FZH0, (b) FZH1, (c) FZH2  
and (d) FZH3 (reproduced from [35] with permission from Elsevier) and (C) Photoluminescence of (a) pristine, 
(b) 1HAp, (c) 2HAp and (d) 3HAp (reproduced from [84] with permission from Elsevier).
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described the formation of core-shell structures on argon ion implanted polymer-
based zinc ions incorporated HAp and reported that the zinc ions and the polymer 
lead to formation of many defects which in turn produces additional energy states. 
The PL intensity at the lower fluence samples (1 × 1014 ions/cm2) showed enhance-
ment in the PL intensity due to the presence of higher radiative active centers. On 
increasing the fluence viz., 1 × 1015 ions/cm2 and 1 × 1016 ions/cm2, the PL intensity 
was decreased owing to the formation of more non-radiative centers [108]. The 
incorporation of metal ions such as iron not only play a major role in tailoring the 
optical properties but also when exposed to magnetic field, they tend to change their 
morphologies depending on the magnetic field strength and have potential biological 
application such as protein absorption [109]. It could also lead to the development of 
magnetic based prolonged PL emission. Hence, the structure and morphology play a 
prominent role in altering the radiative/non-radiative recombination sites which can 
be correlated to the PL intensity decay.
6. Summary and future outlook
The effect of electric field, electromagnetic dispersion, dielectric relaxation 
and correlated structural variation of the doped HAp samples was discussed. The 
role of hydroxyl ions, frequency exponent and the mechanism of ac conductivity 
by translation and hopping motion in the doped HAp samples were elaborated. 
Further, the electrical studies showed that the polarized surface charge either posi-
tive or negative, could alter the growth of bone cells on HAp. The surface charge, 
microstructure, densification, porosity, phase, electrical dipole reversal and its 
strong orientation were responsible for the enhancement in the dielectric constant 
of the doped HAp samples. The optical response depends on the dopant size and 
its concentration and associated phase transformation. The formation of different 
energy levels and electronic level transitions on doping enabled the tuning of the 
PL intensity and multi-color emissions which are independent of the excitation 
wavelength. The drug-loaded doped HAp samples and their PL intensity were 
correlated to the rate of drug release. Thus, the europium ion-doped HAp behaves 
as a one-dimensional nanoprobe for tracking the drug release. Further, different 
synthesis routes, doping, and co-doping are capable of generating new energy 
levels between conduction and valence band. Moreover, it was understood that the 
respective radiative and non-radiative emission were due to the activated lumines-
cent centers and the concentration quenching of the doped samples.
Electro-opto biomaterials could be developed for the rapid healing of bone 
defects and fracture owing to the enhanced bone cell proliferation and growth. 
Current, in vitro and in vivo analysis routes must be improved further to control 
infection and to enhance the cell growth after implantation. To have an exact 
biomimicking of the bone, multielemental incorporation of the HAp is essential. 
Still, there is a lack of advanced analysis technique to have an insight of the surface 
charge interaction with the bone cells and how these charges assist the precipita-
tion, mineralization, and growth of bone tissues. Solar/photon and magneto/light-
based advanced biomaterials need to be developed for rapid healing and recovery.
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There are several sources from which hydroxyapatite (HAp) can be obtained
and may be broadly categorized as synthetic or biogenic. Elevated interest in recent
times has pushed for the development of several procedures for extracting HAp
from biogenic wastes due to their excellent composition and morphology resem-
blance to the human calcified tissue (B-type carbonated HAp). Notable biogenic
sources reported for HAp extraction span bovine bones, fish scales, corals, egg-
shells, and snails among other calcium-rich sources. However, most of the synthetic
methods are laborious and therefore result in high production costs. In this chapter,
we discuss the synthesis of B-type carbonate substituted HAp from an untapped
biogenic source, Achatina achatina shells, using a simple precipitation method and a
controlled heat-treatment method. This unique treatment method affected the sub-
stitution resulting in different crystallographic parameters and revealed a novel
material for bone implants and enamel applications.
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1. Introduction
Hydroxyapatite (HAp) is a member of the calcium apatite (group of phosphate)
family with a high concentration of hydroxyl group [1–3]. Stoichiometric HAp,
Ca10(PO4)6(OH)2 can exhibit either monoclinic or hexagonal crystal structures
[4, 5]. The most frequently reported hydroxyapatite crystal structure is the hexago-
nal system, which consists of unconnected, PO4
3 tetrahedra with Ca2+ in the inter-
stitial space and a chain of OH ions along the c-axis to balance the unit cell charges
[4]. This hexagonal crystal structure allows for replacement (substitution) of ions
into the structure. The substitution makes the HAp more reactive and biocompatible
[6, 7]. The human calcified tissue (e.g., bone and tooth enamel) consists of mineral
components similar to carbonated HAp (CHAp) [8, 9]. As a result, extensive
research has been conducted to substitute carbonate into commercial HAp to achieve
a suitable material for hard tissue replacement and implants coatings [10, 11].
There are two main types of carbonate (CO3) substitution that occur in
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and may be broadly categorized as synthetic or biogenic. Elevated interest in recent
times has pushed for the development of several procedures for extracting HAp
from biogenic wastes due to their excellent composition and morphology resem-
blance to the human calcified tissue (B-type carbonated HAp). Notable biogenic
sources reported for HAp extraction span bovine bones, fish scales, corals, egg-
shells, and snails among other calcium-rich sources. However, most of the synthetic
methods are laborious and therefore result in high production costs. In this chapter,
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1. Introduction
Hydroxyapatite (HAp) is a member of the calcium apatite (group of phosphate)
family with a high concentration of hydroxyl group [1–3]. Stoichiometric HAp,
Ca10(PO4)6(OH)2 can exhibit either monoclinic or hexagonal crystal structures
[4, 5]. The most frequently reported hydroxyapatite crystal structure is the hexago-
nal system, which consists of unconnected, PO4
3 tetrahedra with Ca2+ in the inter-
stitial space and a chain of OH ions along the c-axis to balance the unit cell charges
[4]. This hexagonal crystal structure allows for replacement (substitution) of ions
into the structure. The substitution makes the HAp more reactive and biocompatible
[6, 7]. The human calcified tissue (e.g., bone and tooth enamel) consists of mineral
components similar to carbonated HAp (CHAp) [8, 9]. As a result, extensive
research has been conducted to substitute carbonate into commercial HAp to achieve
a suitable material for hard tissue replacement and implants coatings [10, 11].
There are two main types of carbonate (CO3) substitution that occur in
hydroxyapatite, namely A-type and B-type. A-type occurs when CO3 replaces OH
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groups, while B-type substitution occurs when CO3 replaces PO4 in the apatite
structure. If these substitutions take place concurrently, an AB-type substitution
occurs. Among the types of substitution, literature reports that B-type CHAp is
highly similar to the human calcified tissue, which contains 3–5 wt% of carbonate in
the lattice of the phosphate [12–15].
Laboratories have advanced in methods for the synthesis of B-type CHAp but
the methods are laborious and expensive. For example, the method most frequently
reported in the literature is the one proposed by LeGeros [16]. Herein, the prepara-
tion begins by adding PO4/CO3 solution in a stepwise manner into Ca(NO3)2�4H2O
solution at a temperature of 90°C. The mixture is stirred for 5 h at a pH of 11 and the
precipitates filtered and dried for 10 h at 100°C in an oven. The B-type CHAp is
then identified using X-ray diffractometry (XRD) and infra-red (IR) spectrometry.
The XRD is a good analytical tool to study the substitution since; CO3 has a smaller
planar ion diameter than the tetrahedral PO4 group, and thus the substitution of
CO3 with PO4 will result in a decrease of the a-axis and a small increase in the c-axis
of the unit cell. On the other hand, in a narrow range, vibrating bonds of functional
groups in a material vibrate with a characteristic wavenumber [17], which is why IR
spectroscopy is used to study the functional groups.
In this chapter, the authors discussed a simple precipitation and heat treatment
method for the preparation of B-type CHAp from Achatina achatina (AA) shells and
phosphate-containing solution. Additionally, the XRD and IR results obtained for
the substitution are discussed.
2. Obtaining calcite from the AA shells for HAp preparation
Achatina achatina (AA) is the giant African snail ubiquitously scattered
throughout the African continent particularly inWest Africa, Ghana. The land strata
of the soil are made up of various ions, and the eating habit of the snails enables the
ingestion of these ions into their shells in trace amounts. The AA shells, however,
serve as a rich source of calcium carbonate (CaCO3)—a precursor for HAp prepara-
tion compared to other biogenic sources like bovine bones, fish scales, corals, egg-
shells, and other landmark snail shells. CaCO3 mainly exists in two crystal forms:
aragonite and calcite. The aragonite structure as indicated by the XRD pattern in
Figure 1(a) exists in ‘raw ground’ AA shells after the shells are washed with running
water to remove sludge and dried in the open air for 6 h. The structure contains
impurities like sulphate (SO4
2�) and is indicated in the IR spectra in Figure 2(a).
These impurities consequently rule out raw AA powders as carbonate precursors for
the HAp formation. Thus, the raw AA powder is calcined at high temperatures to
burn the impurities and convert the aragonite structure into calcite. The calcination
temperature typically used is between 600 and 800°C [18] [see Figure 1(b)–(d)].
The IR spectra in Figure 2(b) and (c) support XRD patterns, which show that the
temperatures (600 and 700°C) facilitate the conversion of the aragonite structure to
calcite. The calcite functional groups occur at wavenumbers 712, 856, and
1418 cm�1. The calcite structure is formed at the two temperatures, however, the
ideal calcination temperature for HAp synthesis is between 800 and 850°C. These
temperatures bring an additional phase to the calcite to initiate the HAp preparation.
The evidence is shown in Figure 2(d) where a dual-phase of calcite and calcium
hydroxide [Ca(OH)2] is observed. The calcite absorbed moisture from the atmo-
sphere during the open-air drying; so, under high temperature (800°C) the CaCO3
decomposes to form Ca(OH)2. The reaction pathway is given by Eqs. (1) and (2):
CaCO3 þH2O !heat 800°Cð Þ CaO:H2Oþ CO2↑ (1)
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CaO:H2O ! Ca OHð Þ2 (2)
The reaction is confirmed with IR results in Figure 2(d) showing the hydroxyl
group (OH�) of calcium hydroxide at wavenumber 3642 cm�1, and calcium oxide
(CadO bonding) stretches from wavenumbers 400 to 700 cm�1 in calcite.
Figure 1.
XRD patterns of (a) raw uncalcined AA powder and (b) calcined AA powder at 600°C (c) 700°C (d) 800°C.
Figure 2.
IR spectra of (a) raw uncalcined AA powder and (b) calcined AA powder at 600°C (c) 700°C and
(d) 800°C.
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phosphate-containing solution. Additionally, the XRD and IR results obtained for
the substitution are discussed.
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Achatina achatina (AA) is the giant African snail ubiquitously scattered
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of the soil are made up of various ions, and the eating habit of the snails enables the
ingestion of these ions into their shells in trace amounts. The AA shells, however,
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Figure 1(a) exists in ‘raw ground’ AA shells after the shells are washed with running
water to remove sludge and dried in the open air for 6 h. The structure contains
impurities like sulphate (SO4
2�) and is indicated in the IR spectra in Figure 2(a).
These impurities consequently rule out raw AA powders as carbonate precursors for
the HAp formation. Thus, the raw AA powder is calcined at high temperatures to
burn the impurities and convert the aragonite structure into calcite. The calcination
temperature typically used is between 600 and 800°C [18] [see Figure 1(b)–(d)].
The IR spectra in Figure 2(b) and (c) support XRD patterns, which show that the
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3. HAp preparation
HAp is prepared from 0.3 M solution of diammonium hydrogen phosphate
(DHP, pH of 8.12) and 5.7 g of calcite. The calcite is dissolved in distilled water of
volume 0.15 cm3 and the same volume of calcite is measured for DHP. The DHP is
then added stepwise while stirring at 40°C for 1 h. The stirring time controls the
particle size. The longer the stirring time the smaller the particle size [14]. The
calcite mostly preferred for HAp preparation has Ca(OH)2 phase; so, in aqueous
solution, the Ca(OH)2 quickly dissociates into 2Ca
2+ and 2OH�, whereas
(NH4)2HPO4 produces (NH4)2OH and a monophosphoric acid (HPO4). The
monophosphoric acid reacts with OH groups released by the calcium hydroxide to
form a phosphate ester through a condensation reaction. The phosphate ester reacts
with Ca to form HAp. The reaction is allowed to age for 24 h to enable HAp crystals
growth [14]. The ammonium hydroxide is filtered together with water to obtain the
HAp crystals. The reaction pathway is given in Eq. (3):
10Ca OHð Þ2 þ 6 NH4ð Þ2:HPO4 þ 2H2O ! Ca10 PO4ð Þ6 OHð Þ2 þ 12NH4OH lð Þ þ 8H2O
(3)
4. B-type carbonated HAp preparation
The calcite (CaCO3) in the mixed-phase of the HAp precursor decomposes into
calcium (Ca2+) and carbonate (CO2�3 ) during stirring. The calcium is used as part of
the HAp formation and the CO2�3 lies behind the lattice of phosphate (PO
3�
4 Þ. The
ionic diameter of PO3�4 is larger than that of CO
2�
3 , thus the first masked the latter
and is not detected using XRD. The IR spectra in Figure 3(a) show major functional
groups of HAp and minor functional groups of carbonate. The PO3�4 groups of HAp
Figure 3.
IR spectra of (a) HAp without heat treatment and (b) HAp with heat treatment at 850°C. The figure is
obtained from Asimeng et al.
124
Biomaterials
occur at wavenumbers 1028, 963, 600, and 563 cm�1 whereas CO2�3 groups are
found at 1435 and 874 cm�1. The HAp is subjected to a temperature of 850°C for
12 h for annealing and normalizing. The heat treatment initiates the substitution of
CO2�3 for PO
3�
4 as indicated in Eq. (4). Figure 3(b) shows functional groups of the
heat-treated HAp. The CO2�3 groups at 1435 cm
�1 are now prominent and the OH�
groups, which are absent in HAp without heat treatment, are also intense, which
serves as evidence of B-type carbonate HAp.
Ca10�x2 PO4ð Þ6�x OHð Þ2 þ CO3x !
heattreatment Ca9:5 PO4ð Þ5CO3 OHð Þ2 (4)
5. Discussion
Natural sources for hydroxyapatite synthesis have generated a lot of interest in
recent times due to the various advantages it presents over synthetic sources in
terms of similarity to the biological apatite (bone and dental). Some of these sources
include but are not limited to plants, bovine bone, eggshells, and snail shells. All
these biogenic sources have calcium carbonate as a precursor for HAp synthesis.
Plant and algae, however, do not have a lot of calcium carbonate as compared to the
other sources like bovine, eggshells, and snail shells [19]. The extraction of HAp,
therefore, becomes somewhat laborious as there is the need for the addition of more
calcium and/or phosphate precursors. This complicated process and the usage of
additional calcium or phosphate source increases the cost of production. Clearly,
this relegates plant and algae as a great source of HAp for biomedical applications.
Biogenic sources such as seashells are rich in CaCO3; however, due to their aquatic
nature, they require additional processes/treatment to transform them into a pure
phase of HAp [20]. The employment of a combination of extraction methods to
achieve the transformation affects the cost of production greatly.
The increasing consumption of snails (Achatina sp.) as a delicacy across all of
West Africa has caused a significant increase in snail shell waste production. The
recovery of these shells allows for HAp synthesis and reduction in solid wastes. It is
recorded in the literature that eggshells and snail shells have a lot of calcium
carbonate but the percentage composition in snail shells is more than in eggshells
[21]. Snail shells are reported to have about 95–99% calcium carbonate [21]. Bovine
bones, comparable to snail shells, present excellent properties to extract HAp but
using bovine bones would require a processing technique (hydrothermal process),
which is very expensive.
Several extraction methods have been documented for the synthesis of HAp.
These fabrication methods include dry methods (solid-state and mechanochemi-
cal), wet methods (chemical precipitation, hydrolysis, sol-gel, hydrothermal, emul-
sion, and sonochemical), and high-temperature processes (combustion and
pyrolysis) [22]. It is mostly reported in the literature that wet chemical precipitation
tops the chart when it comes to cost-effectiveness considering the materials used
and their availability. Also, the use of the wet chemical precipitation method typi-
cally results in a low crystalline material compared to a hydrothermally extracted
HAp. According to ISO 23317, calcium apatite similar to the bone or enamel apatite
should be Ca-deficient and made up of impurities such as CO3
2� and Na+ and have
low crystallinity. It should be noted that for biomedical applications, one desirable
property is nano-sized particles. The extraction of nano-sized HAp has advantages
in terms of high surface activity and ultrafine structures [23–25], higher bioactivity,
and better resorbability than micron-sized particles. With this in mind, the author
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3. HAp preparation
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(DHP, pH of 8.12) and 5.7 g of calcite. The calcite is dissolved in distilled water of
volume 0.15 cm3 and the same volume of calcite is measured for DHP. The DHP is
then added stepwise while stirring at 40°C for 1 h. The stirring time controls the
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solution, the Ca(OH)2 quickly dissociates into 2Ca
2+ and 2OH�, whereas
(NH4)2HPO4 produces (NH4)2OH and a monophosphoric acid (HPO4). The
monophosphoric acid reacts with OH groups released by the calcium hydroxide to
form a phosphate ester through a condensation reaction. The phosphate ester reacts
with Ca to form HAp. The reaction is allowed to age for 24 h to enable HAp crystals
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10Ca OHð Þ2 þ 6 NH4ð Þ2:HPO4 þ 2H2O ! Ca10 PO4ð Þ6 OHð Þ2 þ 12NH4OH lð Þ þ 8H2O
(3)
4. B-type carbonated HAp preparation
The calcite (CaCO3) in the mixed-phase of the HAp precursor decomposes into
calcium (Ca2+) and carbonate (CO2�3 ) during stirring. The calcium is used as part of
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4 Þ. The
ionic diameter of PO3�4 is larger than that of CO
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3 , thus the first masked the latter
and is not detected using XRD. The IR spectra in Figure 3(a) show major functional
groups of HAp and minor functional groups of carbonate. The PO3�4 groups of HAp
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IR spectra of (a) HAp without heat treatment and (b) HAp with heat treatment at 850°C. The figure is
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occur at wavenumbers 1028, 963, 600, and 563 cm�1 whereas CO2�3 groups are
found at 1435 and 874 cm�1. The HAp is subjected to a temperature of 850°C for
12 h for annealing and normalizing. The heat treatment initiates the substitution of
CO2�3 for PO
3�
4 as indicated in Eq. (4). Figure 3(b) shows functional groups of the
heat-treated HAp. The CO2�3 groups at 1435 cm
�1 are now prominent and the OH�
groups, which are absent in HAp without heat treatment, are also intense, which
serves as evidence of B-type carbonate HAp.
Ca10�x2 PO4ð Þ6�x OHð Þ2 þ CO3x !
heattreatment Ca9:5 PO4ð Þ5CO3 OHð Þ2 (4)
5. Discussion
Natural sources for hydroxyapatite synthesis have generated a lot of interest in
recent times due to the various advantages it presents over synthetic sources in
terms of similarity to the biological apatite (bone and dental). Some of these sources
include but are not limited to plants, bovine bone, eggshells, and snail shells. All
these biogenic sources have calcium carbonate as a precursor for HAp synthesis.
Plant and algae, however, do not have a lot of calcium carbonate as compared to the
other sources like bovine, eggshells, and snail shells [19]. The extraction of HAp,
therefore, becomes somewhat laborious as there is the need for the addition of more
calcium and/or phosphate precursors. This complicated process and the usage of
additional calcium or phosphate source increases the cost of production. Clearly,
this relegates plant and algae as a great source of HAp for biomedical applications.
Biogenic sources such as seashells are rich in CaCO3; however, due to their aquatic
nature, they require additional processes/treatment to transform them into a pure
phase of HAp [20]. The employment of a combination of extraction methods to
achieve the transformation affects the cost of production greatly.
The increasing consumption of snails (Achatina sp.) as a delicacy across all of
West Africa has caused a significant increase in snail shell waste production. The
recovery of these shells allows for HAp synthesis and reduction in solid wastes. It is
recorded in the literature that eggshells and snail shells have a lot of calcium
carbonate but the percentage composition in snail shells is more than in eggshells
[21]. Snail shells are reported to have about 95–99% calcium carbonate [21]. Bovine
bones, comparable to snail shells, present excellent properties to extract HAp but
using bovine bones would require a processing technique (hydrothermal process),
which is very expensive.
Several extraction methods have been documented for the synthesis of HAp.
These fabrication methods include dry methods (solid-state and mechanochemi-
cal), wet methods (chemical precipitation, hydrolysis, sol-gel, hydrothermal, emul-
sion, and sonochemical), and high-temperature processes (combustion and
pyrolysis) [22]. It is mostly reported in the literature that wet chemical precipitation
tops the chart when it comes to cost-effectiveness considering the materials used
and their availability. Also, the use of the wet chemical precipitation method typi-
cally results in a low crystalline material compared to a hydrothermally extracted
HAp. According to ISO 23317, calcium apatite similar to the bone or enamel apatite
should be Ca-deficient and made up of impurities such as CO3
2� and Na+ and have
low crystallinity. It should be noted that for biomedical applications, one desirable
property is nano-sized particles. The extraction of nano-sized HAp has advantages
in terms of high surface activity and ultrafine structures [23–25], higher bioactivity,
and better resorbability than micron-sized particles. With this in mind, the author
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has successfully extracted HAp from AA shells with particle size in the nanosize
range in his previous works. Also, it should be noted that results of an earlier work
conducted by Asimeng et al. on the extraction of HAp from the AA shells highlight
particle size, lattice parameters, physiochemical properties, and morphological
characteristics typical of the human enamel apatite. HAp obtained from the AA
shells has further been subjected to a heat treatment to obtain a B-type carbonated
HAp and this has significantly improved the physicochemical properties for
applications in dentistry and orthopedics. The unit cell parameters of HAp with
and without heat treatment are reported by Asimeng et al. The crystallographic
information of the B-type carbonated HAp supports the theory that the unit cell
a-axis decreases whereas c-axis increases as compared to the HAp without heat
treatment.
Table 1 provides a comparative summary of properties of HAp extracted from
the different sources and AA shell.
6. Conclusion
This book chapter discussed the synthesis of heat-treated B-type carbonated
hydroxyapatite (CHAp) from Achatina achatina snail shells and diammonium
hydrogen phosphate (DHP) for human calcified tissue replacement and coatings.
The synthesis process is in three steps: [1] conversion of the shell crystal structure
from aragonite to calcite, [2] precipitation of calcite and DHP to form hydroxyapa-
tite (HAp), and [3] annealing and normalizing the HAp to form B-type CHAp. The
synthesis reveals that calcination temperature plays a key role in step [1]. It was
noticed that temperatures from 800 to 850°C provided an additional phase (calcium
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treatment.
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Abstract
Barium titanate (BT) and barium strontium titanate (BST) are one of the most 
studied ferroelectric materials with excellent piezoelectric properties, which can 
be used to stimulate bone formation by applying an electrical field. It is known 
that this ceramic is biocompatible and can be used for medical applications. New 
hybrid materials based on BT and collagen and BST and collagen, with potential 
applications in bone reconstruction, are presented, emphasizing the potential of 
fabricating 3D structures by integrating hydrothermal synthesis with additive 
manufacturing. Designing such structures may take advantage of rheological 
characterization at single-molecule level for some elastic biopolymers like titin and 
collagen and their molecular dissection into structural motifs that independently 
contribute to the protein viscoelasticity. Atomic force spectroscopy measurements 
on synthetic polypeptides showed that a polypeptide chain containing Ig domain 
modules is protected against rupture at high stretch by Ig domain unfolding, an 
important mechanism for stress relaxation in titin molecules. This property may 
be exploited to enhance the tensile strength of a 3D structure by adding specific 
synthetic polypeptides to the composition of the printing paste.
Keywords: barium titanate, barium strontium titanate, 3D printing, titin, Ig domain, 
fracture mechanics
1. Introduction
Bone defects occur due to malformations, traumatic lesions, and tumor resec-
tions. Biomaterials for bone defect reconstruction consist of osteosynthetic materi-
als that are placed in the cavity left behind by osteotomies or traumatic lesions. 
Other applications refer to dental implants with functional or aesthetic role in the 
facial region. The results of bone reconstruction are dependent on the surgical 
skills, the quality of the adjacent tissue, the size and location of the bone defect, as 
well as the method of repairing the bone defect. Current methods of reconstruc-
tion include simple or vascularized bone grafts, the use of biomaterials, and, more 
recently, the use of growth factors to induce osteoinduction [1].
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studied ferroelectric materials with excellent piezoelectric properties, which can 
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1. Introduction
Bone defects occur due to malformations, traumatic lesions, and tumor resec-
tions. Biomaterials for bone defect reconstruction consist of osteosynthetic materi-
als that are placed in the cavity left behind by osteotomies or traumatic lesions. 
Other applications refer to dental implants with functional or aesthetic role in the 
facial region. The results of bone reconstruction are dependent on the surgical 
skills, the quality of the adjacent tissue, the size and location of the bone defect, as 
well as the method of repairing the bone defect. Current methods of reconstruc-
tion include simple or vascularized bone grafts, the use of biomaterials, and, more 
recently, the use of growth factors to induce osteoinduction [1].
Biomaterials
132
The use of autologous bone for orthopedic reconstruction may be restricted due to 
the limited amount of donor bone from the sampling areas. It is possible that the bone 
tissue taken may require reshaping into custom shapes, which may complicate the 
surgical operation. Also, complications in the case of simple bone grafts include graft 
resorption and increased mortality associated with the sampling area [1].
The benefits of alloplastic materials have been reported in the literature, being 
used as such or in combination with bone transplants or osteoinductive cytokines. 
The procedure can be used not only to replace the missing bone but also to stimulate 
osteoinduction, acting as a scaffold material for bone regeneration. The implanted 
materials should be biocompatible, without any side effects or toxicity. However, 
over time complications and toxicities of implanted biomaterials used in orthopedic 
surgery have been reported, often leading to inflammation associated with leukocy-
tosis and fibrosis.
For osteosynthesis, titanium alloy prostheses offer major advantages in terms of 
biocompatibility, stability, and individual implant placement. Removal of asymp-
tomatic prostheses and screws after fracture healing is still controversial due to the 
fact that the removal procedure could damage the bone [1].
The large variety of biomaterials for bone defect reconstruction makes it dif-
ficult to choose the right material for surgical areas and specific applications. An 
optimal biomaterial meets all the requirements: biocompatibility, stability, intra-
operative matching, product safety, and low costs; in reality, the perfect material 
has not yet been found. The development of future materials aims to improve the 
physical and biological properties, especially regarding surface interactions [1].
While the popularity of hydroxyapatite-based ceramic materials as filler for 
critical bone defects is known in the community of specialists in bioengineering, 
materials science, and orthopedic and dental surgery, only a few studies address 
piezoelectric materials for bone regeneration, such as barium titanate (BT) 
[BaTiO3] and barium strontium titanate (BST) [Ba0.7Sr0.3TiO3]. The potential effect 
of this class of materials in bone tissue engineering is due to its dielectric properties, 
low dielectric loss, and polarization. Sr2+ ion can increase a dielectric constant, and 
it is a trace element in the human body that plays a dual role in bone formation and 
regeneration [2].
On the other hand, barium titanate-based ceramic with perovskite structure 
has been widely used as a ferroelectric material for its attractive properties, such as 
high piezoelectric coefficient (d33 = 191 pC/N) as well as excellent biocompatibility 
and bone regeneration capacity in the complex physiological environment, and is 
further considered as an intelligent material for tissue reconstruction [2–4].
Since 1954, it has been reported that natural bone is a piezoelectric material 
[5–12]. In 1957, Fukada et al. [8] observed that the stress-induced piezoelectric 
effect in bone was due to the slipping of collagen fibers past one another. The 
bone tissue exhibited a very low piezoelectric coefficient of 0.7 pC/N [13] and 
was demonstrated to be biologically active and would respond to micromechani-
cal stress such as the movement of the body itself, leading to the generation of an 
electrical dipole [14, 15]. Piezoelectric materials can provide the electrical stimula-
tion characteristic for natural bone environment as it has been asserted that bone 
growth and repair are promoted by the electrical signals produced when the bone is 
mechanically stressed [16]. Due to their parallel features with the real bone, piezo-
electric materials for bone tissue reconstruction may become the next generation of 
bone grafts [17]. Piezoelectric property of barium titanate could be used as a charge 
supply to stimulate the bone implant healing process. So far, all the piezoelectric 
ceramics used in vivo and vitro were in the dense bulk form [18]. However, owing 
to the interconnected pores to provide a favorable environment for bone ingrowth 
and osseointegration [19], a functional bone implant should be porous [15], to 
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create strong bonds with the host natural tissue by allowing cellular penetration and 
encouraging new cells for tissue regeneration.
One of the best ways to achieve this goal is to use an osteoconductive and porous 
structure to act as a three-dimensional (3D) porous scaffold [2]. Ideally, osseointe-
gration of the grafted material would be accomplished on a long timescale by the 
progressive action of osteoclasts, osteoblasts, and osteocytes which remove the graft 
material and deposit new bone in place [20]. Having a structure that resembles the 
natural design and composition may not always respond to functional requirements 
of a medical application. Bioresorbable scaffolds to replace bone defects must have 
a high porosity—a pore size of 50–800 μm—to allow the infiltration of cells and 
nutrients into the implant [21]; the porosity of the material should accommodate 
new osteon growth, requiring 200 μm pore size, to allow growth of new capillaries, 
optimal for 50 μm pore size, whereas interconnected micropores lower than 10 μm 
improve the metabolic environment and fluid circulation through capillarity [22]. 
The apparent conflicting requirements are met with a 3D design that does not corre-
spond to the natural structure of the bone. Furthermore, improving the osmotic or 
mechanical properties of the synthetic bone graft material by adding components 
that are not present in the natural bone may address the needs of some common 
bone diseases like osteoporosis [23], where graft resorption and replacement by 
native bone tissue may not be the best option.
In recent years, the development of 3D printing techniques for the manufacture 
of ceramic-based scaffold materials has shown promising outcomes [1, 2].
Bioprinting technologies have grown rapidly in the last decade, being also 
known as “additive manufacturing” or “extrusion bioprinting.” Bioprinting can be 
defined as a spatial method of stratified deposition of a biological material (or sup-
port for biological material), based on a computerized, layer-by-layer model, using 
a CAD-CAM system.
The structure of the computerized model can be modified and rearranged with 
the passage of each layer, so as to obtain a complex final model that mimics the tis-
sue structure. The versatility of the technology allows the adoption of an unlimited 
number of material combinations for extrusion, thus ensuring the possibility of 
developing unique three-dimensional models, adapted from case to case. Extrusion 
bioprinting technology is a combination of an automated robotic system, controlled 
by software and an extrusion distribution system of the material in the custom 3D 
structure. This process ensures speed but also structural integrity due to the com-
puterized continuous deposition system. 3D models can be obtained, generated, 
imported, and exported from any CAD system, including data obtained from medi-
cal imaging systems such as computer tomography (CT) and/or nuclear magnetic 
resonance (NMR). The material deposition system can be operated by means of 
a screw mechanism and stepper motor, pneumatically, by piston-compressed air 
mechanism, or by solenoid-electromagnetic system. Deposition systems by screw 
mechanism are more precise, can be better controlled, and also provide controlled 
deposition in the case of very viscous substances. These deposition systems can be 
assembled on a 3D bioprinting machine so that they work in synergy, especially 
if two different materials are deposited. Unlike other additive manufacturing 
processes, extrusion bioprinting does not require large amounts of energy and is an 
environmentally friendly method. In addition it has a high standardization capacity 
and does not require special auxiliary installations. A characteristic is that it can 
produce, under specific conditions, materials with a porous structure and shape 
similar to the anatomical one, likely to attain biocompatibility status.
The 3D printing technique allows the manufacturing of scaffold-type materials 
with complex internal structures and high resolution, designed according to the 
specific needs of each patient. The technology of extruding materials in the form of 
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fact that the removal procedure could damage the bone [1].
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[BaTiO3] and barium strontium titanate (BST) [Ba0.7Sr0.3TiO3]. The potential effect 
of this class of materials in bone tissue engineering is due to its dielectric properties, 
low dielectric loss, and polarization. Sr2+ ion can increase a dielectric constant, and 
it is a trace element in the human body that plays a dual role in bone formation and 
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On the other hand, barium titanate-based ceramic with perovskite structure 
has been widely used as a ferroelectric material for its attractive properties, such as 
high piezoelectric coefficient (d33 = 191 pC/N) as well as excellent biocompatibility 
and bone regeneration capacity in the complex physiological environment, and is 
further considered as an intelligent material for tissue reconstruction [2–4].
Since 1954, it has been reported that natural bone is a piezoelectric material 
[5–12]. In 1957, Fukada et al. [8] observed that the stress-induced piezoelectric 
effect in bone was due to the slipping of collagen fibers past one another. The 
bone tissue exhibited a very low piezoelectric coefficient of 0.7 pC/N [13] and 
was demonstrated to be biologically active and would respond to micromechani-
cal stress such as the movement of the body itself, leading to the generation of an 
electrical dipole [14, 15]. Piezoelectric materials can provide the electrical stimula-
tion characteristic for natural bone environment as it has been asserted that bone 
growth and repair are promoted by the electrical signals produced when the bone is 
mechanically stressed [16]. Due to their parallel features with the real bone, piezo-
electric materials for bone tissue reconstruction may become the next generation of 
bone grafts [17]. Piezoelectric property of barium titanate could be used as a charge 
supply to stimulate the bone implant healing process. So far, all the piezoelectric 
ceramics used in vivo and vitro were in the dense bulk form [18]. However, owing 
to the interconnected pores to provide a favorable environment for bone ingrowth 
and osseointegration [19], a functional bone implant should be porous [15], to 
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create strong bonds with the host natural tissue by allowing cellular penetration and 
encouraging new cells for tissue regeneration.
One of the best ways to achieve this goal is to use an osteoconductive and porous 
structure to act as a three-dimensional (3D) porous scaffold [2]. Ideally, osseointe-
gration of the grafted material would be accomplished on a long timescale by the 
progressive action of osteoclasts, osteoblasts, and osteocytes which remove the graft 
material and deposit new bone in place [20]. Having a structure that resembles the 
natural design and composition may not always respond to functional requirements 
of a medical application. Bioresorbable scaffolds to replace bone defects must have 
a high porosity—a pore size of 50–800 μm—to allow the infiltration of cells and 
nutrients into the implant [21]; the porosity of the material should accommodate 
new osteon growth, requiring 200 μm pore size, to allow growth of new capillaries, 
optimal for 50 μm pore size, whereas interconnected micropores lower than 10 μm 
improve the metabolic environment and fluid circulation through capillarity [22]. 
The apparent conflicting requirements are met with a 3D design that does not corre-
spond to the natural structure of the bone. Furthermore, improving the osmotic or 
mechanical properties of the synthetic bone graft material by adding components 
that are not present in the natural bone may address the needs of some common 
bone diseases like osteoporosis [23], where graft resorption and replacement by 
native bone tissue may not be the best option.
In recent years, the development of 3D printing techniques for the manufacture 
of ceramic-based scaffold materials has shown promising outcomes [1, 2].
Bioprinting technologies have grown rapidly in the last decade, being also 
known as “additive manufacturing” or “extrusion bioprinting.” Bioprinting can be 
defined as a spatial method of stratified deposition of a biological material (or sup-
port for biological material), based on a computerized, layer-by-layer model, using 
a CAD-CAM system.
The structure of the computerized model can be modified and rearranged with 
the passage of each layer, so as to obtain a complex final model that mimics the tis-
sue structure. The versatility of the technology allows the adoption of an unlimited 
number of material combinations for extrusion, thus ensuring the possibility of 
developing unique three-dimensional models, adapted from case to case. Extrusion 
bioprinting technology is a combination of an automated robotic system, controlled 
by software and an extrusion distribution system of the material in the custom 3D 
structure. This process ensures speed but also structural integrity due to the com-
puterized continuous deposition system. 3D models can be obtained, generated, 
imported, and exported from any CAD system, including data obtained from medi-
cal imaging systems such as computer tomography (CT) and/or nuclear magnetic 
resonance (NMR). The material deposition system can be operated by means of 
a screw mechanism and stepper motor, pneumatically, by piston-compressed air 
mechanism, or by solenoid-electromagnetic system. Deposition systems by screw 
mechanism are more precise, can be better controlled, and also provide controlled 
deposition in the case of very viscous substances. These deposition systems can be 
assembled on a 3D bioprinting machine so that they work in synergy, especially 
if two different materials are deposited. Unlike other additive manufacturing 
processes, extrusion bioprinting does not require large amounts of energy and is an 
environmentally friendly method. In addition it has a high standardization capacity 
and does not require special auxiliary installations. A characteristic is that it can 
produce, under specific conditions, materials with a porous structure and shape 
similar to the anatomical one, likely to attain biocompatibility status.
The 3D printing technique allows the manufacturing of scaffold-type materials 
with complex internal structures and high resolution, designed according to the 
specific needs of each patient. The technology of extruding materials in the form of 
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pastes, which are passed through a nozzle or hole to obtain fibers arranged as three-
dimensional structures of different shapes, is suitable for the manufacture of hard 
tissue scaffolds in bone tissue engineering.
Scaffolds are of utmost importance in tissue engineering because they provide 
the necessary support for cell proliferation and differentiation. Also, the scaffold’s 
architecture defines the final form of the new organ. Biocompatibility of scaffolds 
made by 3D printing, as well as different aspects of their interaction with cells, has 
been explored in numerous studies by in vitro and in vivo tests [21].
The extrusion-based additive manufacturing techniques are favorable for print-
ing scaffold structures due to the ability to process a wide range of biomaterials with 
controlled porosity and to generate interconnected pores, which represent essential 
requirements for cell growth [22]. The topography of the surface of the biomaterial 
as well as its architecture on the micro- and nanoscale plays an important role in 
bone tissue engineering. Cao et al. have shown increased tissue regeneration and 
decreased inflammatory reactions in the case of aligned fiber scaffolds, compared 
to scaffolds whose fibers were randomly arranged [24].
Regarding 3D printing of barium titanate (BT) ceramics for medical applica-
tions, Schult et al. [25], have shown that BT powder can serve as a material for bone 
reconstruction, obtained by 3D printing cylindrical parts with 11.7 mm in diameter 
and 3.51 mm high, out of the three BT-based mixtures. The first mixture, M1, 
consisted of untreated BT powder, a stable polymer, and a flow additive—AEROSIL 
R8200. The second mixture, M2, has the same composition as the first, but BT was 
previously subjected to a heat treatment of calcination, using for this a fraction of 
the sieved powder of 60–80 μm and a flow additive. The third mixture, M3, also 
contains calcined BT, but in this case the fractions <125 μm and 125–250 μm were 
used in a ratio of 1:2, without adding flow additives, because the powder has good 
fluidity. To bond the material, a soluble polymer granulate with a mean grain size 
of 50 μm was used in all three mixtures. Solupor-Binder (Voxeljet AG, Germany) is 
used as a binder fluid. The binder partially dissolves the polymer granulate so that 
the ceramic particles glue together. The porosity was visible in all samples, being 
beneficial for cell growth. After sintering, the largest contraction was observed 
in the case of the M1 sample, of 75.53%, but the other two also recorded relatively 
high contractions, M2 of 40.55% and M3 of 29.51%. The results reported in their 
study confirm that porous barium titanate ceramics can be used as a 3D structure 
for bone tissue engineering and bone formation can be promoted by electrical 
stimulation [25].
In other study, a binder jetting additive manufacturing technology was used to 
fabricate robust geometric barium titanate specimens of 12 × 12 × 3 mm3 by using 
commercial BT powder [26]. The results presented in their work have shown that 
3D printing allows the manufacture of custom, conformal, geometrically complex 
piezoelectric devices for next-generation industries such as biomedical ones. One 
example includes the possibility of an energy-harvesting active biomedical implant, 
the shape of which could be customized for patient-specific geometry correspond-
ing to anatomical features and use (e.g., a bone implant that will eliminate the need 
for battery replacement and resulting follow-on surgeries).
2. Design of multilayered ceramic materials
Fractures occur in ceramics as a result of crack propagation. The science 
of design against fractures is based on the pioneering work of A.A. Griffith 
(1893– 1963) who proposed an energy balance approach to predict fracture 
strengths in materials [27]. Thus, crack growth is associated with the release of 
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strain energy and absorption of energy to create the two flanking surfaces. In a 
succinct manner, we may calculate the stress level  ϭ f when crack propagation occurs 
using the Griffith equation:
  ϭ f =  √ 
_
 2Eγ _𝝅𝝅a ,  (1)
where E is the Young modulus, γ is the surface energy, and a is the size of the 
crack or defect. This describes well very brittle materials, which do not exhibit 
plasticity domains before fracture. A more general description was developed based 
on the original Griffith equation by Irwin [28] and Orowan [29] as follows:
  ϭ f =  √ 
_
 E  ς c _𝝅𝝅a , (2)
where critical strain release rate parameter,  ς c , was introduced to consider the 
energy dissipation into material due to a ductile behavior of the material. A more 
detailed description of the problem is provided by Roylance [30].
The design of fracture-resistant materials by combining viscoelastic polymers 
with ceramic materials would be either as composites (separate components) or in 
the form of mixtures. A composite beam made of multiple layers of ceramics inter-
rupted by polymer layers would be protected against catastrophic crack propagation 
across layers. Based on the Griffith energy balance approach, it is possible to find 
out the ceramic layer thickness that would maximize fracture resistance. Griffith 
equation was historically used to describe fracture resistance dependency on grain 
size (dgrain) in carbon steel and thus explain some catastrophic failures of low-grade 
steels at temperature transitions. At plastic to brittle transition of the material, 
the crack was considered to propagate along the whole grain and dissipate at grain 
boundaries. Replacing a = dgrain in Eq. (2), it results:
  ϭ f = v √ 
_
 E  ς c  _
𝝅𝝅  d grain 
 , (3)
Analogously, for a multilayered ceramic material (Figure 1) shaped as a beam 
with equally thick longitudinal layers, we plot fracture stress against layer thick-
ness, considering the most unfavorable situation when the crack expands immedi-
ately across the whole layer. The relative units refer to maximal fracture stress and 
beam thickness for normalization. From the fracture stress curve, it results, at a first 
view, that very thin layers would provide the beam with maximal protection against 
fractures. Another criterion for optimization is provided by efficiency reasoning.
Subjected to tensile stress, the beam would distribute the load on individual 
layers according to their thickness. A maximal fracture-proof design of a multi-
layered beam would consider that even a single layer would be able to support the 
whole beam load, meaning that the tension applied on the layer is lower than the 
beam fracture tension. Intuitively, a beam consisting of two layers is a minimal 
backup mechanism, whereas more layers may look excessive for most applica-
tions. In the graph in Figure 1, the intersection between the two curves occurs 
for a number of 10 layers. In other words, for a beam designed to resist fracture, 
more than 10 layers would not provide reliance on single layer last standing (the 
initial premise), whereas less than this number lowers the fracture-safe tension 
limit. Therefore 10 longitudinal ceramic layers, uncoupled for fracture propaga-
tion, may already provide the safest design for tensile load fractures in a beam. The 
underlying supposition is that the ultimate tensile strength has the same order of 
magnitude as the fracture strength. Transversal loads on the beam would require 
a change in the design of the multilayered beam; still the reasoning example for 
longitudinal loads demonstrates how to look for the optimal grain size in order to 
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pastes, which are passed through a nozzle or hole to obtain fibers arranged as three-
dimensional structures of different shapes, is suitable for the manufacture of hard 
tissue scaffolds in bone tissue engineering.
Scaffolds are of utmost importance in tissue engineering because they provide 
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made by 3D printing, as well as different aspects of their interaction with cells, has 
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The extrusion-based additive manufacturing techniques are favorable for print-
ing scaffold structures due to the ability to process a wide range of biomaterials with 
controlled porosity and to generate interconnected pores, which represent essential 
requirements for cell growth [22]. The topography of the surface of the biomaterial 
as well as its architecture on the micro- and nanoscale plays an important role in 
bone tissue engineering. Cao et al. have shown increased tissue regeneration and 
decreased inflammatory reactions in the case of aligned fiber scaffolds, compared 
to scaffolds whose fibers were randomly arranged [24].
Regarding 3D printing of barium titanate (BT) ceramics for medical applica-
tions, Schult et al. [25], have shown that BT powder can serve as a material for bone 
reconstruction, obtained by 3D printing cylindrical parts with 11.7 mm in diameter 
and 3.51 mm high, out of the three BT-based mixtures. The first mixture, M1, 
consisted of untreated BT powder, a stable polymer, and a flow additive—AEROSIL 
R8200. The second mixture, M2, has the same composition as the first, but BT was 
previously subjected to a heat treatment of calcination, using for this a fraction of 
the sieved powder of 60–80 μm and a flow additive. The third mixture, M3, also 
contains calcined BT, but in this case the fractions <125 μm and 125–250 μm were 
used in a ratio of 1:2, without adding flow additives, because the powder has good 
fluidity. To bond the material, a soluble polymer granulate with a mean grain size 
of 50 μm was used in all three mixtures. Solupor-Binder (Voxeljet AG, Germany) is 
used as a binder fluid. The binder partially dissolves the polymer granulate so that 
the ceramic particles glue together. The porosity was visible in all samples, being 
beneficial for cell growth. After sintering, the largest contraction was observed 
in the case of the M1 sample, of 75.53%, but the other two also recorded relatively 
high contractions, M2 of 40.55% and M3 of 29.51%. The results reported in their 
study confirm that porous barium titanate ceramics can be used as a 3D structure 
for bone tissue engineering and bone formation can be promoted by electrical 
stimulation [25].
In other study, a binder jetting additive manufacturing technology was used to 
fabricate robust geometric barium titanate specimens of 12 × 12 × 3 mm3 by using 
commercial BT powder [26]. The results presented in their work have shown that 
3D printing allows the manufacture of custom, conformal, geometrically complex 
piezoelectric devices for next-generation industries such as biomedical ones. One 
example includes the possibility of an energy-harvesting active biomedical implant, 
the shape of which could be customized for patient-specific geometry correspond-
ing to anatomical features and use (e.g., a bone implant that will eliminate the need 
for battery replacement and resulting follow-on surgeries).
2. Design of multilayered ceramic materials
Fractures occur in ceramics as a result of crack propagation. The science 
of design against fractures is based on the pioneering work of A.A. Griffith 
(1893– 1963) who proposed an energy balance approach to predict fracture 
strengths in materials [27]. Thus, crack growth is associated with the release of 
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strain energy and absorption of energy to create the two flanking surfaces. In a 
succinct manner, we may calculate the stress level  ϭ f when crack propagation occurs 
using the Griffith equation:
  ϭ f =  √ 
_
 2Eγ _𝝅𝝅a ,  (1)
where E is the Young modulus, γ is the surface energy, and a is the size of the 
crack or defect. This describes well very brittle materials, which do not exhibit 
plasticity domains before fracture. A more general description was developed based 
on the original Griffith equation by Irwin [28] and Orowan [29] as follows:
  ϭ f =  √ 
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where critical strain release rate parameter,  ς c , was introduced to consider the 
energy dissipation into material due to a ductile behavior of the material. A more 
detailed description of the problem is provided by Roylance [30].
The design of fracture-resistant materials by combining viscoelastic polymers 
with ceramic materials would be either as composites (separate components) or in 
the form of mixtures. A composite beam made of multiple layers of ceramics inter-
rupted by polymer layers would be protected against catastrophic crack propagation 
across layers. Based on the Griffith energy balance approach, it is possible to find 
out the ceramic layer thickness that would maximize fracture resistance. Griffith 
equation was historically used to describe fracture resistance dependency on grain 
size (dgrain) in carbon steel and thus explain some catastrophic failures of low-grade 
steels at temperature transitions. At plastic to brittle transition of the material, 
the crack was considered to propagate along the whole grain and dissipate at grain 
boundaries. Replacing a = dgrain in Eq. (2), it results:
  ϭ f = v √ 
_
 E  ς c  _
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Analogously, for a multilayered ceramic material (Figure 1) shaped as a beam 
with equally thick longitudinal layers, we plot fracture stress against layer thick-
ness, considering the most unfavorable situation when the crack expands immedi-
ately across the whole layer. The relative units refer to maximal fracture stress and 
beam thickness for normalization. From the fracture stress curve, it results, at a first 
view, that very thin layers would provide the beam with maximal protection against 
fractures. Another criterion for optimization is provided by efficiency reasoning.
Subjected to tensile stress, the beam would distribute the load on individual 
layers according to their thickness. A maximal fracture-proof design of a multi-
layered beam would consider that even a single layer would be able to support the 
whole beam load, meaning that the tension applied on the layer is lower than the 
beam fracture tension. Intuitively, a beam consisting of two layers is a minimal 
backup mechanism, whereas more layers may look excessive for most applica-
tions. In the graph in Figure 1, the intersection between the two curves occurs 
for a number of 10 layers. In other words, for a beam designed to resist fracture, 
more than 10 layers would not provide reliance on single layer last standing (the 
initial premise), whereas less than this number lowers the fracture-safe tension 
limit. Therefore 10 longitudinal ceramic layers, uncoupled for fracture propaga-
tion, may already provide the safest design for tensile load fractures in a beam. The 
underlying supposition is that the ultimate tensile strength has the same order of 
magnitude as the fracture strength. Transversal loads on the beam would require 
a change in the design of the multilayered beam; still the reasoning example for 
longitudinal loads demonstrates how to look for the optimal grain size in order to 
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build fracture-resistant polymer-reinforced ceramic materials. Thus, decreasing 
the grain size to nanometer level does not bring additional fracture resistance to 
millimeter-thick ceramic objects. The 3D printed material in Figure 5 is made of 
ceramic-collagen filaments ~0.6 mm thick oriented in two perpendicular directions 
and connected in the nodes. The filaments are made of globular grains 2–10 μm in 
diameter. This structure actually relies on the binder to hold the grains together. 
The space between grains is large enough to accommodate biopolymer filaments 
as binder; one way to produce such filaments in place is to populate the spongy 
structure with fibroblasts and grow them in culture, as we show here. Then a weak 
link will reside inside ceramic-polymer hybrid grains.
3. Ceramic-polymer hybrid materials
Adding a polymer to a ceramic material in 3D printing is in the first place a mean 
to modulate the viscosity of the printing paste and support complex 3D structures 
while they are raised by adding material. Keeping the polymer in place or removing 
it by post-processing of the printed object depends on the contribution of the poly-
mer to the mechanical properties of the printed object. The brittleness of glasses and 
ceramic materials is usually addressed by reinforcing the brittle material with elastic 
fibers, either as composite or as mixture. In mixtures, nanoscale contact between 
ceramic materials and polymers intimately modulates the elasticity of the resulting 
material. Aragonite and hydroxyapatite have a very high elastic modulus, around 
100 GPa, and a fracture toughness of ∼1 MPa/m1/2. With those values, based on 
some common assumptions, Chen et al. estimated [31] that the brittleness domain 
of the material is in the nanometer range. Biological structures based on aragonite 
(nacre) or hydroxyapatite (like bones) rely on elastic biopolymers as binders to 
increase their fracture resistance by dissipating the stress energy. Irwin and Orowan 
approach on fracture propagation assumes that stress energy is dissipated around 
fracture tip by plastic deformations, in which a purely entropic polymer does not 
accomplish. A mechanism for plastic deformations in nacre resides in micrometer-
sized parallel platelets that are able to slide on each other. In this case, the binder 
breaks and forms attachments to the aragonite platelets while the stress is dissipated. 
This occurs at a micrometer range. On a nanometer scale, viscoelasticity inside the 
binding biopolymer may provide another mechanism for stress relaxation.
Figure 1. 
A proposed criterion for fracture-proof layer thickness in layered beams made of brittle ceramics exposed to 
longitudinal stretch. Intersection between curves describing ultimate tensile tension of a layer (orange), and 
beam fracture tension (blue) provides a point of optimal layer thickness to stand alone against the whole beam 
stretch load.
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The idea of mixing collagen and ceramic powder in a paste for printing bone grafts 
or other bone-like structures for medical applications is based on similarity with the 
natural bone. Ideally, osseointegration of the grafted material would be accomplished 
on a long timescale by the progressive action of osteoclasts and osteoblasts which 
remove the graft material and deposit new bone in place. Having a structure that 
resembles the natural design may not always respond to functional requirements of a 
medical application. For example, the porosity of the material should accommodate 
new osteon growth, requiring 200 μm pore size, to allow growth of new capillaries, 
optimal for 50 μm pore size, whereas interconnected micropores lower than 10 μm 
improve the metabolic environment and fluid circulation through capillarity [32]. In 
a mixture, the viscoelastic polymer should significantly add toughness to effectively 
dissipate strain energy from initiating cracks in ceramics. A relevant group of biologi-
cal polymers are the proteins involved in the elasticity of animal tissues. An impres-
sive coordinated effort was made to understand the contribution of the giant protein 
titin to the elasticity of the striated muscle, detailed on structural, mechanical, and 
enzymatic description of the functional segments in titin molecules. A comprehen-
sive review on the subject is provided by Prof. Wolfgang A. Linke [33].
The Ig domains in titin were described for their viscoelastic role, protecting 
titin from breaking under excessive stretch. In 1996, Improta, Politou, and Pastore 
determined the structure of I27 titin Ig domain by nuclear magnetic resonance 
(NMR) techniques [34]. The I27 titin Ig domain structure consists in two β sheets 
packing against each other, each β sheet containing four β strands. Stretch-induced 
unfolding of the Ig structure provides significant additional extension to the titin 
molecule, as demonstrated by Linke and Fernandez laboratories [35, 36]. Atomic 
force microscopy of single molecules was used to investigate synthetic polypeptides 
based on repetitive Ig domain gene constructs.
In Figure 2 we replotted from literature some AFM force spectroscopy mea-
surements on collagen I molecules [37], a synthetic polypeptide fragment made 
of 8 repetitive I27 titin Ig domains [38] and a synthetic protein made of repetitive 
modules found in dragline spider silk protein (16 SPI and 4 SPII modules) [39]. 
Extension of collagen molecule in the nanometer range generates almost no force, 
starting to rise at 300 nm extension. Instead, a single I27 module already provides 
Figure 2. 
Comparison of force extension AFM measurements in collagen I single molecules (blue), collagen I 
interconnected molecules (light blue), a synthetic polypeptide made of 8 repeats of I27 titin Ig module (red) and 
a synthetic protein fragment made of repetitive modules from dragline spider silk protein (black). Replotted 
and adapted from Linke et al. for (I27)8 [38], Bozec and Horton [37] for collagen I, and Oroudjev et al. [39] 
for modular recombinant protein from spider silk.
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build fracture-resistant polymer-reinforced ceramic materials. Thus, decreasing 
the grain size to nanometer level does not bring additional fracture resistance to 
millimeter-thick ceramic objects. The 3D printed material in Figure 5 is made of 
ceramic-collagen filaments ~0.6 mm thick oriented in two perpendicular directions 
and connected in the nodes. The filaments are made of globular grains 2–10 μm in 
diameter. This structure actually relies on the binder to hold the grains together. 
The space between grains is large enough to accommodate biopolymer filaments 
as binder; one way to produce such filaments in place is to populate the spongy 
structure with fibroblasts and grow them in culture, as we show here. Then a weak 
link will reside inside ceramic-polymer hybrid grains.
3. Ceramic-polymer hybrid materials
Adding a polymer to a ceramic material in 3D printing is in the first place a mean 
to modulate the viscosity of the printing paste and support complex 3D structures 
while they are raised by adding material. Keeping the polymer in place or removing 
it by post-processing of the printed object depends on the contribution of the poly-
mer to the mechanical properties of the printed object. The brittleness of glasses and 
ceramic materials is usually addressed by reinforcing the brittle material with elastic 
fibers, either as composite or as mixture. In mixtures, nanoscale contact between 
ceramic materials and polymers intimately modulates the elasticity of the resulting 
material. Aragonite and hydroxyapatite have a very high elastic modulus, around 
100 GPa, and a fracture toughness of ∼1 MPa/m1/2. With those values, based on 
some common assumptions, Chen et al. estimated [31] that the brittleness domain 
of the material is in the nanometer range. Biological structures based on aragonite 
(nacre) or hydroxyapatite (like bones) rely on elastic biopolymers as binders to 
increase their fracture resistance by dissipating the stress energy. Irwin and Orowan 
approach on fracture propagation assumes that stress energy is dissipated around 
fracture tip by plastic deformations, in which a purely entropic polymer does not 
accomplish. A mechanism for plastic deformations in nacre resides in micrometer-
sized parallel platelets that are able to slide on each other. In this case, the binder 
breaks and forms attachments to the aragonite platelets while the stress is dissipated. 
This occurs at a micrometer range. On a nanometer scale, viscoelasticity inside the 
binding biopolymer may provide another mechanism for stress relaxation.
Figure 1. 
A proposed criterion for fracture-proof layer thickness in layered beams made of brittle ceramics exposed to 
longitudinal stretch. Intersection between curves describing ultimate tensile tension of a layer (orange), and 
beam fracture tension (blue) provides a point of optimal layer thickness to stand alone against the whole beam 
stretch load.
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The idea of mixing collagen and ceramic powder in a paste for printing bone grafts 
or other bone-like structures for medical applications is based on similarity with the 
natural bone. Ideally, osseointegration of the grafted material would be accomplished 
on a long timescale by the progressive action of osteoclasts and osteoblasts which 
remove the graft material and deposit new bone in place. Having a structure that 
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medical application. For example, the porosity of the material should accommodate 
new osteon growth, requiring 200 μm pore size, to allow growth of new capillaries, 
optimal for 50 μm pore size, whereas interconnected micropores lower than 10 μm 
improve the metabolic environment and fluid circulation through capillarity [32]. In 
a mixture, the viscoelastic polymer should significantly add toughness to effectively 
dissipate strain energy from initiating cracks in ceramics. A relevant group of biologi-
cal polymers are the proteins involved in the elasticity of animal tissues. An impres-
sive coordinated effort was made to understand the contribution of the giant protein 
titin to the elasticity of the striated muscle, detailed on structural, mechanical, and 
enzymatic description of the functional segments in titin molecules. A comprehen-
sive review on the subject is provided by Prof. Wolfgang A. Linke [33].
The Ig domains in titin were described for their viscoelastic role, protecting 
titin from breaking under excessive stretch. In 1996, Improta, Politou, and Pastore 
determined the structure of I27 titin Ig domain by nuclear magnetic resonance 
(NMR) techniques [34]. The I27 titin Ig domain structure consists in two β sheets 
packing against each other, each β sheet containing four β strands. Stretch-induced 
unfolding of the Ig structure provides significant additional extension to the titin 
molecule, as demonstrated by Linke and Fernandez laboratories [35, 36]. Atomic 
force microscopy of single molecules was used to investigate synthetic polypeptides 
based on repetitive Ig domain gene constructs.
In Figure 2 we replotted from literature some AFM force spectroscopy mea-
surements on collagen I molecules [37], a synthetic polypeptide fragment made 
of 8 repetitive I27 titin Ig domains [38] and a synthetic protein made of repetitive 
modules found in dragline spider silk protein (16 SPI and 4 SPII modules) [39]. 
Extension of collagen molecule in the nanometer range generates almost no force, 
starting to rise at 300 nm extension. Instead, a single I27 module already provides 
Figure 2. 
Comparison of force extension AFM measurements in collagen I single molecules (blue), collagen I 
interconnected molecules (light blue), a synthetic polypeptide made of 8 repeats of I27 titin Ig module (red) and 
a synthetic protein fragment made of repetitive modules from dragline spider silk protein (black). Replotted 
and adapted from Linke et al. for (I27)8 [38], Bozec and Horton [37] for collagen I, and Oroudjev et al. [39] 
for modular recombinant protein from spider silk.
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maximal tension of folded state with 28.1 nm stretch and then unfolds and releases a 
strain (red line). Unfolding and full extension of all 8 I27 repeats in the polypeptide 
occurs at ~230 nm stretch, raising the force to 882 pN, which is 59% of the maximal 
single molecule collagen force. Stretching multiple collagen molecules, as they are 
connected by nodes in a net, also fails to deliver significant force at nanometer range 
extensions (light blue line). For comparison, a synthetic recombinant modular frag-
ment from dragline spider silk protein is shown to unfold its modules with a repeti-
tive pattern of 14 nm (black line), releasing lower levels of tension than Ig domain 
unfolding or collagen I molecule node detachment.
Addition of long-range acting binders (developing significant force only at high 
extensions) versus short-range acting binders in the composition of hybrid poly-
mer-ceramic material is not an obvious decision. Increasing collagen I molecule con-
centration would raise the number of cross-links between molecules, thus enabling 
significant force development at lower extensions (as shown in Figure 2, light blue 
line). Ultimately, as concentration is increased, collagen I molecules will assemble 
in fibrils with high strength and low extensibility ropelike structures, 260–410 nm 
wide [40]. This will increase the interspacing between mineral grains or tiles to sizes 
often found in the natural reign of such materials [41]. Mechanical measurements 
(indentation technique) on collagen fibrils (50–200 nm in diameter) dissected from 
rat tail showed a Young elastic modulus in the range from 5 GPa to 11.5 GPa (in air, 
at room temperature) [42], a value at most 1/10 of hydroxyapatite modulus. The 
concept is that collagen fibers contribute less to the elastic stiffness of the bone and 
more to its capacity to absorb deformation energy before it fails, that is, toughness 
[41]. As part of the energy dissipation of the deformative load, the bone structure 
suffers plastic deformations at the microstructural level, and, in living organisms, 
it is repaired and even remodeled to withstand the new actual load configuration. 
If we consider that natural structures evolved to optimize functionality, then it is 
important to understand that optimization also means maximal toughness or the 
solution had to deal with limitations and constrains of the cellular machineries that 
build bone-like biopolymer-mineral structures.
4. 3D printing of ceramic-polymer hybrid materials
Patient-specific design of orthopedic prosthetic devices may improve the 
durability and the performance of the device by adequate distribution of loads 
and by using wear-resistant materials on highly solicited spots. An example is hip 
arthroplasty where bearings may be adequately designed and fabricated to mini-
mize surface friction between elements [43]. With the use of numerical models, the 
shape and mechanical properties of the prosthesis could be optimized according to 
patient characteristics like height, weight, gender, and age. Then, the prosthesis has 
to be engineered for a suitable mounting procedure during the orthopedic interven-
tion and manufactured according to specifications. Some design features like 3D 
shape may be attained with standard manufacturing techniques, and other features, 
particularly those involving material microstructure, are possible only by advanced 
manufacturing. 3D printing combines the advantage of using directly the results of 
numerical modeling to create the prosthetic device—eliminating some intermediate 
steps, with the micrometer precision and versatility of the printing mechanism and 
allowing for microstructuring and the use of various materials for the same piece.
An example of ceramic-polymer hybrid material fabricated by 3D printing 
method is presented. For the first time, 3D hybrid organic-inorganic materials based 
on barium titanate and collagen (BTC) and barium strontium titanate and collagen 
(BST-C), with potential applications as filler in bone tissue engineering, have been 
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developed by extrusion-based 3D printing method, as presented below. Thus, 
hybrid nanostructured powders (BTC and BST-C) were obtained by the hydro-
thermal process at high pressure, starting from Ba(OH)2*8H2O powder, aqueous 
solution of TiO2Cl2, and collagen powder as BTC precursors and Ba(OH)2*8H2O 
powder, aqueous solution of Sr(NO3)2, aqueous solution of TiO2Cl2, and collagen 
powder as BST-C precursors. After the solution pH was adjusted at pH > 10, and 
the hybrid suspension thus prepared was transferred to the Berghof autoclave 
(Germany) and subjected to hydrothermal synthesis at T < 100°C and p = 40 bar 
for 2 h. Afterwards, the hybrid nanostructured powders were filtered and washed 
with distilled water until neutral pH was reached and further spray-dried using a 
LabPLANT SD-06 spray dryer (UK).
Powders resulted after hydrothermal synthesis were mechanically mixed with 
a water-soluble polymer binder (Mowiflex, Kuraray Poval) 20% solution and a 
cross-linking agent (Baymedix® FD103, Covestro), obtaining a viscous paste which 
is further used as a feedstock in the 3D printing process using 3D BioScaffolder 
system (SYS-ENG, Germany) equipped with BioScaffolder software (SW) 3.0. The 
technological flow is briefly depicted in Figure 3 (synthesis of hybrid powders, 
preparation of paste, and 3D printing of hybrid structures).
Some examples of 3D hybrid structures obtained with different nozzles and 
rotation angles between 2 successive layers (90° and 45°, respectively) are given in 
Figure 4.
5.  Manufacture of 3D structures based on barium titanate and collagen 
and barium strontium titanate and collagen by 3D printing method
3D printing is a highly versatile technique to fabricate complex structures with 
high precision and nanometer resolution. The principle of this technique is based 
on the extrusion of continuous filaments (inks) in a layer-by-layer sequence using 
Figure 3. 
Technological flow for the fabrication of 3D structures.
Figure 4. 
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computer-aided design (CAD) tools. This method is capable of fabricating struc-
tures with feature sizes on the microscale (0.1–100 μm) and mesoscale (>100 μm), 
depending on the nozzle diameter. The ability to fabricate a variety of structures 
requires a good control over the formulation and rheological behavior of the inks 
and the printing parameters (velocity printing, pressure extrusion). The funda-
mental advantage for any lattice structure are that it is self-supporting (to bear 
on itself) without the need for inside supports. Another key aspect for the use of 
porous structures is pore interconnectivity. Porosity is defined as the total percent-
age of bare spaces in a solid and is a morphological property independent of the 
material.
The 3D structures were obtained as described above, using the 3D printing tech-
nique and BioScaffolder (SYS-ENG, Germany) device, connected via a USB port to 
a computer on which the BioScaffolder SW 3.0 software is installed. This software 
allows the configuration of the 3D object to be created in this program or imported 
from a CAD-CAM program, as well as the setting of the printing process param-
eters for the 3D object (scaffold), made by depositing several layers of extruded 
fibers. The shape of 3D structure can be also set using BioScaffolder software. Thus, 
cubic, octagonal, and cylindric shapes can be obtained.
6. Morpho-structural characterization of 3D structures
BTC and BST-C structures fabricated as described above have been charac-
terized using different techniques: scanning electron microscopy coupled with 
energy dispersive X-ray analysis (SEM/EDX), X-ray diffraction (XRD), and optical 
profilometry.
SEM/EDX analysis was performed using a FEI E-SEM Quanta 200 microscope 
equipped with EDX. XRD analysis was performed using a Rigaku MiniFlex 2 
diffractometer. Optical profilometry measurements were performed using Veeco 
WYKO NT1100.
6.1 SEM/EDX characterization
SEM images of two representative samples (BTCM-1 and BST-C1) are depicted 
in Figures 5 and 6.
Figure 5b shows a typical image of a 3D structure with fibers having thickness 
of 512–587 μm, while the distance between them varies between 762 and 1093 μm. 
Figure 5a clearly shows how the fibers are arranged in multiple layers in the 3D 
structure. The round-shaped particles of barium titanate-based nanopowders can 
be observed in Figure 7c, as a result of BaTiO3 spray-drying.
In the case of BST-C1 sample, the porosity of the structure can be observed in 
Figure 6a (cross section). The fiber thickness varies between 860 and 1064 μm, 
Figure 5. 
SEM images of BTCM sample: (a) cross section of 3D sample; (b) front image at 20×; (c) front image at a 
higher magnification—10,000×.
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while the distance between them is about 105–543 μm (Figure 6b). Similar with 
BTCM-1 sample, spherical particles of BaxSr1−xTiO3 nanopowders are observed in 
Figure 6c. EDX analysis is presented in Table 1.
6.2 XRD characterization
XRD spectra of two representative samples (BTCM-1 and BST-C1) are pre-
sented in Figure 7. From Figure 7, it can be seen that the main characteristic peak 
of BaTiO3 in sample BTCM-1 corresponds to 2θ = 39.71 and interplanar distance 
d = 2.268. The crystallite size related to this peak is 14.1 nm, and it was calculated 
using Scherrer equation. In the case of BST-C1 sample, the main characteristic 
peak appears at 2θ = 35.18 and interplanar distance d = 2.549. The crystallite size 
calculated for this peak using Scherrer equation is 8.9 nm. As it can be seen on the 
diffraction spectra, non-doped barium titanate (BTCM-1) and Sr-doped barium 
titanate (BST-C1) powders are slightly shifted. Peak locations are not exactly 
Figure 7. 
XRD spectra of BTCM-1.12 sample (in red) and BST-C1.1 sample (in blue).
Figure 6. 
SEM images of BST-C1 sample: (a) cross section of 3D sample; (b) front image at 33×; (c) front image at a 
higher magnification—1000×
Sample C O Ti Ba Sr Total
BTCM-1 9.04 29.59 25.37 36.01 — 100.00
BST-C1 14.22 26.50 10.78 8.42 40.09 100.00
Table 1. 
Semiquantitative analysis of two representative 3D structures (BTCM and BST-C).
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computer-aided design (CAD) tools. This method is capable of fabricating struc-
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sented in Figure 7. From Figure 7, it can be seen that the main characteristic peak 
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using Scherrer equation. In the case of BST-C1 sample, the main characteristic 
peak appears at 2θ = 35.18 and interplanar distance d = 2.549. The crystallite size 
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Figure 7. 
XRD spectra of BTCM-1.12 sample (in red) and BST-C1.1 sample (in blue).
Figure 6. 
SEM images of BST-C1 sample: (a) cross section of 3D sample; (b) front image at 33×; (c) front image at a 
higher magnification—1000×
Sample C O Ti Ba Sr Total
BTCM-1 9.04 29.59 25.37 36.01 — 100.00
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suitable to PDF cards of BaTiO3 and BaxSr1−xTiO3, which might be explained by the 
presence of binder and collagen in the powder compositions.
6.3 Optical profilometry
Surface roughness of two representative samples (BTCM-1.5 and BST-C1.3) is 
depicted in Figures 8 and 9. The mean surface roughness Ra (the average roughness 
of the surface) of BTCM-1.5 is about 600 nm.
The mean surface roughness Ra (the average roughness of the surface) of BST-
C1.3 is about 2.29 μm.
7.  The stability and biocompatibility of BTCM 3D printed materials for 
in vitro tests
The BTCM materials were sterilized by immersion for 4 h in an 8 ml sterile 
phosphate buffer containing 1% penicillin/streptomycin and 0.25 mg/ml ampho-
tericin B (Fungizone) and then washed three times with an 8 ml of sterile phos-
phate buffer to remove the excess of Fungizone and penicillin/streptomycin. After 
4 h of sterilization, the BTCM material retains its structure almost intact and can 
be handled with care in the next steps. The residues released from BTCM materials 
at the end of the sterilization period were undetectable visually and demonstrated 
the biomaterial stability in phosphate buffer. After sterilization the materials to be 
analyzed were moved into an 8 ml completely sterile DMEM culture medium and 
kept for 24 h in the incubator at 37°C. This step intended to analyze the impact 
of the soluble compounds released by the materials, if any, in the cell culture 
medium on cell morphology and adhesion. The DMEM medium resulted from the 
24 h of incubation with BTCM materials was further used for culturing 1070Sk 
CCD fibroblasts and SKMel23 metastatic melanoma cells. The CCD fibroblasts 
(passage 23) and SKMel23 melanoma cells (passage 3) were seeded in a cell 
culture six-well plate at a density of 2 × 104 cells/well, cultured in DMEM medium 
Figure 8. 
Surface roughness of BTCM-1.5 sample.
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(control) or DMEM medium resulted from incubation with BTCM materials, 
for 24 h, and analyzed in bright-field microscopy. The fibroblasts grown in the 
DMEM medium exposed to the BTCM material were completely adhered to the 
substrate and had a morphology similar to the controls (Figure 10). In the case 
of SkMel23 cells grown in DMEM exposed to BTCM material, the cells also well 
adhered to the substrate. However, their morphology was slightly different com-
pared to the control cells (Figure 11). Next we investigated whether SkMel23 cells 
were able to adhere to the BTCM material itself. For this purpose, a suspension 
Figure 10. 
Fibroblasts grown in DMEM (a, b, c, g, h) compared to fibroblasts grown in DMEM previously exposed 
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24 h of incubation with BTCM materials was further used for culturing 1070Sk 
CCD fibroblasts and SKMel23 metastatic melanoma cells. The CCD fibroblasts 
(passage 23) and SKMel23 melanoma cells (passage 3) were seeded in a cell 
culture six-well plate at a density of 2 × 104 cells/well, cultured in DMEM medium 
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for 24 h, and analyzed in bright-field microscopy. The fibroblasts grown in the 
DMEM medium exposed to the BTCM material were completely adhered to the 
substrate and had a morphology similar to the controls (Figure 10). In the case 
of SkMel23 cells grown in DMEM exposed to BTCM material, the cells also well 
adhered to the substrate. However, their morphology was slightly different com-
pared to the control cells (Figure 11). Next we investigated whether SkMel23 cells 
were able to adhere to the BTCM material itself. For this purpose, a suspension 
Figure 10. 
Fibroblasts grown in DMEM (a, b, c, g, h) compared to fibroblasts grown in DMEM previously exposed 




containing 100 × 104 SKMel23 cells in an 8 ml complete DMEM medium was 
added onto the sterilized BTCM material and previously preincubated in DMEM 
according to the protocol described above and further cultured for 24 h in com-
plete DMEM medium.
After 24 h the culture medium was removed, and the BTCM material was 
washed three times with 8 ml of sterile PBS. The material was then moved using 
a sterile metal spatula to another six-well plate in order to evaluate only the cells 
adhered to the material and to exclude those that adhered to the plastic surface of 
the well. The BTCM material was incubated with 8 ml of sterile trypsin for 10 min, 
at 37°C with gentle shaking every 3 min to ensure a good detachment of cells. The 
supernatant was transferred to a 15 ml tube to which 6 ml of complete DMEM was 
added for trypsin neutralization and was centrifuged for 5 min, at 1500 rpm. The 
cell pellet was recovered at the bottom of the tube, and cells were counted after 
dilution 1/1 with trypan blue, which stains only the dead cells. From 100 × 104 
SkMel23 cells seeded on BTCM material, a number of 8 × 104 cells were recovered 
after 24 h, which indicates that at least 8% of SkMel23 cells were able to adhere to 
BTCM material.
Figure 11. 
SkMel23 cells grown in DMEM (a, b, e, f) compared to SKMel23 cells grown in DMEM previously exposed to 
BTCM material for 24 h (c, d, g, h) (bright-field microscopy 10× magnification, a–d and 40× magnification, 
e–h).
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8. Conclusions
Materials based on BT or BST and collagen are candidates for medical applica-
tions in bone reconstruction and enhancement, suitable for 3D printing technolo-
gies that allow patient-specific shape, microstructure, and composition of the 
artificial bone. Artificial graft osteointegration at the interface with the natural 
bone will be facilitated by a printed porous structure that allows cellular infiltra-
tion, adherence, and growth. An example of ceramic-polymer hybrid material 
fabricated by 3D printing method was presented here. For the first time, 3D hybrid 
organic-inorganic materials based on barium titanate and collagen (BTC) and 
barium strontium titanate and collagen (BST-C), with potential applications as 
filler in bone tissue engineering, have been developed by integrating hydrothermal 
synthesis with additive manufacturing (extrusion-based 3D printing method). 
Morpho-structural characterization of 3D structures clearly showed multiple 
layers of fibers deposited at various angles in the 3D structure. Fiber thickness is 
around 500–600 μm in the case of BTCM sample. Both BTCM and BST-C samples 
are composed of spherical particles with crystallite size (estimated from X-ray 
diffraction patterns) of 14.1 nm (for BTCM) and 8.9 nm (for BST-C).
The 3D printed BTCM materials are physically stable and do not release toxic 
soluble compounds in cell culture medium. The BTCM material structure allows the 
adhesion of SkMel23 cells and possibly of other cell phenotypes as well. The cells 
recovered after being in contact with 3D printed BTCM materials are fully viable.
Mechanical properties of the 3D printed bone graft may be modulated at the 
nanometer scale by addition of collagen or other biopolymers into the printing 
paste, whereas at the microscale a composite structure could be completed by the 
infiltrating cells lying down on the collagen fibers. We propose some criteria to 
design bone materials that may share the remarkable toughness and self-repairing 
capabilities of the natural bone and the improved fracture resistance conferred 
by novel biopolymer-ceramic hybrid printing pastes. The 3D printing technology 
is thus suitable to address various bone pathologies, ranging from traumatic bone 
destruction to anomalous remodeling that occurs in osteoporosis. The results we 
presented here recommend the novel 3D structures as potentially biocompatible 
and support their use for further in vitro or animal model assays.
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